Drugs, personality, sleep and performance by Carruthers-Jones, David Iain
DRUGS, PERSONALITY, SLEEP AND PERFORMANCE
by
DAVID IAIN CARRUTHERS-JONES, B.Sc. (Psychol. London)
Thesis presented for the Degree
of Doctor of Philosophy in the
University of Edinburgh.
Summary
An attempt has bean r. do to study some of tho
disruptive effects of a variety of established and
now drugs on people, during both obr-nic administration
and witho-rawa. 1. A number of measures have boor, used
including performance tests, sleep '~TT, rolf-'rating
rv od scales and two personality scales- but relatively
less emphasis has been placed oh the sV ep 2HG measures.
Chapter 1 discusses the backer-un--' o research in
this area and out lines some of the pr bloms involved in
the prescription of drugs. Approcir:'-ion of the
hazards c>f over generous proscribing, in terms, of both
the psychological w Ifore of the pati« nt a.nd disruptive
side-effects, is increasing and official bodies have
boon established to assoso the full range of drugs*
effects in relation r their suitability for marketing.
Fcllov/ing reviews of earlier research on perfor¬
mance, sleep and subjective fooling states (Chapter 2)
and the methods logy (Chapter 3), nn a:cp- rimer/ is
described in which tho effects of three hypnotics were
compared in young adults (Chapter 4). Two newer
drugs, mesoridazine and Perlopine, were compared with
sodium amylobarbitone and placebo. Thanks to the
inclusion of the placebo group it was clear that
performance tended to improve, on moc:' tests, with
repeated testing, and that while administration of a
i
drug may- no :-, cause . largo dooromenin performance
. transformation of 'ho drug groups' t allow
."or ih.j placebo group oh ngos, may help o quantify
m.r - realistically he drugs' off :1s.
Tho value ?f ihi : study in .ti.n to real-life
is discussed in Chop'or b, Such rel r/..nsc is
important in experimental studios of this typo o.od
possible methods of improvement are suggested, including
the modification af xlsMng r.ts, h- i;rtr- -.'cation of
now onjs and the use of subjects in an ago group
similar that far which tho drug is most lively to
bo proscribed, Fr- n , r view of the literature, it
v/ae appa.vonl that thor may be quite different response
pa;tterns in different age groups on a variety of tests
and, therefore, "'ho most appropriate modification was
considered to be the use of subjects in an older age
group.
The first study using older subjects is described
in Chapter 5. Assessment of the effects of r.escri-
dcrine on seven subject's indicated little disruption
of either performance or sleep parameters during both
administration one withdrawal. However, examination
of the raw performance data, suggested inter-individual
differences in response to the administration of the
drug.
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Chapter 7 r:-vIr.'soaroh into inter-individual
forone ';3 in porf usnanc :• patterns. In Chrpler 3
—.trospsctivo :b.ya Is of p ri f ' h ■ 1 x from the
studies d&€6rib&d In Chapter? 4 and 6 is carried out:
results indicitc-1 that there might V- differences
between ext. reverts and introvert o, no assessed by the
".P.I. , in response "'"a run .ri 1 izine on1 that thin
effect might be consist of; ;ierase age groups.
Th? crite.rion for selection ... a subject in the
study, described in Ohapt or 9, woe an I-scale score of
at least one and h .If stand-,::;.! \v; \ ■ ' i.. ns ..bevo or
be lev/ the mean on F- m d. f the t'ysondc Personality
Inventory-. The aim war- to attempt to replicate,
uc?.ng a larger samplo, the findings described in
Chapter C. Although cone differences wore found
between the groups, n.-tably on subjective sleep
quality and morning vitality, these were not as clear
as expected on the performance measures and ivere
against the prediction on the subjective measures.
The effects of two preparations considered to
promote sleep, nitrazepam and Horliobs, were compared
in Chapter 10. Both improved sleep, objectively and
subjectively, and had little effect on performance,
even with continued administration.
Chapter 11 describes a pilot study of the effect
of a new hypnotic, tomazepan, on the sleep of three
iii
oj der subjects. Torsozoom incron-sod sloeo duration,
reduced sleep or net latency one' bed 15.+t le effect on
the ov roll preport. 3.on of stages PCM ~nd NRCM 34 -■.*
Subjective sioeo quality and nord wore initially
improved. Withdrawn7 produced a subjective
deterioration of feeling on all four scales. It.
reduced total siren tine and increased el nop onset
latency.
The- results of the studies, and their implica¬
tions, are discussed in Chapter 13, The suitability
and sensitivity of some of the tests employed are
evaluated in relation to +he findings of others and
pas sibio nod if5. o. a11one a re ou11ined.
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Life is a constant Interaction between organism
and environment. Change and stress may be transitory,
as in a disagreement with a friend or colleague, or there
may be difficulty in getting off to sleep, or stress may
be major as in the death of a close relative. Any stress
carries an emotional price-tagi recurring stresses may be
more than we can cope with.
Leslie Weatherhead, in his book, "Psychology in the
Service of the Soul", published in 1929, felt that stress
could be coped with by "having a cold bath ....
substituting the undesired or stressful mental picture
by a religious one .... and having a prayer".
Although possibly valid then and still for some
nowadays, this type of response to stress has become less
common and many people, especially in Western society,
try to cope with the variety of stresses, described by
Alvin Toffler in his book, "Future Shock", by taking
drugs. The drugs may be available generally, such as
alcohol and nicotine, or on prescription from a doctor.
The consumption of drugs meant to calm the nerves
and improve mood and sleep quality has risen
astronomically in recent years. In 1969 doctors in
Britain wrote over 13 million prescriptions for
barbiturates, 6 million for non-barbiturate hypnotics,
5 million for chlordiazepoxide, 5 million for anti¬
depressants, and a further 5 million for amphetamines.
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We are all aware of the beneficial therapeutic effects
that these drugs may have, but their side-effects have
been less well publicised and appreciated, even within
medical circles. It is important to ensure, however,
that a patient, while under treatment, is not adversely
affected or at risk in his daily life. If he is
affected, or at risk, then one problem is merely being
replaced by another, which may be more dangerous in that
its existence may not be fully recognised by doctor or
patient. In the late 1960's a small but growing number
of doctors began to appreciate the dangers of the
barbiturates and started a voluntary prescribing ban.
Yet still over one-half of all sleeping pills prescribed
are barbiturates. Prescribing of barbiturates fell
from 17.2 million prescriptions in 1965 to 13.1 million
in 1970. Non-barbiturate prescriptions rose, during
the same period, from 2.9 to 7.1 million. Ironically,
the main increase involved a new drug called Mandrax
which, it was gradually realised, was just as dangerous
as the barbiturates. The drug is particularly open to
overdose and abuse and there have been over 8,000 cases
a year of Mandrax and barbiturate poisoning. Prescrip¬
tion rates of Mandrax are now reduced in favour of a new
money-spinner, Mogadon, yet there is evidence that, while
Mogadon is not toxic (General Practitioners* Research
Group Rep. 79, 1965; Smith, 1966) or as abused as
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Mandrax, it can still cause a decrement in intellectual
and psychomotor performance for up to 24 hours after a
single dose is taken (Malpas, Rowan, Joyce and Scott,
1970).
Pressures of work and advertising make it
difficult for the doctor to consider the merits and
demerits of drugs and the welfare of his patients as
carefully as he would like. In 1973 drug companies
spent more money in Britain on advertising than on
research and the result is that doctors, deluged with
promotional material, too often prescribe blindly in a
jungle of competing products. In its 1966 annual
report the Committee on Safety of Drugs stated that it
was not concerned with efficacy of drugs except where
safety was involved. After admitting that it had
granted product licences to a number of "relatively
worthless" drugs, it went on to say that: "There are
some who believe that it is impossible to make this arti¬
ficial distinction between the efficacy of a drug and its
safety; others consider that responsibility regarding
efficacy must be left to the prescribing doctor and that
there is a limit to the extent to which the public should
be protected from spending their money on medicines as
long as they are not actually harmful".
This complacent attitude is now beginning to
disappear and the 1973 Annual Report of the Committee
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on Safety of Medicines, set up by the Medicines
Commission indicated that official attitudes are
hardening. But there is still a long way to go as
more than two-thirds of the drugs rated by the now
defunct Standing Joint Committee on the Classification
of Drugs as unacceptable on either grounds of safety
or efficacy are still being prescribed in Britain.
Reasons for this situation are not difficult to
find. Drugs continue to be promoted by brand name and
it is very difficult for doctors to obtain comprehensive,
independent and comparative information about drugs'
effectiveness. It has been a hallowed tradition in
medicine that any doctor must be permitted to prescribe
what he thinks best for his patient. This liberality
is admirable but it presupposes that the doctor in the
years since his graduation has remained informed,
educated and critical of each and every medical
preparation the industry has promoted; this promotion
being executed with ever-increasing pressure and skill.
Doctors, it may be argued, are not susceptible,
as are other mortals, to the wiles of the clever
advertiser but history suggests that clinical experience
is not always a reliable guide to efficacy. It took,
for example, hundreds of years to counteract the
clinical impression that bleedings, sweatings, vomitings
and purgings were beneficial and gold is still used by
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reputable medical scientists in the treatment of
rheumatoid arthritis. The modern drug jungle is
probably no less haphazard judging by the survey
commissioned by the Sainsbury Committee into doctors'
prescribing habits. Asked what they would give for
five common illnesses, a group of 463 practitioners
prescribed 30 different drugs for osteoarthritis,
35 for childhood eczema, 35 for acute adult diarrhoea,
40 for an acute attack of bronchitis, and more than 40
for a peptic ulcer. Several of the drugs have since
been rated by both British and American classification
bodies as either ineffective or potentially toxic.
Unfortunately two of the major recommendations of
the Sainsbury Committee have been ignored. The first
was that all drugs should be marked with their thera¬
peutic grading and that a comprehensive guide for doctors
of approved drugs should be published. The second was
that the Medicines Commission should be responsible for
this rating of drugs according to effectiveness.
In the United States a tougher attitude has been
taken to claims for drugs. In 1966 the Food and Drugs
Administration launched an evaluation study of more than
4,000 drugs which had been marketed before efficacy
requirements had been introduced. For each of their
drugs, the companies were instructed to submit evidence
of effectiveness including the relevant references.
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This would allow judgement of whether the claims made
could be substantiated. The panels placed drugs in
one of four categories. The top rating "effective"
was given where there was substantial evidence of
efficacy based on well-controlled trials. The next
rating was "probably effective". This was given to
those claims which were supported by research to some
extent, but on which additional evidence was required.
The third rating "possibly effective" where little
efficacy was evident though the panel thought there
was a possibility that such evidence could be developed.
The fourth rating "ineffective" was given to those drugs
for which there v/as no acceptable evidence of efficacy.
Seven per cent of the F.D.A. reviewed drugs received
this last rating, a ruling that enforced the removal of
the preparations from the market. Of the 4,369 drugs
reviewed, 41 per cent were rated as effective for one
or more condition but there v/as indisputable evidence
for only 19 per cent of the claims made.
Nowadays, the F.D.A. require evidence that a new
preparation has produced favourable results and no
unfavourable and dangerous indications in at least
four species, before that product can be marketed in
the United States. This has led to an increase in the
amount of research required and concurrently an increase
in interest in research into the effects of drugs on
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people's daily lives. The effects of drugs on sleep
patterns have been extensively researched in recent
years, as have the effects on performance in a variety
of tasks considered to employ some of the skills that
people use in their everyday life.
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CHAPTER 2
REVIEW OF MEASURES OF PERFORMANCE
An enormous variety of performance tasks have
been used by experimenters in their attempts to
differentiate between different categories of people
and different types of drugs. McNair (1973) in a
review of studies concerning the behavioural effects
of chlordiazepox ide, diazepam and meprobamate, and
rating the sensitivity of various measures* listed
43 different performance measures. McNair found that
only 10 measures showed significant results in at least
50 per cent of the studies reviewed par measure. He
did not go far enough, however, and neither examined
the methodology of any of the studies nor weighted for
the number of studies referring to each test. Had he
done so, doubts about even some of the supposedly more
sensitive measures might have been aroused for, first,
some of the methodologies are not clear and the
analyses are simplistic, and second, his rating is
given in some instances on the basis of reviewing only
one or two studies per measure, for example, in the cases
of the highly rated continuous performance and visual
threshold tasks.
Although there are so many different tasks, they
tend to fall into broad categories in attempting to
measure some particular component of the battery of
human skills. Thus some tasks, although different in
detail as a result of the experimenters1 theories,
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preferences and idiosyncrasies, will attempt to
measure dexterity, while others are used to measure
memory, decision-making, persistence, or vigilance.
Interest and research into the nature of vigilance
started long before its application in psychopharma-
cology until by now there is an extensive literature
including many books (Buckner and McGrath, 1963;
Sanders, 1967; Davies and Tune, 1970; Mackworth, 1969,
1970; Stroh, 1971; Kornblum, 1973). Mackworth (1950),
in his classic monograph, which reported the first
comprehensive experimental studies of vigilance perfor¬
mance, traced the historical antecedents of the subject
to Wundt, Helmholtz and James, but the term "vigilance"
appears to have been first used in a technical sense by
the British neurologist, Henry Head in 1923 and the
first field investigations focussing on the effects of
fatigue, boredom and monotony were carried out by V/yatt
and his colleagues (Wyatt and Fraser, 1929; Wyatt and
Langdon, 1932).
The development of radar in both Britain and the
United States, in the 1930's and 1940's, necessitated
a considerable amount of research into the human factors
involved in the detection of information presented on
radar displays. Ditchburn (1943) was one of the first
investigators of the psychological aspects of the
lookout's job. He was interested in rates of
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performance deterioration and concluded that a
lookout's vigilance began to deteriorate almost as
soon as he began the task and reached a minimum quickly.
This conclusion was supported by other researchers
using simulated radar and sonar tasks (Lindsley, 1944;
Solandt and Partridge, 1946). However, it was
Mackworth (1950), following an ingenious series of
experiments, who pointed out the theoretical as well as
practical implications of watchkeeping behaviour.
Mackworth examined the characteristics of the
conditions under which watchkeeping vigils were
conducted and noted that not only did the subjects
find the vigils prolonged, boring and inactive, but
they also found that signals, when they occurred,
were small, brief and difficult to discriminate.
With these factors in mind, Mackworth devised the Clock
Test which simulated the essentials of the radar
operator's task while allowing, at the same time,
strict experimental controls over the test situation.
Mackworth supplemented his Clock Test experiments
with two other studies, one concerned with a radar
display and the other with an auditory vigilance
task. Performance and decrement in these two tasks
were essentially similar to results in the Clock Test.
As a result of this extensive series of experiments,
Mackworth concluded that the decrement function was
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independent of modality and that central rather than
peripheral factors mediated performance.
Since 1950, a good deal of vigilance research has
been rationalised on the grounds that it is an area which
is directly relevant to radar-scanning, various military
observation tasks, the safe operation of vehicles and
many industrial situations. Whether or not there are
strict military or industrial applications vigilance
research continues to receive a considerable amount of
attention both from research theorists and from workers
interested in the effects of drugs.
Although a wide variety of techniques have been
employed in the study of vigilance performance most
researchers agree that the term 'vigilance tasks' refers
to a group of task situations having certain features
in common. Essentially a subject is required to respond
over relatively long periods of time to the occurrence
of infrequent stimulus changes. In the meantime there
is a stream of stimuli which have to be neglected while
the subject maintains "a state of readiness to detect
and respond to certain specified small changes"
(Mackworth, 1957). As J.F. Mackworth (1969) has
pointed out, this definition contains an ambiguity,
since a subject who is more 'ready' to detect a signal
may also be more 'ready' to think he has detected one
when in fact no signal occurred. A change in readiness
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may imply either a change in criterion or a change in
sensitivity or both. Both changes may in fact occur
in a vigilance task.
Correct detections is the response measure most
frequently used in vigilance tests. When vigilance is
low, detections are few, while when vigilance is high,
most of the signals will be detected. The type of
stimulus used as a signal can take virtually any form.
Generally the stimuli comprise one of two types. In
the first, stimuli are presented continuously or
intermittently. The target is the stimulus which is
slightly different from the majority. In the second
type the signal may consist of a discrete stimulus which
has been either added to or subtracted from the environ¬
ment. In this latter situation, changes in efficiency
with time on task do not seem to occur (Martz and Harris,
1961), but in a situation where target signals have to
be discriminated from non-target signals decrements do
occur with time (Mackworth, 1950).
Vigilance tasks can be divided into sensory and
cognitive types on the basis of the stimulus characteri¬
stics of the task, but whichever type is used the nature
of the signal is specified for the observer before the
task begins and a practice session is usually given.
Signals, which are usually brief and near the observer's
threshold, occur at irregular intervals although, in
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order to examine changes in performance over time,
the task is generally divided into sub-periods of equal
length with the same number of signals occurring in
each but at different intervals. Some vigilance tasks
lasting as little as 5 minutes have been used (Thompson,
Opton and Cohen, 1963) but tasks tend to be prolonged
and sometimes extend over several hours (Webb and Wherry
1960). An attempt is made to emphasise the boring and
monotonous nature of the task and as little extra-task
stimulation as possible is provided.
Factors influencing vigilance performance fall
into three broad categories; task, response and
responder factors. The first two categories will be
discussed briefly while some of the relevant responder
factors will be discussed here and others will be
discussed at appropriate points in later chapters.
There are several task factors involved in the study of
vigilance but some of the more important ones include:-
Signal Magnitude. The longer a signal lasts, and the
higher its energy level, the greater is the likelihood
of it being detected and consequently the performance
decrement with time on task will be less (Adams, 1956).
Mackworth and Taylor, 1963, found that signal duration
did influence the initial level of detection but not the
decrement, while Davenport (1968), studying the effects
of signal duration and signal intensity simultaneously
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within a factorial design concluded that performance
improved with increases in both duration and intensity.
Signal Distribution. Until 1960, almost all of the
research done supported the hypothesis that increasing
the number of signals improved detection performance
(Jenkins, 1953; Kappauf and Powe, 1959). A lot of
more recent research has also supported this position,
(Loeb and Binford, 1968; Broadbent and Gregory, 1965;
Martz, 1966), although some workers have reported the
opposite effect (Baker et al, 1962) and several studies
have detected no significant effect (Wilkinson, 1964;
Stern, 1966; Stroh, 1969).
Stimulus Frequency. This area has not received as much
attention as signal frequency. Generally, it has been
reported that vigilance performance improves as the
number of non-signal stimuli decreases (Jerison, 1965;
Taub and Osborne, 1968) although Budin (1966) reported
no significant effects and Stroh (1969) reported a
decrease in vigilance performance with decreased
stimulus frequency.
Siqnal-to-stimulus ratio. Several studies have
indicated that the ratio of target signals to non-
target stimuli is of great importance in vigilance
performance (Colquhoun, 1962; Jerison, 1966;
Johnston et al, 1966), although opposition has come
from Jerison (1965), Taub and Osborne (1968) and
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Gtroh (1969). Colquhoun (1962) has suggested that
signal probability, rather than the total number of
either signals or stimuli, is the important determiner
,nd this may in part explain the differences between his
studies and others. Colquhoun employed a small number
of non-signal stimuli so that the signal probability
was 0.5 vhereas the highest signal probability employed
by Jerison (1961) was 0.04, and by T ub and Osborne
(1968) was 0.06. Stroh (1969) employed signal
probabilities varying between 0,0017 and 0.17*
Task Duration. The major portion of any decrement in
performance takes place in the first hour of work
(Mackworth, 1950) but the degree of decrement is
related to several factors, including expected length
of time on task (Jerison, 1958) and anticipation of the
end of the task. Davis (1948) in a study of pilot
error noted that in the last few minutes of a long and
complex task performance deteriorated markedly,
possibly because the subject*s attention was pre¬
empted by factors other than the task. Most
vigilance studies, however, report the opposite result
(Alluisi and Hall, 1963; Bergum and behr, 1965;
Catalano, 1973).
Noise/irrolevant auditory stimulation* All reviewers
of the effects of noise on efficiency have noted that
noise may either improve, impair or have no effect on
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performance (Davies, 1968). It generally appears,
however, that difficult tasks involving noise of
higher pitch and intensity show greater decrement
(Broadbent, 1951, 1954, 1957).
Response Factors
Correct detections and ommission errors. Detection
rate has always been the most Important measure used
in studies of vigilance performance. The score is
usually either plotted against time or expressed as
a raw total score, sometimes in the form of a
percentage and sometimes as the probability of the
signal being detected. Omission errors represent the
number of signals the observer failed to detect. In
most vigilance tasks the detection rate declines with
time on task with the largest decline occurring in the
first half-hour. There Is evidence, however, that
decline begins from the very first signal, and that the
length of delay from the start of the task to the
first signal can be important.
Commission errors. A commission error is made when a
signal is reported when none in fact was presented.
In early studies false positive identifications were
ignored since few occurred. Alternatively omission and
commission errors were summed to form a composite error
score. Traditionally, commission errors have been
attributed to a "reprehensible tendency to guess" and
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changes in false positive rate were considered not to
be related to correct detections (Broadbent and
Gregory, 1963b). Other researchers have found positive
correlations between the two measures (Colquhoun, 1961).
Finally, it has been noted that within any experiment
the majority of commission errors are made by a
minority of the subjects and this has led to the
emphasis of individual differences in the generation
of commission errors (Wiener, 1963), possibly based on
different perceptions of the demand characteristics of
the task (Orne, 1962).
Decision criteria. Since the early I960's changes in
approach to the analysis of vigilance performance have
occurred. It was realised that false alarms are not
unimportant but that they are related to correct
detection and that correct detection and false positive
detection rates vary depending on changes in the
subjects' discrimination and criterion.
Signal detection theory is based on the assumption
that there is no finite threshold for detection of
signals. It suggests that there is an overlap between
the distributions of noise alone and noise plus signal
and that any particular observation might have come from
either distribution. The decision as to whether the
observer will accept an event as a signal is based on
the probability that the event is a signal and the values
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attached by the observer to the decisions that are
possible. An observer may be cautious and reserve
detection only for events he is certain about or he
may be lax and detect all the events he suspects are
signals as well as the ones he is sure about. With
this strategy he is more likely to obtain more correct
detections but he is almost certain to make more
commission errors as well. d' is the measure of the
subject's discrimination process, while beta is a
measure of the decision process. These measures are
derived from psychophysical data (Green and Swets,
1966) and are used in an attempt to specify whether
changes both in the number of correct detections and
the number of false positives reflect a change in the
sensitivity of the sensory system or a change in the
observer's criterion value.
Loeb and Binford (1964) examined changes in an
auditory vigilance task. Half second pulses were
separated by two second intervals. The signal was a
slightly louder pulse, which occurred 40 times in 80
minutes. The main change was an increasing strictness
of criterion (beta) but with little change in d'. A
later study, however, found a marked increase in d' on
an auditory task, suggesting some learning, which
improved sensitivity, between the first and ninth
sessions, as they also replicated the 'beta' increase
found in the earlier study (Binford and Loeb, 1966).
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Responder Factors
Responder factors are the patterns of response
obtained from subjects which are not the result of
manipulation of the task f ctors and experimenter-
imposed response requirements but of such things as
time of day, frequency of testing and age and
individual differences.
Time of day
Performance at the same task does not remain
uniform throughout the 24 hour period. Diurnal
variations in performance ippear to be associated
with the diurnal bo 'y temperature rhythm (Kleitman,
1933; Colquhoun, 1971b), simplistic representa¬
tion is the two-state hyp hesis. The 24 hour cycle
is divided into two phoses, the sleep phase and the
active phase. During the ~armer phase body tempera¬
ture, blood pressure, respiration rate and ur! ary
excretion are at low levels while during the latter
phase the levels are higher. It is only the peak
and the trough of the rhythms that coincide with the
phases, however, and oscillations continue throughout
the 24 hours. Generally, performance levels are
higher during the ' y but again there are oscillations
with some researchers finding performance peaking
around midday (Kleitman and Doctorsky, 1933) while
others have found a "post-lunch dip" which does not
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seem to be related to whether or not the subjects have
had lunch (Colquhoun 1971b). Recent work has related
differences in pattern of performance through the day
to personality factors and this will be discussed at a
later point.
Frequency of resting
The pattern of responding in terms of both
correct detections and commission errors changes with
repeated testing. The importance of pre-task training
has been highlighted by the work of Colquhoun and Baddeley
(1967) and Floyd, Griggs and Baker (1961)• Improve¬
ment is particularly indicated by a decreasing number
of commission errors which will be high initially but
will decline rapidly with practice (Bakan, 1955;
Gettys, 1964; Buckner, Harabedian and McGrath, 1960,
1965). Alluisi and Hall (1963), on the other hand,
found an improvement between the first and second
session but a decline in the fourth session, when
performance was the same as in the first session.
Mackworth (1950) found that the initial level
of detection in the three tasks that he studied was
lower in the second session while Buckner, Harabedian
and McGrath (i960, 1965) using an auditory vigilance
task found that there was a decrease in performance
from day to day. Binford and Loeb (1966) found a
considerable improvement in detections from session
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to session with false alarms high initially but
rapidly decreasing. Binford and Loeb suggested that
several changes take place in a vigilance task with
repeated testing. Changes in criterion occur mainly
in early sessions, while subjects are adjusting their
criterion to suit the signal probability that they
find. Once learn.ing has reached a maximum, a
decrement in detections will still occur and the extent
of this will be influenced by a variety of factors,
including drugs, noise, fatigue and distraction.
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THE EFFECTS OF DRUGS ON
MEASURES OF PERFORMANCE
The effects of drugs on measures of performance
^arly research into, and theories of, drug action
in performance tendod to differentiate only between
stimulants and depressants. It was assumed that the
extent and type of effect of iifferent drugs in the
same category would be similar. Thus in vigilance
performance the normal pattern is one of decreasing
detections and commission errors. Stimulants were
considered to maintain detection rate while not
affecting the false positive detection pattern.
Depressants, on the other hand, were considered to
reduce detections and increase or stabilise false
positive detections, thus indicating a reduction in
sensitivity (df) through the session.
Steinberg (1954) suggested that central
depressant drugs may act selectively to impair newly
acquired rather than well-established behaviour, and
will show a greater effect on performance with greater
complexity of task. While leading in the right
direction the diversity of drugs and their pharmaco¬
kinetic effects had still not been recognised. Thus
diversity goes beyond not only differentiation into
stimulants and depressants but also beyond divisions
of tranquillizing agents and hypnotics and indeed drugs
prescribed for similar symptoms may have quite different
actions. Linnoila and Mattila (1973a) point out such
differences between diazepam and chlordiazepoxide.
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Barbiturates
Von Felsinger, Lasagna and Beecher (1953) found
impaired performance on a battery of psychological
tests including tasks of visual perception, attention
and computation between 51A and 7% hours after a small
dose of pentobarbitone sodium (100 mg.). Support for
these results came from a study which showed that
pentobarbitone significantly reduced a mean detection
rate compared to a control group (Talland and Quarton,
1966). Kornetsky, Vates and Kessler (1959) compared
the effects of another barbiturate, quinalbarbitone
(100 mg. and 200 mg.), with chlorpromazine (100 mg.
and 200 mg.). Examination of the hypnotic and residual
effects on performance showed that 15 hours post-
medication there was significant impairment on a digit
symbol substitution task, symbol copying and tapping
speed for both doses of chlorpromazine and the higher
dose of quinalbarbitone.
In later studies, involving one of the above
authors, quinalbarbitone was found to have caused a
greater performance deficit on an unpaced digit symbol
substitution task than did chlorpromazine, with the
opposite being true on a paced version of the DSST and
the continuous performance task (Kornetsky and Orzack,
1964; Mirsky and Kornetsky, 1964).
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Talland and Quarton (1965) found small but
reliable barbiturate effects with both simple and
choice visual reaction time tests. These results
were supported by Frankenhaeuser and Post (1966).
Low doses of barbiturates, i.e. less than 100 mg.
have generally been considered to have little
deleterious effect on psychological tests. However,
it has been shown that amylobarbitone (60 mg.) can
depress critical flicker froquency (Turner, 1965) and
that amylobarbitone (50 mg.) can have an adverse
effect on performance in a one-hour vigilance task in
which the subjects were required to distinguish two
different tones (Bye et al, 1974). A 100 mg. dose
also caused a lengthening of simple auditory reaction
time.
Barbiturates tend to potentiate the effects of
alcohol. A study of performance on a typing task
found that phenobarbitone (150 mg.) slowed performance
and reduced errors and that alcohol speeded performance
and increased errors, while the two together speeded
typing still further and further increased errors
(Joyce et al, 1959).
Miller (1962) studied the effects of pheno¬
barbitone (30 mg.) three times daily for 6 days.
Under simulated driving conditions subjects were re¬
quired to brake on the appearance of a red light.
The barbiturate caused slower reaction times.
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Tranquillizers and, hypnotics
In recent years there have been an increasing
number of drugs of this type, which have been gradually
gaining ground in competition with the barbiturates,
both for the relief -C nxi 'y and, at higher dose
levels, th induct*' of * . They h ive been
generally considered to be safer than barbiturates and
theoretically the administration of such a drug should
enhance 'riving an' h r skill• 1 p " rraanco in hyper-
anxious p ' ients. a '.he thor hand, reduced nxiety
with drug-taking nay reduce ggrossi: thresholds and
uncontrolled behaviour may ecur whore it did not
before (Lynch et il, 1975; ahworth, 1975).
Malpas at \1 (1970) compared the effects of
single ' * as f nitrazepam (5 or 10 mg.), amylo-
barbltone (100 or 200 mg.) or placebo in normal healthy
subjects who took the treatment before going to bed in
their own hones 1 /'.ten1' ' ' h labor atcry for sting
next day. 'nsescr a' v//o by al/ep quastiennair:,
subjective mood scale, card-sorting and dfG. Subjects
did not report morning hangover effects after any
treatment and rated themselves having had a better
night*s sleep after the high loses of both drugs than
after pi c::' . 7 ' lingo " 'r • / i aess
were reported ifter ry 'rug treatment but decision
bin In 'h -g ' ' /:\s 'Ignlf 1 a antly '.owed
af' or b/'h '/-ago in " ■ 1 ;~j ' - ' *':sr be
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.lower dose of amylobarbitone In the complex part of
the task for up to 17 hours after treatment. Malpas
et al concluded th the effects of nitrazepam are at
least as prolonged as those f amylobarbitone and
pointed out that certain kinds of performance may be
significantly slowed the next day even though the
subjects may be unaware of this.
Malpas (1972) examined the time course of the
sedative effects of nitrazepam (5 or 10 mg.) and
amylobarbitone (100 or 200 mg.) with particular regard
to the times of onset of drug effect and the times of
maximal effect. Card-dealing and digit symbol
substitution tasks and subjective ratings were used in
assessment. Results on the objective tests showed a
marked dose-related, effect on both drugs with nitrazepam
having effects more marked than those of amylobarbitone.
The two drugs were subjectively rated as similar at the
high doses with clear dose-related differences for
amylobarbitone. However, subjects seemed unable to
differentiate between the two doses of nitrazepam and
it was suggested that a subject's willingness or ability
to judge his state accurately may be more impaired by
nitrazepam than by amylobarbitone.
Malpas and Joyce (1969) examined the effects of
nitrazepam (5 or 10 mg.) and amylobarbitone (100 or 200
mg.) on card-dealing, card-sorting and digit symbol
substitution (DSST) when the subjects had had a light
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meal before attending the laboratory. The slowing
effects of the larger dose of amylob ~rbitone were not
apparent until 90 minutes after administration, whereas
the effects of nitrazepam wore clear it 30 minutes.
This is in contrast to a later study where the effects
of amylobarbitone appeared after 30 minutes and those
of nitrazepam after 30 minutes (Malpas, 1972).
Bond and Lader (1972) tested normal subjects on a
battery of physiological and psychological tests twelve
hours after a hyponotic dose of butobarbitone sodium
(100 and 200 mg.) or nitrazepam (5 or 10 mg.) and
compared with a placebo. The tests used included
self-ratings, the Gibson spiral maze, cancellation,
arithmetic, tachistoscopic number recognition, reaction
time, tapping, card-sorting, the digit symbol substitu¬
tion test and several electrophysiological measures.
There were clear differences between the drugs and placebo
in several tests. At the lower dose levels nitrazepam
caused more impairment than butobarbitone but at the
higher doses, where effects were marked, there was little
difference between the drugs. It seemed that the
impairment was greater in the motor aspects of perfor¬
mance. Tapping rate and the motor aspect of the card-
sorting task was severely impaired, while reaction time
was prolonged. However, while digit symbol substitution
decision-time, card-sorting and arithmetic were affected
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the decrement was smaller. Self-rated quality and
onset of sleep were affected by both doses of both
'rugs. Both doses of nitrazepam and the higher dose
of butobarbitone induced significant!y greater feelings
of sleepiness on wakening but only the effect of the
latter lasted until the testing session.
Bond and Lader (1973) examined performance on a
battery of tests 12, 15, and 18 hours after a hypnotic
dose of butobarbitone (150 mg.), flur zooam (15 or 30
mg.) or a placebo. The measures included subjective
self-ratings of sleep quality and onset, and feeling
on wakening, and tests of auditory reaction time,
complex visual reaction time, tapping, cancellation,
card-sorting, symbol copying and DSST. DSST was most
affected and was significantly impaired by both drugs
at the first testing. The symbol copying task was
affected for a longer period but only by flurazepam.
It was suggested that flurazepam exerts a motor impair¬
ment while butobarbitone affects the cognitive element
of the DSST. The conclusion about the effect of
butobarbitone appeared to conflict with results in an
earlier study where greater emphasis was placed on the
detrimental effect that the barbiturate had on the motor
aspects of performance (Bond and Lader, 1972).
Both flurazepam and butobarbitone exerted an
adequate hypnotic effect but caused sleepiness on
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wakening. Subjects rated themselves as having felt
more alert after taking pi cobo, nor discontented
after butobarbitono, and more relaxe ' ..nd calm after
flurazepam. It was concluded that flurazepam had
affects similar to nitrazepam in that the subjective
effects were less unpleasant than the barbiturate,
but the disruptive effects lasted longer.
Adams (.1974), using the same drugs and dose
levels as Bond and Lader (1972), assessed performance
the following day on a variety of tasks including
short-term memory, proof reeling, concept identifica¬
tion, visual search and lines classification. A
significant drug effect was found only on the memory
task and then only with the higher dose levels of the
drugs. Despite the fact that no subjective or EEG
evaluations were made it was suggested that the results
indicated that the effect of the drugs on performance
resulted from a deterioration in quality of the
induced sleep. Bond and Lader (1972), using psycho¬
motor, subjective and EEG assessment, in the examination
of such a hypothesis, found no relationship between
sleep quality and subsequent performance.
Jaatala et al (1971) examined the effects of
another benzodiazepine, diazepam, on subjective and
objective measures. Subjective effects of the drug
were marked with an increase in "euphoria" in men and
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in "depressivity" and "withdrawing" in women.
Diazepam impaired performance on a DSST and also
affected the ability to repeat numbers series in both
sexes.
Chlordiazepoxide, in single doses of less than
40 mg., in several studies, has shown little effect on
psychomotor performance or driving skills (Idestrom and
Cadenius, 1963; Kielholz et al, 1967, 1969; Austen et
al, 1971). Higher doses have caused reversible eye
muscle imbalance and impaired perception (Murray, 1961).
Diazepam (Valium 2.5 mg. and 5 mg.) has been
shown adversely to affect vigilance (Bye et al, 1974)
and to increase the adverse effects of alcohol
(Myrsten et al, 1967).
The study of the effects of tranquillizers and
hypnotics on performance patterns is only beginning
and while the effects of these drugs in interaction
with alcohol has been even more limited, the practical
importance is evident. Linnoila and his colleagues
in Helsinki have taken a lead in undertaking large-
scale studies into the effects of a variety of drugs,
alone and in combination with alcohol, on performance
tasks and simulated driving skills. The performance
tasks included tests of choice reaction, co-ordination
and divided attention.
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Linnoila and Mattila (1973a) found that diazepam
alone shortened reaction time and reduced the number of
mistakes on a choice reaction test. When it was given
in combination with alcohol, however, all parameters
measured were markedly impaired without similar loss
in subjective capacity of performance. In the
simulated driving test diazepam increased collision
frequency and neglect of the rules, coupled with
serious steering errors, and a reduction in tachycardia
induced by an emergency situation (Linnoila and Mattila,
1973b).
Chlordiazepoxide (10 mg. and 25 mg.) caused dose-
related reductions in reaction time and had little
effect on co-ordination (Linnoila and Mattila, 1973a).
In combination with alcohol there was little enhancement
of the alcohol-induced impairment of attention, reaction
time, reaction errors and co-ordination performance.
The differences between the effects of diazepam and
chlordiazepoxide were suggested to be related to the
pharmacokinetics of the two drugs since the former is
more rapidly absorbed. The lack of potentiation of
alcohol is in support of other reports (Frankenhaeuser
et al, 1965; Dundee, 1969).
Nitrazepam (10 mg.) did not modify skills
significantly when used as a hypnotic with testing 10
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hours after administration. When tested in
combination with alcohol, subjects were still
unaffected but attention was impaired after 30,
90 and 150 minutes (Linnoila and Mattila, 1973a).
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Tricyclic antidepressants
Antidepressants have been found to be a
potential danger to drivers, since patients taking
tricyclic antidepressants have commonly found small
doses of alcohol have caused very strong effects
(Ashworth, 1975). Amitrityline (8 mg./kg.) has
potentiated the adverse effects of alcohol on normal
subjects, while the drug alone produced a decrement
on the pursuit rotor task (Landauer et al, 1969;
Milner and Landauer, 1971).
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Phenothiazlnes
Most research falling into this category has used
chlorpromazine (CPz). The limited amount of research
there has been has underlined the paradoxical situation
of testing drugs in normal subjects when the drugs are
intended for abnormal populations. In all the studies
examining the effects of CPz on schizophrenics,
performance improved when the drug was administered,
while when CPz was administered to animals and normal
humans a performance decrement occurred.
Gilgash (1961) showed improvement in intellectual
functioning with CPz administration in catatonic
schizophrenics, and Daston (1959) found an improvement
in Wechsler Memory Scale subtests with chronic
schizophrenics. Similarly, prochlorperazine has been
found to improve performance on the Wechsler Digit
Symbol and Digit Span subtests (Lehmann, 1959).
In animal research, Wilson (1965) found that CPz
reduced detections by monkeys to a very low level, and
Kornetsky and Bain (1965) found that CPz reduced the
responding rate of rats in a kind of vigilance task.
Brimer, Schnieden and Simon (1964) examined the
effects of CPz (50 mg.) and chlordiazepoxide (10 mg.)
on tests of judgement of conceptual relationships.
They found greater decremental effects with CPz than
with chlordiazepoxide.
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Kornetsky and Orzack (1964) and Mirsky and
Kornetsky (1964) found that although a group given
chlorpromazine performed better than a group given
quinalbarbitone on an unpaced version of the DSST,
the chlorpromazine group performed at a poorer level
on a paced DSST task on a CPT.
Loeb et al (1965) found significant decreases
in sensitivity during an auditory vigilance task with
a group cf subjects given chlorpromazine.
Milner and Landauer (1971) studied the effects
of chlorpromazine and alcohol on pursuit rotor and
choice reaction performance. Chlorpromazine
(l mg./kg.) caused deterioration in performance levels
next morning and potentiated the deleterious effects
of alcohol on the pursuit rotor.
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Amphetamine and other stimulants
Amphetamines generally improve vigilance perfor¬
mance. Loeb et al (1965) found that although there
was no difference in the initial level of detection,
the usual decrement with time on task did not occur.
Mackworth, J.F. (1965), using only a visual vigilance
task and interpreting the data using signal detection
theory, also found the initial level unchanged and the
progressive decrement reduced after amphetamine.
Talland and Quarton (1966) showed an absolute
improvement in performance on a visual vigilance task
in a group given methamphetamine (15 mg. per 150 lb.
body weight). Other researchers using a smaller dose
(5 mg.) found little effect (Neal and Pearson, 1966).
Even though amphetamine has the effect, at least
at higher dose levels, of inhibiting the appearance of
a performance decrement it appears to have little
effect on commission errors (Hearst and Whalen, 1963;
Mackworth, 1965; Loeb et al, 1965; Neal and Pearson,
1966).
Talland and Quarton (1965) failed to find an
amphetamine effect with either a simple or choice
visual reaction time task. Frankenhaeuser and Post
(1966), on the other hand, found a clear effect on
simple visual reaction time.
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Trumbo and Gaillard (1975) compared the effects
of an amphetamine, phentermine (20 mg.) and a
barbiturate, hexobarbital (600 mg.), on visual and
auditory serial reaction time and found that the
amphetamine effect was specific to visual RT and
occurred only when time uncertainty was maximal.
The barbiturate effect was specific to auditory RT,
and was independent of the amount of time uncertainty
involved. These differences were explained by the
hypothesis that the barbiturate may have reduced the
immediate arousal properties of the auditory signals
whereas the amphetamine facilitated performance by
enhancing the subjects' ability to maintain recepter
orientation, attention to the task and motor
preparation.
Brown et al (1974) examined the effects of
amphetamine (10 mg.) and fenfluramine (30 mg.) on
tapping, reaction time, digit symbol, card-sorting
and cross-out tests. It was hypothesised that
amphetamine would increase speed and decrease
accuracy, that fenfluramine would decrease scores,
and that a combination of the two would produce
performance patterns lying between the two extremes.
Subjects performed before drug administration and at
45, 90, 150 and 210 minutes after ingestion.
Findings revealed significant differences between
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amphetamine and fenfluramine but no consistent
differences between fenfluramine and placebo.
Performance in the combination condition was
similar to that under amphetamine alone.
Amphetamine, in a single therapeutic dose,
temporarily increases alertness but large doses
may produce irritability and inability to concentrate.
Residual effects include tiredness and depression.
These effects have implications for driving and other
skilled performance requirements. Preliminary results
of work at the Road Research Laboratory suggest that
consumption of amphetamines may cause greater disrup¬
tion than alcohol (Ashworth 1975) and a Canadian study
found that people taking amphetamine either alone or
in combination with other drugs had higher than
average accident rates for their age, sex and driving
experience while those dependent on barbiturates or
tranquillizers had lower than expected rates (Smart
et al, 1969). It has been suggested that the latter
finding is due to a disinclination to drive after
taking the drug (Ashworth, 1975).
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Alcohol
The effects of alcohol, although dependent on
age, personality and setting, are secondary to central
nervous system depression. This characteristically
includes dose-related increasing impairment of thought
processes and decreased mechanical efficiency. Evans
et al, (1974) used a series of doses of alcohol
calculated to produce a blood alcohol concentration
of 0, 25, 50, 75 and 100 mg./o and evaluated psycho¬
motor impairment and subjective impression. Per¬
formance on all measures, including pursuit meter,
wobble board, delayed auditory feedback and a modified
Cornell Medical Index, showed a linear dose-related
deterioration.
Lewis (1973) administered two different dose
levels of alcohol and assessed performance on card-
sorting, hand-eye co-ordination and problem solving
of differing degrees of complexity. On the easy tasks
there were no significant differences between the drug
and control groups but on the more difficult tasks a
dose-related decrement was found.
Moskowitz and DePry (1968) examined the effect
of alcohol on auditory detection under conditions of
concentrated and divided attention. The two tasks
were presented binaurally, one required the detection
of a tone and the other required the recall of six
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digits. The concentrated attention condition
involved the performance of one of the tasks while
the other was ignored: the divided attention task
involved performance of both tasks simultaneously.
An alcohol treatment of 0.52 gms. alcohol/kg.
bodyweight did not impair performance of either
task under the concentrated attention condition but
division of attention severely impaired accuracy.
A more recent study has examined the effect of
alcohol on division of attention in the visual
modality (Moskowitz and Sharma, 1974). Subjects
were required to fixate on a central light while
attempting to detect signals in their peripheral
field of vision. The central light, under the three
different information load conditions, either remained
constant or blinked at one of two different speeds
with the subjects being required to report the number
of blinks that had occurred in a twenty-second trial.
The peripheral lights were presented at any one of
thirty-two different positions at angles ranging
from 12 to 102 degrees. Results were similar to
those in the previously reported study since the
simplest test condition showed no alcohol-induced
impairment of detection. Furthermore, inaccuracy
increased as a function of increasing Information
processing demands, with the deficit being unevenly
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distributed between the tasks and the greater
impairment being in peripheral detection.
Hockey (1970) demonstrated that the deficit is not
intrinsically in peripheral detection but is related
to attentional priorities established by training or
by the conditions of the experiment.
These data suggest that performance of practical
tasks requiring the co-ordination of information from
a diversity of sources will be deleteriously affected
if a subject has received alcohol. The effect of
alcohol on driving skills has been studied by several
researchers and it has been mainly conducted using
simulators. The assessment of impairment in real-
life driving situations has been rare (LeDain et al,
1972; Klonoff, 1974).
Generally, in assessment on a simulator, per¬
formance has been affected in a manner similar to
that found on the tests already mentioned. Drew,
Colquhoun and Long (1958), testing the effects of
small amounts of alcohol found "impairment followed
absorption of alcohol into the blood stream such
that the larger the blood alcohol level, the larger
the effect". There was no sign of a threshold
level which had to be exceeded before impairment was
manifested.
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Moskowitz (1971) described two experiments
examining alcohol-induced impairment in simulator
performance. In the first, most of the information
came from a film projection on a screen, while in the
second a subsidiary task was added. Although in both
studies the average peak blood alcohol level was 0.085%
there was no alcohol effect in the first study; in the
second, however, there was a marked and significant
impairment on many of the performance assessment
measures and an increase in within-subject variability.
The studies of Linnoila and his colleagues in
Helsinki, Into the effects of alcohol on a variety of
skills including choice reaction, co-ordination and
divided attention as well as driving skills, have
already been mentioned. Simply, a decrement on the
tests was found when alcohol alone was administered
and this interacted with some of the other drugs
tested to increase impairment and errors even further
(Linnoila and Mattila, 1973a,b).
From an early date attempts have been made to
assess the effect of alcohol in driving skills.
Epidemiological studies have compared the accident
rates of drivers taking alcohol with those of non-
drugged drivers. Borkenstein (1963) conducted a
survey of over 10,000 subjects and calculated that
a driver with 60 mg./lOO ml. blood alcohol
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concentration was twice as likely to have an
accident as a sober driver. Goldberg and Havard
(1968) have suggested that the probability is six
times greater at 100 mg./lOO ml. and twenty-five
times higher at 150 mg./lOO ml.
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Marihuana
A number of studies have reported the effects of
marihuana on vision. Significant decrements have
been demonstrated on autokinesis (Sharma and
Moskowitz, 1972), central vision signal detection
(LeDaln, Campbell, Lehmann, Stein and Bertrand, 1972),
and peripheral signal detection (Moskowitz, Sharma and
McGlothlin, 1972).
Caldwell, Myers, Domino and Mlrriam (1969) found no
effect on auditory absolute, differential frequency and
amplitude thresholds under conditions where subjects
controlled the levels of mar5.huana consumed.
Moskowitz and McGlothlin (1974) controlled the
amount received and subjects received 0, 50, 100 and
g
200 pg -4 -THC per kg. bodyweight. There were two
conditions of signal detection. In the concentrated
attention condition subjects were required to detect
the presence or absence of a tone in a three-second
burst of white noise. In the divided attention
condition subjects had to repeat a series of 6 digits
presented simultaneously with the noise burst.
Significant dose-dependent decrements were obtained
under both experimental conditions. Signal detection
theory analysis indicated a dose dependent reduction in
sensitivity (d')» independent of change in the subjects
detection criterion (B), with a tendency to an increase
in false positive identifications.
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Evans et al (1973) examined the effects of
different dose levels (0, 3, 6, 9 jug per kg. of
^ -THC) on performance and found a linear decrement
in stance stability hut n~ bo so-relat ed impairment
of mental performance, as evaluated by delayed
auditory feedback, or hand-eye co-ordination,
although in the latter t r.k there was an impairment
when comparing placebo against drug.
Kiplingor et al (1971), on the other hand,
demonstrated a doso-related linear decrement in
both psychomotor and mental performance. They
used higher concentrations (0, 6.. 25, 12.5, 25
and 50 jug per kg. THC). Other studies by the same
group of researchers support these results (Manno,
Kiplinger, 3cholz and Forney, 1971).
Casswell and " rks (1973) studied the effects
of marihuana on a divided attention task and on
driving in a simulator in both naive and experienced
smokers. 1 decrement was found in both groups on
the attention task jhile no decrement was found in
the simulator.
Other studies on the drug's effects on driving
skills have shown clear -detrimental effects.
Rafaelson et al (1973) studied the affects of both
cannabis and alcohol and found that both drugs
increased the time required to brake and start,
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while alcohol increased and cannabis decreased the
number of gear changes.
Klonoff (1974) examined the effects of marihuana
in low and high doses (cigarettes contained either
4.90 mg. *2?-THC :• 8.40 mg. ^i^-THC) en driving
performance in both a restricted traffic free area
and during peak traffic flow hours in a city centre.
Klonoff concluded that marihuana does have a
detrimental effect on driving skills, especially
under normal city street driving conditions and at
night.
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A REVIEW OF MEASURES OF SLEEP
With the developing use of the electro¬
encephalogram sleep research was able to move away
from reliance on motility and estimates of sleep
latency, quality and duration. At first, stages of
sleep v/ere based on the presence or absence of alpha
rhythm and the amount of high voltage slow wave
activity. However, the major discovery resulting
from the use of all-night EEG was that sleep is not a
unitary state but comprises two separate types.
This realisation arose from the pioneering work of
Aserinsky, Dement and Kleitman (Aserinsky and
Kleitman, 1953, 1955; Dement and Kleitman, 1957).
There are available several reviews of the physiology
and psychology of the two types of sleep (Oswald, 1962;
Jouvet, 1965; Koella, 1967; Freemen, 1972).
The two sleep states can be differentiated by the
EEG, but usually two other polygraphic variables are
used as well. These measure changes in chin muscle
tension and eye movements. The two sleep states are
commonly known as REM (rapid eye movement) and NREM
(non-rapid eye movement). The former type is
characterised by low voltage EEG with rapid, jerky
movements of the eyes occurring in intermittent bursts
and commonly preceded by a second or two of 2-3 c/sec
"saw-tooth" v/aves. Chin EMG is almost absent,
respiration is variable and shallow, heart rate is
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rapid and blood pressure is variable. If subjects
are wakened from RIM sleep they generally describe
their immediately preceding mental life as dream¬
like and vivid.
NREM sleep contains BEG slow waves, spindles
and K-cornplexes. There is slow, regular respiration
and heart rate. Blood pressure is irregular and the
chin EMG decreases from wakefulness. Eye movements
are either non-existent or slow and rolling. Mental
life has been described as thought-like and repetitive.
This state is customarily divided into stages 1, 2, 3
and 4 (Rechtschaffen and Kales, 1968).
Discussion about the need for and the value of
sleep, has taken place since the time of Hippocrates,
and continues today. Some consider sleep to be
vestigial in humans and produce as evidence, people
who seem normal yet need little sleep but generally
sleep is considered to be necessary since it occupies
such a large proportion of our existence and since it
is generated by active brain stem mechanisms (Jouvet,
1972). It seems that rather than being a passive
state due to the loss of waking stimuli, it exerts a
major role in central nervous systems functioning,
and REM sleep is additionally intriguing since
firstly, the neural activity of the brain is at levels
equal to that of aroused waking (Hobson and McCarley,
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1971) and secondly it shows a unique ontogenetic
pattern of greater occurrence in infancy and least
occurrence in old age (itof'Ewarg, Muzio and Dement,
1966).
bleep may be considered to be homeostatically
regulated since deprivation leads to compensation.
Total sleep deprivation leads to an excess of REM
sleep on recovery nights. However, this is not
usually manifested until the second recovery night,
while the first night ox undisturbed sleep shows an
excess of stage 4 (Berger and Oswald, 1962). This
is suggestive of restorative priority.
Selective deprivation of stage 4 sleep leads to
excess on subsequent recovery nights (<ignew et al,
1964). Restriction of sleep to 5 hours nightly
for several nights led to an absolute increase in the
duration of stage 4 in preference to compensation of
stages 1, 2 and 3 which are more common in the later
part of the night's sleep (Dement and Greenberg, 1966).
This led to the suggestion that stage 4 is "worth more"
than stage 2. REM sleep deprivation leads to a
compensatory rebound, as well (Moruzzi, 1969).
Dement (i960) woke subjects every time a REM period
started and kept them awake for 2 minutes before
allowing them to go back to sleep. Since NREM
sleep normally precedes REM sleep, REM deprivation
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occurred. When normal sloop was allowed on
subsequent nights a REM rebound occurred with a
gradual return to baseline levels after several
nights.
In the cat, normal REM time is about 15% of
total recording time but REM rebounds as high as
40% have been reported following deprivation
(Jouvet, Vimont and Delorme, 1965). The amount
of REM rebound has been found to be directly pro¬
portional to the amount of REM sleep lost during
the deprivation period (Jouvet et al, 1964). Also,
during deprivation the number of attempts to enter
REM sleep increases dramatically after only a few
hours (Stern and Morgane, 1974) and the intensity of
REM sleep, as measured by eye movement density and
muscular twitches, also increases (Dement, 1967).
There is, therefore, evidence that both kinds
of sleep are necessary. Disruption of the normal
patterns could be considered to be undesirable since
it immediately leads to attempts to compensate for
the losses whether they be general or specific.
Initially the rebound Is large but with time it
reduces until the normal pattern has been regained.
Given acceptance of this point of view, it is
not unreasonable to suggest that if a drug were to
distort the normal proportions of the two kinds of
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sleep the effect could properly be regarded as an
adverse or undesirable one. There h .s been,
therefore, an incr so in the amount o" research
into the effects of 'rugs on .loop !terns.
There has been interest especially in the drugs
/h" h help y.eopl t sleep r, in smaller doses,
to reduce anxiety. The mushrooming of this area
of research has been called n "ever increasing
* hypnop 1e thora * (".sell., 1967).
There are several problems endemic in sleep
research. The expense and laboriousness of all-
sight polygruphy limits the number of subjects and
the number of nights monitored in iny single study.
The diversity of results from different 1 boratories
even when using the sam drug could be attributed to
a variety of cause inclo 'ing different dose levels,
insufficient numbers of subjects, insufficient
acclimatization to the laboratory, designs testing
the effects of different drugs on consecutive nights
and the taking of unmonitored naps or surreptitious
drugs.
The effects of different dose levels of
chlorpromazine on sleep are varied. Low doses
increase REM, high doses depress REM, and intermediate
doses show no change in sleep stage percentages
(Lewis and Evans, 1969). The construction of that
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traditional pharmacologic:1 tool, the dose-response
curve would be appropriate but using human subjects
would involve an enormous amount of recording.
It is difficult also to get th right sort of
subjects and persuade them to abstain from alcohol
or other social drugs for any length of time
(Mellinger et al, 1971).
The *non-independence of successive nights'
effect was first described in addicts (Oswald and
Thacore, 1963) and confirm experimentally by
Rechtschaffen and Maron (1964) and Oswald and Priest
(1965). Brannen and Jew ti (1969) .dministered two
phenothiazines on successive nights ;lternately.
They concluded that promethazine had little effect
while trifluoperazine increased REM, The validity
of this conclusion Is doubtful since it was impossible
to differentiate between one of the drugs' pharma¬
cological action and the amount of compensation
occurring as a result of the action of the drug
taken the previous night.
Only a small number of research workers have
studied the effect on sleep of both repeated
administration and withdrawal of a drug. Generally,
any initial disruption reduces with time and sleep
patterns return towards normal but the degree of
disruption and the speed of return to normal differ
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with different drugs. These factors and the
effects of withdrawal are important points to
consider in relati n to the therapeutic use of the
drug,
A further problem is that most studies use
healthy normal volunteers. I.t is probable, however,
that effects such as anxiety or depression will inter¬
act with a drug to modify the drug's effect on sleep
(Akindele et al, 1970). tkindele (1969) noted that
in normal subjects phenelzine increased stage 2 sleep,
while in a depressed patient the amount of stage 2 was
initially depressed but later recovered to above pre-
drug levels with an eventual return to normal. In
another experiment using phenelzine, two normal
volunteers showed a fall in percentage REM sleep with
a marked withdrawal rebound. Three depressed women
subjects, however, showed total REM abolition (coupled
with greatly improved mood) after a week on the drug
(Akindele, Evans and Oswald, 1970). In this study
there was prolonged inhibition of REM sleep, a
function generally thought to be essential. The
smallness of the REM rebound on withdrawal urges
reconsideration of the hypothesis that the REM type
of sleep is a time of special Importance for cerebral
protein synthesis (Oswald, 1969). It may be that






Oswald et al (1963) were the first to study the
effects of barbiturates on sleeo in depressed patients.
REM percentage was found to fall from 20.6o/ on placebo
nights to 14.S?7 on nights "/hen heptabarbitone (400 mg)
was given. Age matched con+rol subjects showed a drop
from 23, 3?.' to 11.3?' and in both groups there was a drop
in the number of eye movements per unit time. The
increase in NREM sleep was distributed over all four
stages. Baekeland (1967) using pentobarbitone con¬
firmed the depression of REM but pointed out that the
periodicity in the cyclic alternation of the two kinds
of sleep appeared to be unaffected so that REM appeared
when expected but was of shortened duration. Again
the NREM increase was distributed across the four stages.
Other studies with barbiturates have shown the NREM
increase going to only one stage. Lester and Guerrero-
Figueroa (1966) studied both phenobarbitone and
thiopentone and found that both drugs increased the
percentage of stage 4 sleep. '.Villiams and Agnew (1969),
however, found decreased REM and increased stage 2 with
pentobarbitone. This result was supported by a study
using amylobarbitone (Haider, 1969).
Longitudinal studies on the effects of drugs are
costly and time-consuming. Consequently the use of
only a few subjects is common. Oswald and Priest (1965)
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- cor ' ' the sleep of two n n for number of
consecutive nights. Five baseline nights were
followed by nine nights when 400 mg amylobarbitone
were taken nightly. REM percentage dropped for
the first few nights and then returned towards
normal. The lose was increased to 600 mg nightly
for the next nine nights. \ REM Increase again
occurred with a similar return toward normal.
Abrupt withdrawal produced Abnormally short REM
onset latencies coupled with a marked increase in
REM percentage especially in the early part of the
night. This pattern of disruption, although
gradually decreasing, did not return to normal for
five weeks. Evans and Lewis (1968) replicated
this study and cound that chlorpromazine blocked
the REM rebound.
The withdrawal of barbiturates leads not only
to an increase in the amount of REM sleep in the form
of a rebound but it also leads to an increase in the
number of eye movements per unit time (Kales, 1969;
Oswald, 1969b). There is, therefore, a physiological
increase in REM intensity. Furthermore, there is an
increase in the amount and vividness of dreaming with
nightmares frequently described (Kales and Jacobson,
1967; Oswald and Priest, 1965).
54
Non-barbiturate tr anquilliz :c3 and hypnotics
Oswald and ^riest (1905) found J-hat administra¬
tion of nitrazepam reduced REM sleep and on withdrawal
Increased REM sloop and r- 'uced REM onset latency for
up to 4 weeks. These results were supported in another
study with the additional finding that the drug delayed
the appearance of the first REM period of the night
(Loeb et al, 1966). Nitrazepam h as also been shown
to reduce sleep onset latency, shifts to and time
spent in NREM stage 1 and Increase total time spent
in stage 2 sleep (Haider and Oswald, 1971).
Nitrazepam also has effects on REM intensity with
a reduction in the frequency of rapid eye movements
per unit time during REM sleep, and a rebound increase
to above normal on withdrawal (Lewis, 1968), and on REM
activity in relation to occurrence of nightmares (Oswald,
1965) and bizarre dream content (Oswald et al, 1973).
Hartmann (1967) found chlordiazapoxide increased
REM onset latency nd decreased whole night REM percen¬
tage. A later study found REM not greatly affected
for the first few days but decreasing for the remainder
of the four weeks on medication with a concomitant
decrease in stages 3 and 4 and an increase in stage 2
(Hartmann and Cravens, 1973a). Sleep stage percen¬
tages returned to normal in the second week of with¬
drawal with no rebound phenomena noted.
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Kales et al (1970a) r aorted that 30 mg
flurazepam had little effect on REM sleep but
significantly reduced stag - 7 and 1, ->nd that 60 mg
.reduce"' -vhole night R"*' percentage an '' increased REM
onset latency. A long-term study in insomniac
patients indicated that 30 mg of flurazepam greatly
reduced sleep latency, slighlly increased sleep time
and decreased stage 4 (Kales et al, 1970b).
Hartmann (1967) found that flurazepam (30 mg)
increased REM onset latency and reduced whole night
REM percentage. A more recent study using a lower
dose level (15 mg) found no inhibition of either REM
or stage 4 sleep (Johns and Masterton 1974).
Perlapine is chemically unrelated to other
hypnotics, but it has been claimed to be comparable
in efficiency to nitrazepam, (Ando et al, 1970).
Allen and Oswald (1973) found in a pilot study that
10 mg decreased intra-sleep restlessness and REM
duration but did not alter stages 3 and 4 sleep.
A further study confirmed these results and noted
the occurrence of a shortlasting rebound.
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Tricyclic antt-dopr :ssants
Imipramine has been shown to decrease REM sleep
and enhance "EG si op spin. 'I in in \W sleep
(Toyoda, 1964), Increase7 '7 ~.l\ onr latency and
total sleep time and decreased REM percentage has been
demonstrated in cats (Mlsh"' v/a et I, 1965).
Although imipramine does not appear to show dose
effects, desmythyl-imipramine does in cats (Hishikawa
et al, 1965) and in humans (Zung, 1969).
Oswald and his colleagues have studied the effects
of several tricyclic anti-depressants on REM sleep and
intra-sleep restlessness (Dunleavy et al, 1972;
Brezinova et al, 1973). REM duration was reduced by
imipramine, desipramine, chlorimipramine and doxepin
but not by trimipramine or iprindole. The effect
lessened during a month of administration with a
withdrawal rebound lasting about a month. Intra-sleep
restlessness was increased by Imipramine, desipramine




Chlorpromazine and thioridazine have been used
extensively as tranqui 1 lizor s in gor* ':ric and
psychiatric practice. P-tiont. comnl^ints of
sleepiness arc not uncommon and it appears that the
effects on sloop, especially in the case of
ch1orpromarino, or- doso-rolated (Lewis and Evans,
1969). Low doses of chlorpromazine increased REM
percentage, high doses depressed REM and intermediate
doses did not change sleep stage percentages.
Evidence from animal studies have shown that
chlorpromazine can shorten REM onset latency
(Hishikawa et al. 1965) and in large doses can reduce
REM sleep time over the whole night (Hishikawa et al,
1965* Jouvet, 1967),
Hartmann and Cravens (1973b) found significantly
increased total sleep time and decreased wakening in
normal young males, especially in the first few days,
but found no difference in REM and NREM sleep stage
distribution despite considerable effects on home sleep
and mood variables.
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. mphetamine and other stimulants
Rechtschaffen and Maron (1964) demonstrated that
amphetamine can increase TV onset 1 Vncy and the
number of body mov men s • ' • ere. . the proportion
of REM sleep and total c1 o time. Increased
wakefulness and general disturbance complicated the
results. To overcome this, subjects were given
pentobarbitone during the control period and then
amphetamine was introduced as well. With the
barbiturate percentage REM sleep was reduced and when
amphetamine was introduced the amount of REM sleep
halved. The decrease in REM could not, therefore,
be accounted for in terms of increased sleep disturbance.
This conclusion was confirmed by Baekeland (1967).
Withdrawal increases total sleep time and REM
percentage and decreases REM onset latency (Oswald and
Thacore, 1963). These disturbances may persist for
up to two months.
Several amphetamine derivatives have been studied
by Oswald and his colleagues (Oswald, 1970).
Tranylcypromine was found markedly to reduce REM in an
addict but with a rebound increase of up to 75% on
withdrawal (Le Gassicke et al, 1965).
Lewis (1969b) compared several amphetamine
derivatives and found that all except one affected
REM sleep. The exception, fenfluramine, while still
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disturbing sleep, 'id not It :r REM i:. either amount
or distribution. These findings were supported by
Firth et al (1970). Another study from the same
laboratory, however, found ■ se-rel \t d reductions of
REM sleep, increases in in': -sleep restlessness and
changes in slow-wave sleep (Lev/is et al, 1971).
Subjective reports of sleep an 1 mood after
caffeine have revealed inter and infra-individual
variability of reaction (Goldstein, Kaiser and Whitby,
1969), HEG sleep studies have either failed to show
any effects of caffeine (Hartmann, 1965b) or showed
disturbance only in the first 3 hours after caffeine
(Muller-Limmroth, 1972) or have shown the whole night
to be affected (Brezinova, 1974). In the last study
sleep time in older subjects was decreased on average
by two hours and sleep onset latency increased to over
60 minutes after a dose of caffeine (300 rng).
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Alcohol
Gresham et ai (1963) f und the'. rchyl alcohol
in substantial do sac (1 mg/hg) reduo ' REM sleep in
man. Yules et al (1966) using the same dose level
found a decrease on the first night and a rise on
subsequent nights. On st p, Lng vie -hoi RUM
percentages remained above baseline on the first
post-alcohol night, In a later paper the REM sleep
decrease was reported to b: compensat :d for in total
sleep time by Increases in NREM stag: 4 (Yules et al,
1967). REM onset latency ias not affected by either
administration or withdrawal of alcohol.
Knowles et al (1963) studied the effects of two
different dose levels (3.5 oz or 6.0 oz) in one
subject. In the lower dose overall night REM
percentage was not affected but when divided into
halves it was seen that REM percentage in the first
half was reduced and there was a concomitant increase
in the second half of the night. On the larger dose
there was a significant reduction in REM percentage.
A rebound was reported on withdrawal with an increase
particularly in the first part of the night.
A study of patients during withdrawal, including
5 subjects with delirium tremens, found that when they
slept they had a high REM percentage: one patient had
300 minutes of REM sleep, one of the highest amounts
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recorded (Yules et a.l, 1966). Another study of four
alcoholic patients in withdrawal, found that although
two had no sleep at all, the two that slept showed a
high REM percentage and in one case there was 91
minutes of REM out of 91 minutes of sleep (Gross et
al, 1966), The phenomenon of sleep onset REM has also
been reported by Othmer et al (1970).
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SELF RATED FUELING STATES:
A REVIEW
"if ' oc' ' z rr~r,r r- pt qf T
_ -jp v* - ur
"Subjective evaluation is important, if for no
other reason than that the clinical use of tranquilli¬
zing and hypnotic .gen's * "'est fr quently concerned
with alleviation of patients* complaints" (Lasagna,
1954). Such evaluation can be made from two points
of view. First, observer rating has been used
mainly for clinical assessment, fxton-Smith,
Hodkinson and Cromie (1963) described a study in which
nursing st rf wer -s'-e ' J rn; ke an cessment of the
effect of a drug on a group of patients, both during
sleep and on wakening. Using a four-point rating
scale, observer-rating an- self-rating assessments of
the effects of four hypnotics were made. Comparison
showed a high correspondence between the ratings of the
observer and the observed but this was no'-sibly due to
there being only four categories.
Haider (1968) described a study in which the
effects of two hypnotics were compared using both
observer-rating and self-rating techniques.
Nitrazepam (10 mg) and amylobarbitone (200 mg) were
reported to be equally efficient in inducing and
maintaining sleep and the subjects indicated little
difference between the drugs in terms of side-effects.
Clinical observation by staff, however, favoured
nitrazepam since it was considered to induce more
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relaxed sleep, loco hangov md n c mfusion in a
group of 102 geriatric p a11
Hamilton has developed the rating scale technique
for the clinical assessment, of behaviour (i960, 1967),
Hamilton attempted to identify components of illness
-.yndromes by factor an a lyair of clinical ratings and
'escribed 17 such components, rate1 on either 3- or
5-point scales, to be ratod by two experienced
observers working independently at the same interview.
A second approach, used, both experimentally and
clinically, is to get the subject or patient to rate
how he feels by filling in comparison or analogue
scales or adjective check, lists. The self-rating
technique was first described by Hayes and Patterson
(1921). There are several advantages in the use of
the analogue scale since it is simple .nd the rater
may understand and complete the requirements quickly.
It avoids professional preconception and prejudice
and does not require verbal sophistication and prolonged
co-operation and concentration.
Parsons (1963) used a paired comparisons scale
with six successive paired comparisons and found little
difference between three different barbiturates in terms
of sleep quality and likelihood of morning hangover.
Some problems arise from scales of this sort,
however, since what is good for one person may be only
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average for another, and although sleep may have
been considered good after a drug in that it
increased sleep time, reduced restlessness and had
no obvious effect on wakening, if a person or patient
is impaired during the rest of the day in some way,
then there has to be careful interpretation of what
a score means (Kornetsky et al, 1959). Smith and
Beecher (i960) pointed out the complexity of the
problem in a study in which they measured subjective
and objective disruption of performance in college
athletes. The subjects had high levels of "well-
being" and assessed their performance as being
unusually good after 100 mg of secobarbitone.
Objectively measured their performance was markedly
impaired. Similarly, drugs may impair performance
when subjective changes have not been reported
(Munro-Faure et al, 1971).
In an attempt to remove the restrictions implicit
in labels the advantages of the visual analogue scale
have been reiterated in recent years (Gedye et al,
1961; Aitken, 1969), and they have been compared
favourably with other scales in the assessment of mood
changes induced by sedatives and minor tranquillizers
in normal subjects (Kellner, 1972).
The most commonly used form of the visual analogue
scale is the 10 cm line on which the subject is
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required to place a mark in relation to how he feels.
Repeated use allows fine discriminations to be made
and response-set and positive negative skewing can,
therefore, be reduced. The scales have been used in
the study of the effects of analgesics in the treat¬
ment of rheumatoid arthritis (Joyce, 1968), and the
comparative effectiveness of different drugs in the
alleviation of depression (Zealley and Aitken, 1969),
but they have been used most frequently in the study
of drug effects, in both the short and the long term,
in normal subjects (Akindele et al, 1970; Malpas,
1972; Bond and Lader, 1972, 1973; Oswald et al,
1971). Some studies have used only the self-rating
mood scale (Zealley and Aitken, 1969; Dunleavy and
Oswald, 3.973), while others have used as many as
16 scales (Norris, 1971; Bond and Lader, 1974).
The ungraded 10 cm line scale has been used in
two ways. In the first the word 'normal' was placed
at one end of the line and the abnormal adjective was
placed at the other end. This method was used in
two studies described by Zealley and Aitken (1969).
In both studies the 'normal-extreme depression'
dimension was used to study the effect of different
treatments on depressed patients and imipramine was
shown to have a faster speed of action in the
alleviation of depression than protriptyline.
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The 10 cm line scale has been used more
frequently, however, with opposing adjectives at
each end of the line. Aitken (1969) described a
study in which 90 fighter pilots were asked to
indicate how apprehensive they might feel in 10
defined situations. The extremes of the scale
were marked "maximal relaxation - maximal panic".
In order that the data might approximate the
normal distribution an arcsin transformation was
used.
In most studies using analogue scales with
opposing adjectives at each end the subjects are
told that although there are no gradations on the
10 cm line the midpoint approximates normal and they
are to place a mark on the line to indicate how they
feel in relation to how they normally feel. This
approach was used in a study described by Zealley and
Aitken (1969). Using the 'happy - depressed'
dimension they plotted mood swings in manic-depressive
patients at intervals of twelve hours. These swings
were rated by nursing staff and by the patients
themselves and Zealley and Aitken reported that the
patients were better guides to their affective state
than were the nurses.
Malpas (1972) used a 16-item rating battery to
estimate subjective feelings at intervals after taking
67
different drugs, including nitrazepam (5 mg and
10 mg), amylobarbitone (100 mg and 200 mg) and
placebo. The sixteen dimensions were those
grouped by Norris under the categories of mental
sedation, physical sedation, calming effects and
attitudes (Morris, 1971). The most noticeable
effects were that the subjects felt both mentally and
physically sedated with both doses of nitrazepam and
with the higher dose of amylobarbitone. These
differed significantly from placebo after forty
minutes. Subjectively the higher doses had the
same effect, with a dose-related effect evident for
amylobarbitone but not for nitrazepam. Montagu
(1971), using the same rating scales, and comparing
quinalbarbitone (50 mg and 100 mg) with nitrazepam
(3.75 mg and 7.5 mg) found essentially similar results.
Other experiments have been concerned with
measuring effects over longer periods of time.
Usually subjects sleep between being given the drug
and carrying out the tests. In 1951, Goodnow et al
investigated the effects of pentobarbitone and found
that there was a deterioration in performance in
comparison with placebo four hours after the drug was
first taken and that this decrement diminished through
the day. The subjects thought that the lassitude
they felt had not impaired their performance.
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In another study subjects were tested on a battery
of measures twelve hours after a hypnotic dose of
butobarbitone sodium (100 or 200 mg) or nitrazepam
(5 or 10 mg) (Bond and Lader, 1972). Four visual
analogue scales were used to assess sleep quality and
onset, and feeling on wakening and at testing. Both
doses of the barbiturate and the higher dose of
nitrazepam improved sleep quality and only the lower
dose of butobarbitone failed to reduce sleep onset
latency. At the time of testing the higher dose of
butobarbitone still induced feelings of sleepiness but
the effects of nitrazepam had disappeared. A later
study used three scales measuring sleep quality and
onset and feeling on wakening, and a series of 16
scales to assess mood at the time of testing (Bond and
Lader, 1973, 1974). Principal components analysis
extracted three major factors from the series of
scales, including alertness, contentedness and
calmness. Testing was carried out 12, 15 and 18
hours after a hypnotic dose of either butobarbitone
(150 mg), flurazepam (15 or 30 mg) or a placebo.
Both drugs improved sleep quality, reduced sleep
onset latency and increased sleepiness on wakening
but statistical significance was not reached on the
sleep onset measure after either drug: neither did
subjects feel significantly more sleepy on wakening
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after having received butobarbitone. The mood
rating scales showed that the subjects, having taken
the drugs, felt less alert, less contented, especially
after the barbiturate, and calmer, especially after
flurazepam.
Oswald and his colleagues have used visual
analogue rating scales extensively in the assessment
of the effects of a large variety of drugs, including
amylobarbitone (Lewis, 1969), caffeine (Brezinova,
1974), chlorpromazine (Lewis, 1969a), fenfluramine
(Oswald ot al, 1971), imipramine (Oswald et al, 1972),
nialamide (Akindele et al, 1970), perlapine (Allen and
Oswald, 1973), phenelzine (Akindele et al, 1970), and
quinalbarbitone (Lewis, 169a) and have found it a





There are two general models of research
procedure - the extensive and the intensive* The
former is based on the variation between subjects,
with average and percentages relating to the group.
The latter method uses fewer subjects and is based
on changes in the subject on various cessions and
under different conditions.
Then examining the effects of repeated drug
administration, theoretical and practical implications
favour the intensive approach, despite possible
objections. Poulton and Freeman (1966) have suggested
that the first trial in a series in some way sets a
wstandard levelM of performance for the subject, who
then tends to repeat this level on subsequent trials.
This may give misleading results in that if one fails
to get significant effects from the independent variable
one cannot be sure whether there is genuinely no
difference between experiment 1 treatments, or whether
a real difference has been masked by a carry-over
effect from the first trial. In answer to this it
can only be said that If the effect of the administra¬
tion of a drug is masked by such a "carry-over" effect
from the first trial then the effect of the drug, in
this Instance, '_s slight.
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Another possible objection is that when only
small numbers of subjects are used it is not
realistic to extrapolate these results to the
population in general. While this criticism is
accepted it must be pointed out that objections
about group size can be raised anyway, whether
the design be extensive or intensive, since whether
one is better entitled to discuss the population at
large on the basis of results from forty rather than
twenty subjects is arguable.
When the effects on behaviour of a single dose
of a drug are compared with behaviour under placebo
conditions the merits and demerits of the two
approaches may be finely balanced. It has to be
suggested, however, that the underlying theoretical
basis of the argument is insecure since whichever
method or design is employed, the applicability of
the single dose experiment to a general population
who almost never take single doses of drugs is
limited. Invariably, therapeutic drugs are taken
several times; at least once a day and usually for
at least a week. If one is interested in the
long-term effects of a drug during both administration
and withdrawal, then the only approach possible, both
theoretically and practically, is the intensive one
where intra-subject changes over time is the important
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factor. Inevitably there will be inter-subject
differences and although these are not unimportant
a greater emphasis should be placed on whether a
drug generally affects subjects' behaviour and
whether subjects are more affected at some times
than at others. This knowledge can only be
achieved by a repeated measures approach.
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Subjects
A variety of subjects was used in the studies to
be described. Only the characteristics and procedure
common to all will be described here, while details
relevant only to a particular study will be described
in the appropriate section.
All subjects were in good physical and mental
health. All were obtained through personal contact;
none were recruited through advertising since it has
been reported that subjects obtained in this way may
not be a representative sample of the general
population (Rosenthal, 1965). Rosenthal and Rosnow
(1969) reported that volunteers tend to come from
higher educational and occupational levels, have a
higher need for approval, higher intelligence and
lower authoritarianism than non-volunteers. It was
also suggested that sociability, arousal seeking,
conventionality, birth order and age might be
important factors. McLaughlin and Harrison (1973)
studied personality differences in volunteering for
experiments of four types: general, boring, social
or shock. They reported that subjects who volunteered
for the general and social experiments were significantly
more extraverted, as assessed by use of the Eysenck
Personality Inventory, while significantly more high
neuroticism-extraverts volunteered for the shock
experiment.
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It was pointed out to the subjects that, first,
all the drugs had been in clinical use; second,
throughout the period of the study subjects would
have to refrain from taking any drugs, including
alcohol, other than the experimental one, and third
they would have to maintain reasonably regular
bedtimes. Since the studies lasted at least two
weeks, subjects were paid for their co-operation
according to the length of the study. Before a
subject was finally included in a study, he was
formally interviewed by Dr I. Oswald in order to
assess physical and psychological suitability.
Individuals taking any other drugs, or who had
any medical condition which might be adversely
affected by the drug, or which might impair the




For the whole of each of the experiments,
subjects took a capsule about half an hour before
retiring to bed. All studies were divided into
three sections. In the first part of the study
matched placebo pills were taken in order to allow
pill-taking orientation and stabilization and the
recording of baseline measures. In the second part
of the experiment the pills contained a drug, and
in the third part the pills again contained an
inert mixture in order to assess both the objective
and subjective effects of withdrawal without the




Subjects reported to the laboratory at 0820 hours.
Each testing session lasted approximately two hours
and was started at 0830, 1230 and 1630 hours. The
subjects, therefore, worked a "two hours on - two
hours off" schedule between the hours of 0830 and 1830
hours.
The first attendance at the laboratory was devoted
to orientation and task practice. No record of pro¬
gress was kept or used in the analysis of the studies
reported here. Emphasis was placed primarily on the
subjects understanding of, and familiarization with,
the various tasks.
Tasks
Auditory Vigilance: A test of the subjects' ability
to remain attentive to monotonous stimuli and to notice
and report the infrequent occurrence of a different
stimulus. Subjects listened for one hour to a series
of 500 m. sec. "bleeps" embedded in 85db white noise.
The "bleeps" occurred regularly at 2 second intervals.
The subjects' task was to identify and respond to the
forty "bleeps" lasting 400 m. sec., which were
randomly distributed among the 1760 longer "bleeps",
by pressing a button. The subjects' ability to be
accurate was assessed in terms of correct identifica¬
tion of target stimuli and in the rate of false
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positive identifications. In some of the studies
signal detection theory was employed to assess any
changes in the detectability of the stimulus (d*)
and in the subjects* criterion for identification
(beta).
Manual dexterity. This is a test of hand-eye co¬
ordination and fine finger movement. It consists
of the subject putting an oblong pellet down a tube
using the preferred hand. The pellet fitted the
tube only in one orientation. Six one-minute trials
were administered at each testing session. The mean
score was assessed from the number of pellets inserted
on trials 2-5 inclusive. Trial 1 was omitted since
it was considered a "warm-up" and trial 6 was omitted
to counter the "end-spurt" effect (Catalano, 1973).
Digit Symbol Substitution. The subject translated
numerals into corresponding symbols. This was an
adaptation of the coding sub-test of the Wechsler
Adult Intelligence Scale and was considered a high
concentration memory task. Two forms were used in
the studies reported here. The first lasted ten
minutes and used seven symbols. Four sheets, each
containing 200 digits, were presented with the code
and the subjects were instructed to work as steadily
and accurately as possible. Mean score of correct
substitutions was the criterion.
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The second form, used in the studies in which
the first form was not used, lasted five minutes
and employed a key comprising 8 symbols. Fifteen
equivalent versions were again used in order that
carry-over from session to session and possibly
week to week should be prevented.
Card-sorting. Packs of 32 cards were sorted onto a
perspex board (30 x 22^ cm) which was divided into 8
one cm deep compartments (ll x 7 cm). The cards
v/ere shuffled before each trial and the subject
lifted the cards singly from the table, turned the
card face upwards and sorted according to
the trial criterion, using only the preferred hand.
Cards were sorted into 2, 4 or 8 categories on
the basis of either compartment position or card
detail. The former procedure allowed assessment of
motor speed since the subject simply placed the card
in one of 2, 4 or 8 categories serially. The latter
procedure yielded a sorting time comprising both a
motor and a decision component since the subject had
not only to move the card but also decide the
appropriate category for the card on the basis of the
number of dots on the upturned card.
Subjects performed each task twice in a counter¬
balanced order. Decision or information-processing
time was calculated, by category, as the mean sorting
79
time minus the mean movement time. This task
permitted assessment and comparison of a drug*s
effect on increasingly complex tasks.
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Sleep Laboratory Procedure
Subjects reported to the laboratory in the late
evening. After having prepared for bed, subjects had
silver disc electrodes attached to the frontal bosses
and outer canthi for eye movement monitoring.
Electrodes in the midline, F - C_ - P„ distributionz z z
of the international 10/20 system of electrode
placement gave an EEG record, while electrodes over
the sub-mental muscles were used to record muscle
tone.
The subjects retired to a dark, quiet, air-
conditioned room and data collection was continuous
from approximately 2230 hours to 0730 hours.
Prior to any experimental manipulation, baseline
records were obtained* The first two records for
every subject were discarded in view of the 'first
night effect' (Agnew et al, 1966), which reduces
percentage REM sleep and stage 3-d sleep and




Subjects were asked to complete visual analogue
rating scales on a variety of parameters daily for
the duration of each study. Five scales were used
in all, but each study included a maximum of four.
All studies yielded measures of sleep quality and
anxiety while some also included mood and concentra¬
tion and others morning vitality and concentration
but not mood.
Scales were of the 10 cm type. Subjects were
told that the midline, which was not marked,
approximated their usual feeling on this dimension
and that they were to place a mark on the line to
indicate how they felt in relation to how they
usually felt. The raw score was the distance from
the left hand end of the line to the mark in
millimetres.
In each study each subject*s baseline scores were
averaged and each post-baseline score was calculated
in terms of its deviation from the baseline mean.
The mean of the subjects' baseline means was then
calculated and the group mean deviation from the




AN EXPERIMENTAL COMPARISON OF THE
EFFECTS OF THREE HYPNOTICS
Introduction
The study involved the comparison of the
immediate and prolonged effects of two dose levels
of mesoridazine (5 mg and 10 mg), two dose levels
of Perlapine (5 mg and 10 mg), arnylobarbitone (200
mg) and placebo. Withdrawal effects were also
studied.
The phenothiazines have been reported as
effective tranquillizing and hypnotic agents in both
children and adults (Eveloff, 1966). Chlorpromazine
and thioridazine seem to have been the two most
frequently examined drugs in the phenothiazine
family.
Mesoridazine is a sulfoxy side chain derivative
of thioridazine which has been reported to be three
times as potent (Mena et al, 1966; Prusmack et al,
1966). Clinical trials showed significant improvement
in groups of children with behaviour problems (Baldwin
et al, 1967) and a study comparing mesoridazine,
chlorpromazine and placebo in pre-adolescent children
with very severe behaviour problems emphasised the
effectiveness of mesoridazine (Kenny et al, 1968).
Mesoridazine has been recommended for use in the
active phase of alcohol withdrawal (Conn, 1972), but
has been compared unfavourably in this context with
haloperidol and hydroxyzine hydrochloride (Palestine,
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1973). No assessment has been made, however, of the
effects of mesoridazine, at hypnotic dose level, on
performance and sleep in a controlled laboratory
setting.
Perlapine (6-(4-Methyl-l-piperazinyl)-
morphanthridine) is a dibenzoheteroepine derivative
which is structurally related to clozapine (Stille et
al, 1973). Stille et al considered the drug's
sedative and hypnotic effects to result from a strong
inhibitory action on the reticular formation: others
have reported the hypnotic effect to be comparable in
efficiency to nitrazepam (Ando et al, 1970).
Recently reported research on the effects of perlapine
on the metabolism of the biogenic amines in the brain
of the rat has indicated increased turnover of
dopamine in the striatum, noradrenaline in the brain
stem, and 5-HT in the brain (Burki et al, 1975). In
people, perlapine has been shown to reduce sleep onset
latency, decrease intra-sleep restlessness, have little
suppressive effect on stages 3-4 NRF.M sleep and cause
only slight depression of REM sleep with limited rebound
effects on withdrawal (Allen and Oswald, 1973).
Allen (1972) studied the effects of perlapine on
the performance of five adults on a battery of tasks
soon after waking. Neither a 10 mg nor a 20 mg dose
impaired continuous arithmetic, digit symbol
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substitution, manual dexterity or card-sorting.
On the contrary, some improvement over pre-drug
baselines was reported, particularly when the drug
was withdrawn. These changes did not, however,
reach statistical significance.
Perlapine was included in this study to
ascertain whether these results were replicable and
whether practice or drug effects were instrumental
in the improvement in performance, however slight.
This would be determined by comparison with the group
which received placebo throughout the study.
A placebo control group was included to
ascertain the effects of practice on performance over
time. If no control group is included it is difficult
to determine whether changes in performance patterns
are the result of increasing familiarity with the task
or of the different treatment conditions under which
the subject performed the task. It may be that
performance on a particular task shows improvement over
several weeks. Thus improvement may occur markedly
under placebo conditions but may also occur to a lesser
extent despite the disrupting effect of a drug. If
no placebo comparison is available a spurious con¬
clusion of a drug-induced performance potentiation
may occur when in fact a comparison of drug and
placebo patterns would have underlined a relative
decremental effect masked by the practice improvement.
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A barbiturate group was included since the
prescription of barbiturates as hypnotics has been
widely reported and criticised (Dunlop, 1970).
Comparison of the effects of barbiturates and non-
barbiturate hypnotics has been infrequent and almost
all have been single dose studies (Kornetsky et al,
1959; Malpas et al, 1969; Bond and Lader, 1972,
1973; Adams, 1974). Disruptive objective and
subjective effects have been reported from both
categories of drugs, with the barbiturates tending
to have greater disruptive subjective effects
(Haider, 1968) and the benzodiazepines, notably
nitrazepam, showing clear residual effects on
performance (Bond and Lader, 1972).
The effects of a barbiturate, mesoridazine and
perlapine on performance have not previously been
compared using either a single dose or chronic dose
procedure.
Subjects
Subjects for this study were young male
volunteers obtained through personal contact.
The age range was 20-29 years.
The 36 subjects were divided into six equal
groups. Each subject attended the laboratory at
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weekly intervals for six weeks. Placebo control
capsules were administered for the first, second,
fifth and sixth weeks and active drugs* capsules
for the third and fourth weeks. The placebo group
received placebo capsules for the whole six week
period. Capsules were taken on each evening of the
study period about 30 minutes before retiring to bed.
Procedure
The regime for each group was as follows:-
Week 1 2 3 4 5 6
Group
1 Placebo Placebo Placebo Placebo Placebo Placebo
2 " " Mesori- MES M w
dazine (5 mg)
3 « " MES MES H H
(10 mg) (10 mg)
4 " " Perla- PLP " "
pine (5 mg)
5 H n pup plp « "
(10 mg) (10 mg)








1st Jay Drug Test
8th day Drug Tests
1st day flthJraw " Tests












As the experiment spanned nine months, it was
considered important to control for any possible
seasonal variations in performance. Consequently
each set of six subjects attending the laboratory
contained one subject from each group.
There were three two-hour testing sessions in
each test day. These sessions started at 1030,








The following parameters were self-rated by the






The methods of analysis employed were:-
(a) .Analysis of variance on the raw data.
(b) A transformation of the raw data was
calculated in an attempt to allow for the
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practice effect-.- evidenced by the placebo
group (Table 1 ) and to show more clearly
any drug effec' , Henco if a drug had
little effect the transformed values of
the group would approximate to zero.
For each group the week to week
differences were calculated by subtraction
from the group*s own baseline score. Then
a measure of the drug's effect was calculated
by subtracting the corresponding placebo
group week transformed score from the drug
group score. Thus if the placebo group
change was -0.5 and the drug group change
was -0.75 then the transformed performance
decrement effect of the drug is -0.25.
Equally if the placebo group change is +2.5
and-the drug group change is -2.5 then the
decrement in the drug group is -5.0.
For the self-rated assessment scores, the
first of which was completed on rising and
the others on retiring, the group mean score
while on baseline placebo was calculated and
equalised to the scale mid-point. The group
mean score was then plotted for each sub¬
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1. Auditory Vigil nee
1.1 Correct detections (Figure \ Table 2)
Analysis of vari snce shored significant
differences between the groups1 overall detection
scores (p^O.OOl) but there was no groups x weeks
interaction and so st itistical comparison of
administration and withdrawal effects was not
possible.
Examination of Figure ]_, however, indicates
a tendency to decreasing detections through the
period of the experiment. Transformation of the
data in terms of group mean score deviation from
placebo group score cl rifles the effects of the
drugs (Figure l). Mesoridizine, at both dose
levels, appeared to decrease detection on
administration although this effect had dis¬
appeared by the second drug week. Withdrawal
was associated with reduced detections and the
decrement, although not large, lasted for at
least a week.
The effects of Perlapine were paradoxical.
The higher dose showed no initial effect but a
delayed beneficial effect on detections with a
slight decremental effect on withdrawal. The
lower dose level, however, caused a large
disruption of detection which had not disappeared





Source of Variation DF SS MS VR
Groups 5 1078.66 375.73 8.436***
Weeks 4 1720.90 430.22 9.659***
Sessions o 1085.09 542.55 12.181***
Groups Weeks 20 411.77 20.59 0.462
Groups Sessions 10 404.02 40.4 0.907
Weeks Sessions 8 754.67 94.33 2.118*
Groups Weeks Sessions 40 754.00 18.85 0.423
Residual 450 20042.98 44.54
TOTAL 539 27052.07 50.19
Commission Errors
Groups 5 302.96 60.59 1.736
Weeks 4 1252.39 313.10 8.972***
Sessions 2 71.67 35.84 1.027
Groups Weeks 20 420.47 21.02 0.602
Groups Sessions 10 139.75 13.98 0.400
Weeks Sessions 8 352.57 44.07 1.263
Groups Weeks Sessions 40 512.23 12.81 0.367
Residual 450 15704.47 34.90























0 Mesoridazine (5 mg)
• " (10 mg)
L Perlapine (5 mg)
± " (10 mg)
Q Amylobarbitone (200 mg)
FIGURE 1 Vigilance Performance in Young Adults
Initial ^ministration of amylobarbitone
suggested a deleterious effect on detection but
the largest disruptic appeared in the withdrawal
period.
1.2 Commission errors (Figure 2 Table 2)
There ./ere no statistically significant
differences either b_iw~on the groups or in the
Group x weeks interaction.
At both dose levels mesoridazine had
little effect on commission error rate but
withdrawal was associ.t.a with an increase,
especially at the lower drug level.
Perlupine again .ppeared to have para¬
doxical effects. A the lower dose (5 rag)
there was a marked and immediate reduction in
fals. positive At..cti-ns with a sharp increase
immediately upon with „r...wal. fhe larger dose
level, on .he other h-.., , showed little effect
until the second urug week when there was a
reduction in commission error rate which
contir.uod through wi thdr. wal*
.mylobarbitone had little effect in
administration or withdrawal*
1.3 response rata (Figure 2)
This measure is obtained by summing correct














♦- DRUG —WD 1
r\—i 1 1 1
1 2 3 4 5
TEST WEEK
TOTAL RESPONSE
1 2 3 4 5
TEST WEEK
FIGURE 3
an indication of whether a drug had an effect on
response rate as a wh " rather than on one of the
components alone.
There was a st tistically significant
difference between overall group response rates
(p4.0.00l) but there was not a significant Group
x weeks interaction,
Mesoridazine had little effect on overall
responding at either dose level. The lower dose
level caused o. slight initial reduction in
responding but this ha-' disappeared by the second
drug week. The larger dose level affected
response rate only, on withdrawal.
Perlapine (10 mg) appeared to have a
delayed decremental effect which continued into
withdrawal. Perlapine (5 mg), however, caused
an immediate and significant decrease in respond¬
ing which initially disappeared on withdrawal, as
a result of the large increase in commission
errors.
Amylobarbitone caused a reduction in
response rate both on initial administration
and on withdrawal.
1.4 d' (Figure 3 Table 3)
d* is a measure of sensitivity derived





Source of Variation DF SS MS VR
Groups 5 10.2282 2.0456 4.585***
Weeks 4 1.2525 0.3131 0.702
Sessions 2 5.9016 2.9508 6.614**
Groups Weeks 20 8.1718 0.4086 0.916
Groups Sessions 10 4.2443 0.4244 0.951
Weeks Sessions 8 6.2953 0.7S69 1.764
Groups Weeks Sessions 40 9.5395 0.2385 0.535
Residual 450 200.7565 0.4461
TOTAL 539 246.3896 0.4571
(Beta)
Groups 5 20.656 4.131 2.013
Weeks 4 75.966 18.991 9.254***
Sessions 2 1.059 0.530 0.258
Groups Weeks 20 26.112 1.306 0.636
Groups Sessions 10 11.029 1.103 0.537
Weeks Sessions 8 10.184 1.273 0.620
Groups Weeks Sessions 40 24.987 0.625 0.304
Residual 450 923.545 2.052
TOTAL 539 1093.539 2.029
commission errors. statistical analysis
showed significant differences between the
overall group (p<£ 0.001} but there was no
significant interaction effect.
The slight initial drop in d* in both
mesoridazine groups reappeared on withdrawal.
This was a result of he gradual decline in
correct detection with a concomitant rise in
commission errors.
The lower dose level of Perlapine reduced
d* and this reduction was sustained into with¬
drawal. The larger 'ose in contrast increased
d' in relation to placebo, while amylobarbitone
showed little effect.
1.5 /3 (beta) (Figur 3 Table 3)
Beta is a measure of change in criterion
used by the subject to identify target stimuli.
There were no statistically significant
differences between the groups. Initial drug
administration reduced beta in all non-barbiturate
groups but this had disappeared by the second drug
test day in all except the Perlapine low dose
group. Beta was again reduced on withdrawal.
Amylobarbitone had little effect on beta.
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2. Manual dexterity (Figure 4 Table 4)
Analysis of variance showed significant
differences between the groups on overall mean total
scores (p^.0.001), r. wel1 s an improvement in
overall week scores and through the day. There was
no significant groups x weeks interaction.
Mesoridazine had little effect on the performance
of this task except on withdrawal of the lower dose.
Perlapine (5 mg) affected dexterity only on withdrawal
while the higher dose level improved performances.
Amylobarbitone was associated with greatest
disruption in late withdrawal,
3. Digit Symbol Substitution (Figure4 Tabled )
There were significant differences between group
mean scores (p< 0,001) and between week mean scores
(p <-0.001) but there was not a groups x weeks
interaction.
Mesoridazine (5 mg) caused a deterioration of
digit symbol substitution only on withdrawal while
mesoridazine (10 mg) caused a cumulative deterioration
which declined on withdrawal.
Perlapine (5 mg) had an immediate deleterious
effect which increased on withdrawal while the higher
dose had little effect. Amylobarbitone caused the
largest onto-drug disruption. Withdrawal reduced
this effect but performance was still poor in compari¬


















































Source of Variation DF SS MS VR
Groups 5 731.67 146.33 10.016"***
Weeks 4 1158.44 289.61 19.823***
Sessions 655.71 327.85 22.441***
Groups Weeks 20 148.25 7.41 0.507
Croups Sessions 10 39.05 3.91 0.267
Weeks Sessions 8 21.22 2.65 0.182
Groups Weeks Sessions 40 08.71 2. 22 0.152
Residual 450 6574.37 14. 6.1
TOTAL 539 9417.37
Diqit Symbol Substitution
Groups 5 30026.4 6005.3 9.207***
Weeks 4 20865.1 5216.3 7.997***
Sessions O4. 2420.2 1210.1 1.855
Groups Weeks 20 10531.7 526.6 0.807
Groups Sessions 10 4299.3 429.9 0.659
Weeks Sessions 8 3310.5 413.8 0.634
Groups Weeks Sessions 40 4740.7 118.5 0.182
Residual 450 293524.8 652.3
TOTAL 539 369718.5
TABU:' 5
CAJ© -SORTING: Dl-CXSIGN TIME
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4. Card-sorting (Figure 5 Table 5)
There were significant inter-group overall mean
differences (p<£. 0.001). Mosoridazine and amylobar-
bitone had little effect on card-sorting, even at the
eight category level.
The lower dose of Perl pine enhanced sorting
speed at the simple and complex levels but not at the
intermediate level, while the higher dose level caused
relatively greater decrement with increasing task
complexity.
5. Self-rated feeling states (Figures 6-11)
Subjective feeling scales were completed daily
by all subjects.
Mesoridazine did not appear to affect subjective
feelings to any great extent. At the lower dose
level there was an initial beneficial effect on sleep
quality and an impairment in concentration on with¬
drawal. At the higher dose there was an increase in
anxiety which lasted until withdrawal.
Perlapine, on the other hand, produced marked
initial deleterious effects on all four measures
with a subsequent improvement in sleep quality at
the 5 mg level. The other three measures at the
lower dose level and all measures at the 10 mg level








FIGURE 6 Self-rated feeling states: placebo group
FIGURE 7 Self-rated feeling states: mesoridazine (5 mg)









PERLAPINE (5mg) : SELF-RATED FEELING STATES IN YOUNG ADULTS













AMYLOBARBITONE (200mg) : SELF-RATED FEELING STATES IN YOUNG ADULTS
WITHDRAWAL
Amylobarbitone produced the greatest initial
subjective disruption but this had disappeared by
the second drug week and although there was a slight
depression on some of the measures on withdrawal,
this was not marked. There was, however, an
increase in day to day variability.
Discussion
There were no significant groups x weeks inter¬
actions in the analysis of variance but there were
significant group overall mean differences on almost
all the measures. Although this does not allow
comparisons following either the Tukey or the Scheffe
procedure, it was clear that all the drugs to a
greater or lesser extent altered performance on one
aspect or another of the test battery.
Generally Perlapine appeared to affect performance
and self-rated feelings more than either mesoridazine
or amylobarbitone and the effects of Perlapine were
not clearly related to dose level. Certainly in
several of the tests the lower dose appeared to cause
greater disruption both on administration and with¬
drawal, but this differentiation was not so noticeable
in the self-rated feeling data.
Allen (1972) compared Perlapine (10 mg and 200 mg)
with flunidazepam (2 mg and 4 mg) on a variety of tests
and concluded that Perlapine had no deleterious effects
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on performance and indeed showed some improvement over
pre-drug baselines during both administration and with¬
drawal. Since comparison of results is restricted to
the IQrg level of Perlapine the conclusion drawn in
this study with regard to the administration period is
similar. At this dose level the drug appeared to have
no significant detrimental effect on performance, and
indeed on manual dexterity and vigilance. Perlapine
(10 mg) appeared slightly to enhance performance
although this effect tended to disappear on withdrawal.
Unfortunately, Allen (1972) and Allen and Oswald (1973)
did not assess the effects of Perlapine on self-rated
feelings and it is not possible to compare the degree
of subjective effects experienced by the subjects.
The comparison would have been useful in relation to
both the marked subjective disruption noticed in the
10 mg Perlapine group in this study despite the lack
of effect on objective tests, and also to attempts to
interpret the apparently paradoxical dose level effects
of this drug.
Perlapine (5 mg) appeared to have some effect on
performance. Vigilance was affected with a reduction
in responding with the administration of the drug and
an increase, especially of false positive identifications,
on its withdrawal. Card-sorting, on the other hand,
was beneficially affected, especially at the simple and
complex levels.
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The sustained deleterious effect of Perlapine
(5 mg) on digit symbol substitution and the slight
effects on both manual dexterity and card-sorting
do little to clarify the question of whether the
effect of Perlapine is principally on the cognitive
or motor aspect of performance. It was clear,
however, that there was disruption of subjective
feeling at the lower dose level as well as at the
10 mg level (Figure 9 ). Although sleep
quality was generally improved until the drug was
withdrawn, there were disruptions of mood, anxiety
and concentration which continued into the second
drug week. These disruptions were not as considerable
as those induced by the larger dose, however, and it
may have been that the effects at the lower dose level
were not substantial or disorienting enough for the
subjects to be aware of them. If this were so, then
the disruption of performance might be indicative of
the drug's true effect while the subjects given
Perlapine (10 mg) were sufficiently disrupted to be
aware of their impairment and consequently the
performance tests measured this attempt to overcome
deleterious effects of the drug by way of extra
compensatory effort.
In contrast to the effects of both doses of
Perlapine, mesoridazine had little effect on objective
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performance. Any slight initial effects were not
sustained except at the higher dose level in the
digit symbol substitution task. At the lower dose
level subjective effects were negligible while at the
higher dose level there was a transitory initial
effect on three parameters and a continued effect only
on anxiety.
Amylobarbitone did not have noticeably disruptive
effects on performance. Bond and Lader (1972) noted
that a barbiturate (butobarbitone 100 mg) caused less
disruption of performance than did nitrazepam (5 mg
and 10 mg), but pointed out that butobarbitone (200 mg)
also caused disruption. In this study, amylobarbitone
caused less disruption than did Perlapine, especially
in comparison with the lower dose level. However,
there was little difference between the effects of
mesoridazine, at either dose level, and amylobarbitone,
especially when withdrawn.
There were notable differences between the effects
of rnesoridazine and amylobarbitone on subjective
feelings. Amylobarbitone caused marked initial
disruption, which in the case of anxiety levels was
sustained, and there was also an effect on withdrawal.
Haider (1968) also reported a greater disruption with
a barbiturate (amylobarbitone 200 mg) than with a non-
barbiturate (nitrazepam 10 mg).
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The degree of disruption induced by amyiobarbitone
was similar to that caused by the higher dose of
Perlapina and greater than that caused by the lower
dose of Perlapina and both doses of mesoridazine.
A possible explanation for the paradoxical results of
the two dose levels of Perlapine has been outlined
and it may be that a similar situation occurred with
the amyiobarbitone group. Such an explanation could
not be acceptable without a replication study and the
use of tests which do not allow the true effects of a
drug to be hidden by compensatory effort.
This study underlines the complexity of possible
drug effects. Thus the higher dose of mesoridazine
had an initially deleterious effect on vigilance,
manual dexterity and digit symbol substitution but did
not affect card-sorting. Continued administration
was associated with an improvement in vigilance and
card-sorting which might have indicated tolerance if
these were the only tests used, but both manual
dexterity and digit symbol substitution showed
progressive performance deterioration which was reduced
with withdrawal. On the card-sorting task, however,
withdrawal was associated with progressive deteriora¬
tion on the simple and intermediate but not the complex
levels, and in the vigilance correct detections and
commission errors both increased.
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The difficulty of interpretation of such a
complexity of results is obvious. It does reinforce,
however, the importance of the use of a battery of
tests sampling different skills in our behavioural
repertoire when assessing a drug's effects and it
also challenges the validity of single dose studies
assessing effects for only 24 hours after a drug's
administration.
Single dose studies have yielded a lot of informa¬
tion about the initial effects of drugs and the residual
effects as the drugs are excreted from the body.
Several researchers have shown that hypnotic drugs in
single doses may affect behavioural performance and
physiological function for up to 18 hours (Kornetsky
et al, 1959; Malpas et al, 1970). Pharmacokinetic
studies have shown that even after the effects on
performance tests have disappeared the drug is still
active and the rate of disappearance is slow.
Balasubramaniam et al, (1970) showed that for amylo-
barbitone the decay of serum concentration lasted over
48 hours and appeared as a double exponential function
with the first component having a half-life of 0.6
hours and the second a mean half-life of 21 hours.
Other single dose studies have compared different
drugs under similar conditions and have examined both
physiological and psychological functions (Bond and
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lader, 1972, 1973; Malpas ot al, 1970) and in at
least one instance biochemical function as well (Bond
and Lader, 1972).
Several studies have examined the relationship
between prognosis and plasma levels in patients and
underlined the importance of the rate of absorption
and excretion of a drug and its metabolites for
symptom control and improvement (Klein et al, 1974;
Koch and Rohling, 1974; Mackay and Healey, 1974).
The use of such a detailed approach can do much to
clarify the real effects of a drug and to separate
out the effects of artefacts in a way not possible
with examination solely of psychological function.
It is regrettable that such a multifunction
examination has not been possible In these studies.
The use of a chronic administration design is much
more relevant to the practical therapeutic drug-
taking procedure and the use of EEG and bioassay
techniques might have clarified several results
which can only be described as paradoxical and
explained tentatively when only the psychological
function data is available.
It was stated in the introduction that a
placebo group was included in this study in order
to assess the effects of practice on the tests
employed. On several of the tests such effects
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were apparent and in these cases improvement occurred
on each of the five test weeks (Table 1 ). Both
manual dexterity and digit symbol substitution showed
clear practice improvement despite the devotion of one
whole day to orientation at the beginning of the study.
There was an improvement in vigilance performance as
measured by d', and commission errors but there was
a reduction in correct detections as well. Practice-
appeared to have little effect on card-sorting in
either its motor or cognitive component.
Examination of the self-rated feeling state data
of the placebo group is also Instructive. The
spontaneous fluctuations that occur over a long period
of time are clear. These fluctuations occur naturally,
and not in response to a drug, as a result of day-to-day
occurrences during work and social life and could be
considered as "noise". As such it is important for
comparison with groups receiving drugs since deflections,
for better or worse, might be interpreted as drug
effects when in fact the deviation does not exceed the
normal.
The value of the inclusion of the placebo group
is clear. Were it not for the inclusion of the placebo
group conclusions about the lack of effect or even
slightly potentiating effects of some of the drugs
might have been drawn. Awareness of the effect of
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practice on several of these tasks allows for
transformation of tho raw data to a form in which it
is clear that there are effects both initially and on
withdrawal and to the formulation of the conclusion
that although in some instances a drug may have little
effect on psychomotor performance there are occasions
when an expected improvement may be inhibited until




DISCUSSION OF TASK AND SUBJECT PARAMETERS IN
RELATION TO THE CLINICAL USE OF DRUGS
There are drawbacks in the type of subjects that
have generally been used In experimental studies. For
practical reasons mainly men arc used, the vast
majority of whom are young. .Then we look, however,
at the potential market for the drugs' therapeutic use
we find that the largest proportion are middle-aged, or
older, and female. Ideally then, we would use such
people and patients suffering from neurotic or
psychiatric illness in our studies, but in the former
it is difficult to get a sufficient number to partici¬
pate, and in the latter to withdraw patients'
medications and substitute a drug of unproven
beneficial value is unethical, as well as unpractical.
At a theoretical level, also, our choice of
subjects is unsatisfactory. The inverted U theory
suggests that anxiety or arousal enhances performance
up to an unspecifiable optimal point beyond which
performance is hindered. If our anxious subject is
beyond the optimal point then the administration of an
anxiolytic might improve performance, where the same
dose of anxiolytic in a subject whose anxiety level is
not beyond the optimal point will result in a perfor¬
mance decrement. It is difficult, therefore, to
extrapolate from data from normals to people with
neurotic problems.
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Given that wo ~r • attempting to study how well
a -'rug enables a subject t "• cope with stress, without
deleterious ro.de effects, we are faced with several
way? in wh: eh v/e con modify our approach to mimic the
clinical situation marc closely.
First, we can retain the tasks and. the young male
subjects but vary the amount of stress under which our
subjects work. Second, wo can again use the same
subjects but change the tasks we require them to perform,
ant third, we can use the same or new tasks but with a
more appropriate type of subject.
In the first category, there are a wide variety
of ways in which stress can be varied.
Noise has been widely used as a distractor and
stressor. Broadbent in his book 'Decision and Stress'
(1971) writes extensively on its advantages and
failings. In general 95db appears to be the critical
level above which subjects find it difficult to cope.
The major problem is habituation but if noise and quiet
ar : alternated then habituation is largely prevented.
The degree of difference between the noise level and
the quiet appears to be critical.
Such a method could be additionally refined by
building in a system of incentives to improved
performance by setting targets at, or slightly better
than, the subjects' ability, with or without reduction
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of the noise level as a reward.
An incentive system without the use of noise
could bo based on financial reward or penalty. The
problem with incentive systems and noise stressing,
however, is that each subject has to have a tailor-
made schedule because while performance patterns
between subjects may be similar and intra - subj ect
variance very small, actual levels of performance and
sensitivity may vary greatly, It would be virtually
impossible to determine and maintain such systems
while testing several subjects simultaneously, and
moreover, it would be difficult to recreate exactly
similar levels of stress on each of the several times
the subject attends the laboratory.
Another way cf studying stress may be in terms
of experimenter and interaction effects. Several
researchers have looked at the effects of friendly or
serious experimenters on subjects. The problems of
assessing and controlling conditions are many and
interpretation of results can be difficult. For
ex.ample Starkweather (.1959) looked at the effect of
giving different combinations of drugs to people
working in pairs on a trail-marking task. He
suggested that a subject given a depressant would be
slower than a subject given a stimulant, and that a
pair given depressants would be slower than pairs in
which one subject was given a stimulant and one a
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depressant, or in which both wor g g iven u stimulant.
His results showed paradoxically that the pairs
roo-.ivir.g depressants performed significantly better
tha.. the pairs receiving stimulants.
A second way of modifying our experimental
approach is to introduce tasks which in themselves
have a stressful or distracting component. There are
a variety of tasks which come into this category.
The choice reaction-time test can be used either
as an experimenter-paced or subject-paced task with a
variable amount of monitoring and response-requirement
complexity. The divided attention task is a variation
on the same theme. Moslcowitz and DePry (1968) used
such a task in studies on the effect of alcohol, testing
the hypothesis that performance decrement would be
greater in the drug condition in the divided attention
task than it would in a vigilance task. Their results
supported the hypothesis.
The advantage of using a divided attention task is
that it may closely resemble the conditions that people
have to face every day. A cpecial type of divided
attention task is the driving simulator. Most
research has studied the effects of alcohol but other
drugs have also been tested (Drew, Colquhoun and Long,
1958; Rafaelsen et al, 1973).
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Another divided attention task has boon developed
by Alluisi {1972) in en attempt to study 3 more
realistic v/ork situation. He has used a Multiple
Task Test Performance Battery which includos three
watchkeaping and three active tasks. The three watch-
keeping tasks have to be continuously monitored while
one of the active tasks is performed. .Alluisi has
been specifically interested in endurance limits and
the effects of illness and has not considered drug
effects in any consistent way.
Ir: the critical tracking task the subject
attempts to track accurately a moving target. The
complexity of the tracking pattern and the difficulty
of control of the subjects* styles can be varied
during the testing session without the subject being
fully aware of this. The criteria are how many
errors the subject makes and for how long he persists
at the task.
So far I have considered only modifications of
the experimental procedure but a major contribution
in the attempt to obtain a realistic idea of a drug's
side-effects roust include the use of appropriate
subjects. A review of the psychopharmacological
literature will show that whatever drug has been
tested the subjects almost invariably comprise healthy
young male university students or naval ratings.
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McNair (1972) reports 95)1 of subjects came into this
category. These types of subjects arc easy to
obtain since- some undergraduates have to provide a
number of hours as a subject as part of their course
requirements, end others are placed in a situation
where it is difficult to contract-out.
It is suggested that it is more relevant to use
subjects whs are similar in age and type to those
people who arc likely to be the drug's potential or
actual therapeutic market. In the case of sleeping
pills and anxiolytics, this market is largely middle-
aged and female. Even when such a subject sample is
used it can still only be suggested that the results
obtained may be typical of the population at large.
A more positive statement is not possible since even
in an older age group the peculiarities of the
volunteers may preclude generalization to the population
as a whole (McLauchiin and Noble, 1973).
There is ample evidence from a variety of
researchers that the performance patterns of young
people can be quite different from those of older
people. Examples are given below.
It is generally agreed that decreasing speed in
responding to stimuli is a normal part of ageing.
There are, however, substantial individual variations
(Maddox and Douglass, 1974), and some older people are
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capable of responding even faster than some younger
people. At Duke University, Botwinick, with various
collaborators, has been studying reaction time in older
people both longitudinally and in comparison with
younger people. Botwinick and Thompson (1966)
analysed reaction time into two components, pre-motor
time and motor time and found that the elderly were
slower in both parts. Other researchers have found
longer latencies only in motor-time (Waugh, Fozard,
Talland and Erwin, 1973). A second study by
Botwinick showed that the elderly improved their
reaction time with practice under certain conditions,
while younger subjects did not (Botwinick and Thompson,
1967). Two further studies showed that there are
greater individual differences along the elderly and
that some of the slower reactions may be related to
lack of exercise (Botwinick and Thompson, 1968a, 1968b).
A later study indicated also that the intensity of the
stimulus and the preparatory interval can be important
(Botwinick and Storandt, 1973).
In the processing of non-verbal stimuli older
women exhibit a marked lack of proficiency (Elias and
Kinsbourne, 1974) while both sexes may show a reduced
efficiency of reasoning performance and memory compared
with younger subjects (Brinley, Jovick and McLaughlin,
1974). Rimoldi and Vander Woude (1969) have published
112
data indicating first an increment and later a
decrement in problem-solving ability with increasing
age while Schaie and Labouvie (1974) have, on the
other hand, challenged the assumption of generalised
cognitive deficit in the elderly.
Davies and Griew (1965) reviewing the literature
on age differences in vigilance performance concluded
that age was not a significant factor.
Davies and Tune (1969) suggested that no
difference in either detection or commission errors'
rate between younger and older adults was found by
York (1962), Griew and Davies (1962) and Davies and
Griew (1963). In the latter two papers it had been
hypothesised that if a difference in performance
existed then it was in the reception and organization
of the incoming sensory data that the effects would be
most likely to be apparent. In their first experiment
Griew and Davies required subjects to listen to digits
for 40 minutes. Three consecutive odd digits were the
target. Older subjects detected significantly fewer
signals than did younger subjects while there was no
difference between commission error rates. This
difference was attributed to short term memory effects
and not to vigilance decrement. In the second
experiment a written list was checked against a spoken
list. No significant age differences occurred. The
task variables were again radically changed, but still
no consistent age differences were found.
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Despite these results there has been evidence
over the last ten years that age differences in
vigilance do exist. Surwillo and Quilter (1964),
using the Mackworth Clock Test, found that an older
group of subjects detected an average 64.4% of
signals compared with 72.0% by a younger group.
The performance pattern was similar until the last
quarter when the younger subjects improved while the
older subjects continued to deteriorate.
Harkins et al (1974) found that young subjects
made fewer omission and commission errors and Tune
(1966a,b), requiring subjects to listen to digits
presented at the rate of one per second, found that
whereas younger and older subjects made approximately
the same number of correct detections, the older
subjects made many more errors of commission. The
argument advanced to account for this finding was that
older people were insuring themselves against failure
to detect wanted events by reporting many events as
wanted, even though they were not. In terms of signal
detection-theory analysis the results demonstrated a
reduction in detection efficiency with age because the
older subjects adopted a less cautious criterion.
These results have also been interpreted as showing
that older subjects may be underaroused and, therefore,
make more responses in order to keep up arousal in a
monotonous situation.
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Supportive data for under-arousal being a causal
factor has been produced by other researchers (Sanford
and Maule, 1971; Neal and Pearson, 1966). In the
latter study, using a similar auditory vigilance task,
they found that giving subjects a depressant drug, and
thus presumably lowering their arousal level, resulted
in a significantly higher proportion of false positive
responses. Furthermore, Davies and Krkovic (1965)
showed a decrease in EEG alpha activity in a 90-minute
task concomitant with a decrease in vigilance
efficiency.
There is ample evidence that older people show
less confidence and greater caution (Botwinick, 1966),
especially in novel situations (Craik, 1969). Wallach
and Kogan (1961) found that aspects of decision-making
changed with age in the direction of reduced confidence
in judgements and in greater "deterrence of failure".
A study by Botwinick, Brinley and Bobbin (1958) showed
that older subjects generally preferred to gather more
.information from a display before committing themselves
to a response, and Welford (1961) showed that older
people require relatively more data for confidence than
for accuracy.
Initially the diversity of findings is hard to
reconcile but it appears that in tasks where decisions
are experimenter-paced, older subjects seem to perform
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similarly to younger subjects in correct detection but
make many more false-positive detections. This may be
related to arousal levels or simply to the "deterrence
of failure" strategy, i.e. increases in response rate
raise the probability of correct detections as well as
increasing false alarms. Support for the deterrence
strategy comes from subject-paced studies where older
subjects generally gather more information than they
need before committing themselves to a decision.
It would appear then that there are differences
in response patterns and levels between subjects of
different ages. The extent of these differences
would .seem to indicate that the most suitable method
of assessment of the effects of drugs which are most
likely to be prescribed to an older age group is not
to make the testing procedure more complicated but to
use subjects of that age group. Although it is more
difficult to obtain such volunteers, the greater
extrapoiative validity may well justify the endeavour.
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CHAPTER 6
A STUDY OF THE EFFECTS OF MESORTDAZING
ON SLEEP AND PERFORMANCE
Introduction
Mesoridazine, a derivative of thioridazine, has
been suggested to be useful, in comparison with chlor-
prornazine, in the control of severe behaviour problems
in pre-adolescent children (Baldwin et al, 1967; Kenny
et al, 1968} and to be loss successful than haloperidol
in the control of problems occurring in ■'"he acute phase
of alcohol withdrawal (Palestine, 1973). A study
reported earlier, comparing the effects on performance
and feeling states of mesoridazine (b mg and 10 mg),
Perlapine (5 mg and 10 mg) and amylobarbitone (200 mg),
found that mesoridazine had an effect on performance not
statistically different from placebo. Neither was there
disruption of self-rated subjective feeling state.
A pilot study of the effects of a hypnotic dose
of mesoridazine on all-night EEG and other electro¬
physiological features in two middle-aged women found
that there was a reduction in intra-sleep restlessness
and no effect on either REM or NREM stages 3-4
(Oswald and Lewis, unpublished). The lack of sleep
disruption in subjects considered to bo representative
of Lhu group for whom hypnotics are most frequently
prescribed, coupled with apparently limited disruption
of daytime performance, indicated that mesoridazine
might be a hypnotic of potentially wide therapeutic use.
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Thus a larger study was planned using more subjects
and studying both sleep EJ2G and daytime performance
in an older age group.
Subjects
Seven subjects were used; 4 women of agos 48,
5b, 56 and 62, and three men aged 52, 59 and 60.
Hone had taken CHS drugs in the previous year, They
took no alcohol throughout the period of the study
and followed a regular way of life. They were
chosen to represent, by age and sex distribution, the
typical population of hypnotic users. They were in
satisfactory physical health, but had a high incidence
of personal problems, e.g. one had become widowed in
the preceding year, another had been divorced, and
another had had a major change of life circumstances.
Procedure
The present author was not principally involved
in the sleep study but, since the sleep and performance
studies were planned to run together and employed the
same subjects, the results of both will be reported,
with relatively less emphasis placed on the former.
The aim is solely to maintain continuity and
completeness.









































In the sleep part of the study each subject
attended the sleep laboratory on a total of nineteen
nights, spread over seven weeks. The intervals betv/een
nights were the same for all subjects. Where 2-3
and 1 - 3 is shown above this means that there were one
or two adaptation nights under full laboratory
conditions preceding actual recording nights.
Mesorid&zine (10 mg) or matching placebo capsules were
taken prior to retiring to bed throughout the whole
perioo of the study, including the orientation weeks.
The subjects came to the sleep laboratory and
were prepared for the night's recording in a way
similar to that described earlier. Recording started
at approximately 2230 hours and continued until 0715
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hours, so giving a period of 8.5-9 hours for recox-ding.
At the end of the study all records were ceded
and scored blind in random order in terms of the
conventional sleep stages defined by Rechtschaffen and
Kales (1968). The raw scores were processed to give
data concerning the amount of sleep, sleep onset
latency (first NREM stage two), the latency to REM
sleep onset, the amount of each stage of sleep, the
amount and distribution of periods of wakefulness
during the night, the distribution of transitions
between stages of sleep during the night, and
percentages.
In the performance part of the study all seven
subjects reported to the psychopharrnacology laboratory
at 0815 hours on nine consecutive Sundays, the first
two of these being allocated to laboratory orientation
and task practice. On each of the nine days, there
were thx^ee sessions starting at 0830, 1230 and 1630
hours following the "two houx^s on - two hours off"
schedule.
The first two attendance days were for orientation
only and performance scores on these days were not
included in the analysis. The seven days of analysed
testing included the 16th placebo (pre-drug) day, the
day after the first drug night (D^), the day after the
eighth drug night (Dg), the day after the 15th drug
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night (D1t.), the day after the first night of
•L >J
withdrawal placebo ('.-V ), the eighth withdrawal placebo













In general, mesoridazine did not greatly affect
the normal pattern of sleep. There were large inter-
individual differences in sleep onset latency and sleep
duration. Mesoridazine had little effect on the former
but moan total sleep time was greatest on th^ first drug
night and least on the first withdrawal night. Intra-
sleep restlessness and time spent in stage 1
(drowsiness) declined during drug administration and
showed a rebound on withdrawal.
Sustained administration did not suppress NREM
sleep stages 3-4. As is common in this age group,
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two subjects had very little stage 3-4 sleep, but
in their cases as well there was no indication of
any change induced during drug administration.
The clearest effect of the drug was on RIM sleep
duration, which was increased, with a negative rebound
most marked on the second withdrawal night. The six
drug nights contained a higher percentage of REM sleep
than eight out of nine of the non-drug nights.
Increased REM sleep percentage was accompanied by
reduced REM onset latencies while taking the drug and
this effect disappeared on withdrawal.
Perform;nee
All data were analysed using analysis of variance
( finer, 1962).
1. Auditory Vigilance.
(1.) Correct identifications. There was a slight
deterioration in accuracy from the beginning to
the end of the testing period. This change was
not statistically significant and there was no
overall day mean onto-drug decrement (Figure 12
Tabic 6 }. Neither was there a withdrawal effect.
Examination of morning session accuracy scores
indicates that there was no obvious onto- or off-
drug hangover effect which might have been hidden
by averaging over the three sessions in the day

























































SESSION 1 2 o
WEEK MEAN
1 21.36 + 9.118 18.00 + 9.678 18.71 7.297 19.52
2 21.43 + 10.96 20.29 + 11.368 16.43 ± 8.121 19.38
3 18.00 + 10.015 20.00 + 8.963 15.00 ± 7.483 17.67
4 18.00 + 10.52 20.29 + 7.89 20.86 + 9.805 19.71
5 19.71 + 8.915 16.57 + 9.378 21.29 ± 9.638 19.19
6 15.96 ± 9.173 20.57 + 9.467 21.14 ± 9.72 19.19
7 14.43 ± 11.19 15.57 + 9.744 17.43 ± 10.85 15.81
TABLE 7
VIGILANCE: FALSE POSITIVE DETECTIONS
SESSION .1 2 3
WEEK MEAN
I 41.14 ± 35.611 29.86 ± 26.041 31.71+ 36.62 34.2
2 35.29 ± 37.02 40.86 ± 49.68 34.43 + 34.29 36.9
3 28.57 + 33.331 23.43 ± 21.44 28.00 ± 33.011 26.7
4 18.00 + 17.72 25.29 ± 32.09 31.14 + 45.447 24.8
5 33.14 + 37.548 19.43 ± 22.97 25.57± 31.8 26.0
6 18.57 ± 25.8 26.29 + 40.54 20.00 + 29.705 21.6
7 22.86 + 34.705 10.86 + 10.46 16.43 + 26.895 16.7
(2) False positive identifications. There was
a steady, but non-significant, decline over the
seven week period. This pattern is not
different from the one expected during repeated
testing. Examination of the morning session data
indicates that there was an increase in false
positive identifications on the morning
following masoridazine withdrawal {V/^), but there
was also an increase in inter-subject
variability (Table 7).
(3) Total responsivity. This measure has been
considered by some to be more indicative of change
than either errors of omission or commission alone.
Apart from a slight increase on first administra¬
tion there was a decline in responsivity through
the study (Figure I2)• There were no
statistically significant changes, either through
the weeks or sessions, and possible effects, e.g.
week 2 session 2, and weak 6 session 2 (Table 8),
were confounded by inter-subject variability.
(4) d*. This transformation, based on signal
detection theory, showed a gradual, non¬
significant, rise in sensitivity through the
study (Table g). In neither day nor morning
session scores was there any indication of an




SESSION 1 2 3
WEEK MEAN
1 63.00 + 32.161 47.86 +MM 20.481 50.43 + 33.11 53.8
2 56.71 * 29.199 61.14 + 41.719 50.86 28.5 56.2
3 46.57 + 29.24 " 43.43 + 16.94 43.00 + 30.392 44.3
4 36.00 ± 15.055 45.57 + 26.153 52.00 + 38.492 44.5
5 52.86 + 34.624 36.00 ± 20.866 46.86 + 28.656 45.2
6 34.43 ± 22.187 46.86 + 35.32 41.14 24.086 40.8
7 37.29 ± 32.366 26.43 + 8.482 33.86 23.583 32.5
TABLE 9
VIGILANCE: d«
SESSION 1 2 3
WEEK MEAN
1 2. 207 ± 0.662 2.141 ± 0.987 2.244 + 0.672 2.197
2 2.347 ± 0.996 2.530 * 0.867 2.204 + 0.836 2.360
3 2.395 ± 0.485 2.414 + 0.322 2.263 ± 0.800 2.357
4 2.237 + 0.968 2. 280 ± 0.843 2.425 ± 1.001 2.295
5 2.401 ± 0.336 2.397 + 0.966 2.403 + 1.044 2.400
6 2.604 + 1.065 2.473 + 0.948 2.869 + 1.258 2.649
7 2.484 + 1.246 2.379 + 1.043 2.765 + 1.053 2.545
TABLE 10
VIGILANCE: BETA (LOG)
SESSION 1 2 3
WEEK MEAN
1 2.37 ± 0.56 2.44 + 0.48 2.61 + 0.42 2.47
2 2.29 ± 0.49 2.36 _+ 0.61 2.46 ± 0.54 2.37
3 2.50 ± 0.73 2.65 ± 0.45 3.03 + 0.76 2.72
4 2.89 ± 0.66 2.86 0.56 2.71 ± 0.57 2.82
5 2. 57 ± 0.53 3.33 + 0.78 2.84 + 0.63 2.91
6 3.67 ± 0.82 3.23 + 0.61 3.88 ± 0.85 3.59
7 3.20 ± 0.86 3.18 + 0.64 3.65 ± 0.73 3.34
(o) p> (beta). A change In beta is suggested
to be a change in the criterion employed by a
subject in his decision of //nether a signal is
i target signal or not. The upward trend
through the study described an increase in
caution as the study progressed (Table 3D).
There was a slight reduction in caution, in
comparison with baseline, which persisted through
the day, on first taking the drug, but this did
not persist and no withdrawal effect was evident.
2. Manual dexterity.
The general pattern through the study was of
improvement. Neither administration nor withdrawal
appeared to inhibit improvement, certainly in the later
sessions of the day (Figure 13, Table ll) and there was
not a significant weeks or weeks X sessions effect.
However, it should be pointed cut that out of twenty-
one mean observations in this task the poorest was on
the morning after the drug was first administered.
3. Digit symbol, substitution (Figure 13)
Mesoridazine appeared to have little effect on
the pattern of improvement expected in this task with
repeated testing. Performance was poorer in the third
drug week (b^) and this was the result of a depression
solely in the morning session score. Although this






1 30.25 + 5.02
2. 30.11 + 6.89
3 31.46 5.47
4 31.64 + 6.50
5 31.46 + 4.64
6 31.89 + cn COo
7 32.93 + 5.75
o 3
MEAN
31.75 ± 5.31 31.64 + 4.23 31.21
32.11 ♦ 6.46 32. 21 ± 4.87 31.48
31.96 4* 5.87 33.32 ± 5.25 32. 25
32.75 ± 6.15 33.07 ± 6.10 32.49
33.04 i 9.37 38. ^0 + 6.01 32.73
33.71 6.26 34.11 + 5.85 33.24
34. 11 7.02 35.32 ± 6.76 34.12
TABLE 12
DIGIT SYMBOL SUBSTITUTION
SESSION 1 2 3
WEEK MEAN
1 176.29 4. 45.61 185.00 + 44.16 189.29 + 42.19 183.5
2 179.71 J. 46.48 187.14 + 47.01 194.29 •h 35.92 187.0
3 190.71 41.95 184.71 -f 37.01 190.00 34.35 188.5
4 177.14 -t 44.38 191.71 41.23 188.57 + 35.07 185.8
5 197.71 •f 38.99 197.29 + 40.00 192. 29 37.42 195.8
6 204.86 J. 38.08 208.57 + 36.61 196.86 38.08 203.4
7 206.57 31.00 212.43 jh 42.43 195.14 + 34.06 205.0
subjects it was not of sufficient magnitude to
achieve statistical significance (Table 12).
4. Card-sorting: Decision time.
Analysis of variance revealed no significant
changes in performance on this task at any level of
complexity during either administration or withdrawal
of mesoridazine. Examination of the mean overall
day data (Tables 13 and 14) indicates a progressive
impairment at the simple and complex levels which
disappeared on withdrawal. The decrement appeared
to occur, however, in the lunch-time and afternoon
sessions and an improvement occurred, at all levels of
complexity, in the morning session with continued
administration. This paradoxical effect disappeared
on withdrawal and, at the more complex levels of card-
sorting, the first withdrawal day morning session scores
were the slowest sorting scores of the whole study
(Tables 13 and 14). This possible withdrawal effect
was not significant statistically, however, and it had
disappeared by the lunch-time testing session.
Self-rated Subjective Feeling States
There was a clear indication that sleep was rated
as improved overall during the period of drug administra
tion and apart from a brief deterioration on the first
morning after a blank pill had again been given, the





SESSION 1 2 3
WEEK
1 12.71 13.10 13.49
2 14.59 13.19 12.53
3 13.46 13.40 14.11
4 13.71 14.54 14.39
5 13.90 14.53 13.39
6 14.61 14.60 13.37
7 14.40 11.49 12.63
Four Categories
1 19.56 17.90 17.81
2 18.04 17.31 19.97
3 18.36 19.03 17.79
4 16.83 16.79 19.64
5 20.21 19.77 18.33
6 19.96 18.41 16.69

























































There was a fairly cl r indication of a hang¬
over effect on morning vit lity twenty minutes after
rising for the period of drug administration.
Withdrawal brought some initial improvement.
There was some reduction in anxiety with drug
administration, especially initially, but this was not
noticeably below the mean. It is interesting to note
that there was no acute anxiety rebound on withdrawal.
Immediately following the first night, of
administration of the active drug, there was an obvious
subjective impairment of self-rated concentration.
Following this, thorc was a continued depression of
ability to concentrate but this was only slightly below
the mean.
Discussion
In the dose used, and in middle-aged volunteers,
mesoridazine appeared to have little effect on either
sleeps psychomotor performance or self-rated feeling
states. Some previous evidence had suggested that a
phenothiazlne, in a small clinical dose, could Increase
RDM sleep duration slightly (Lewis and Evans, 1969),
but there had been no previous report of a hypnotic
drug increasing REM duration over a prolonged period
and causing a negative rebound on withdrawal.
Mesoridazine Is also notable for its lack of
suppression of NREM sleep stages 3 - 4. If certain
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sleep stages are relate! to particular restorative
processes,, and '-here is evidence supporting loth RUM
sleep (0swale1, ,1969a) and HREM sleep stages 3-4
(Honda et al, 1969; Sassin et al, .1969) in such
roles, then a lack of disruption similar to that
occurring during mecoridazino administration might
be of relevance and importance during long-term
hypnotic administration.
In comparison with temazepam, reported in
another section not to have disruptive effects on
overall sleep parameters, mesoridazine caused less
change in hour by hour distribution of REM sleep and
caused less disruption of subjective feeling states
both on administration and withdrawal.
The subjective ratings suggest an improvement
in sleep quality and a slight reduction in anxiety
and morning vitality. The onto-drug impairment of
concentration had disappeared by the second drug day
and there was a withdrawal effect only on sleep
quality on the first night of withdrawal. This is in
contrast to what has been reported, using these
techniques, for nitrazepam (Oswald et al, unpublished),
temazepam, perlspine and sodium amylobarbitone as
reported in other sections, and for sodium amylobarfcitone
and benzoctamine (Ogunremi et al, 1973).
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The lack of disruption of psychomotor perfor¬
mance both when nesor5.dar.ino vms first given and when
it was abruptly withdrawn, was remarkable. No measure
shewed a reliable and. statistically significant drug-
associated change through the period of the study.
Performance on certain tasks tends to improve with
repeated testing. Manual dexterity and digit symbol
substitution are examples of this type. On the former
task the lowest mean session score was on the morning
after the drug was first administered, but the
difference between this score and the mean baseline
morning session score was less than 1%, while the
standard deviation of each was at least 20J", and the
moan midday session score was over 1/' bettor than the
corresponding mean baseline session score. In view
of the inter-subject variability it would bo unreasonable
to ascribe to the drug an effect other than a possible
inhibition of performance improvement. Similarly with
digit symbol substitution, although there was a
deterioration of performance on the morning session of
the third drug test day this possible effect had
disappeared by the midday session and no extrapolative
importance can be attached to it. Withdrawal had no
effect on the performance of these two tasks, even on
the morning after the drug was first replaced by a
placebo.
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Th .Irug appe~ re -d poo -:Lbly to h vs some slight
effect on perf' rm ano-: f : h her w sks at this
point, however, for there was an increase in false
P' silive detections in the vigilance t.-.sk and an
Increase in decision sorting time, which increased
with increasing task complexity. These effects
had disappear .- 5 by mid 1 y.
The overall effect of mosorid sine on perfor¬
mance was, at the most, slight and transitory and no
consistent effect war noticed, even on initial
administration and withdrawal. Thether the lack of
effect resulted from limited drug impairment or from
insufficient test sensitivity will bo discussed in a
letter section. The- lack of offact, however, is in
con.tr st tc the effects of other hypnotics on perfor¬
mance. In a study reported earlier, perl..pine was
sh- m ;o be associated with impairment of performance
and disruption of self-rated subjective feelings in
young adults. A similar pattern of disruption was
noted, in the same study, in a group receiving
amylobarbiton®, Fvc-n in subjects given only - single
dose of a hypnotic significant disruption of
performance has boon shown. For example, several
barbiturates have boon shewn fcr cause 'ocremonts on a
variety of psycho1 gical testa, including pentobarbitone
(Von Felsinger et al, 1953), quinalbarbitone (Kometsky
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et al, 1959)» amylobnrbitono (Malpas ot al, 1979;
Malpas, 1979.), and bu+.ob rbitone (Band and hader,
1972, 1973), a? have novara! non-barbiturate
hypnotics, including flurazep.sm (Bond and Lader,
1977), nitrazepam (Bond and kader, 1972; Malpas et
al, 1979) and diazepam (Bye et al, 1974),
The enly scores in this study which are com¬
parable with those in the studies mentioned above are
on the morning after first administration since the
"residual" effects referred to in some of the studies
cannot be compared to the possible effects of abrupt
withdrawal after continued administration. The acute
effects of mesoridazine on performonce vnuld apnear to
bo less disruptive than the acute effects of other
hypnotic.::, little is known about the effects of these
other hypnotics on performance with continued administra¬
tion and it may be th ? disruption diminishes. Sleep
studies have reported, however- that while tolerance
usually develops and sleep stage patterns return
towards normal this process may take several weeks and
there may be disruption on withdrawal as well.
The lack of disruption of psychomotor performance
coupled with the- limited effects on subjective feeling
states and slow wave sleep, end the potentiation of
P.7M sleep, would indicate that raesoridnzine is a
hypnotic suitable for wide clinical application yet
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there were large inter-individual differences in
response pattern. Some subjects appeared to show
rapid changes, while others appeared to be affected
more gradually through the period of taking the drug
and for longer through the day.
It was considered that such differences might
be related to personality factors and a "post-hoc"
analysis was undertaken in an attempt to discover a
possible relationship. The results of this analysis
will be discussed in Chapter 8.
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CHAPTER 7
REVIEW AND DISCUSSION OF INDIVIDUAL
DIFFERENCES IN PERFORMANCE
The use of normal subjects without resort to
attempts at differentiation employing one or other
personality typology presupposes either a homogeneity
of response pattern among subjects or that any
differences will balance out. These attitudes may
be satisfactory for some research areas but it is
reasonable to assume that if there are different types
•>
of personality and that these different kinds of people
have different response patterns in performance tasks
and on other parameters then the pattern of response to
drugs will also be different.
Implicitly there are difficulties in comparing
personality types. Individual 'atypicality' of
response to drugs may be almost as common as typicality.
Von Felsinger et al (1955, 1956) found approximately 50%
of subjects on such drugs as morphine, amphetamine and
phenobarbitone produced atypical responses. The reason
for this may lie in the variety of other factors involved
in personality but not used as criteria in a particular
study. Subjects may have one personality factor in
common, but may differ in others and a particular
response pattern is likely to result from the interaction
of several different factors. A personality type
implies a pattern of characteristics but the more precise
one becomes, the more difficult it is to find subjects
who match all the criteria. The holistic approach is
often forced to settle for less precision than it would
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like and this unfortunately may make it difficult to
test adequately the predictive hypothesis. The more
general traits, such as introversion-extraversion and
neuroticism, seem to represent a compromise here.
Eysenck (1957) has developed a theory postulating
two fundamental dimensions of personality: extraversion
and neuroticism. Eysenck has inferred that underlying
these behaviourally measured dimensions there are
physiological substrata. The level of neuroticism is
considered to be related to the strength of autonomic
nervous system activation in the presence of anxiety-
provoking stimuli. Extraversion is considered to be
related to the level of cortical arousal and is a
function of the rate of build-up and dissipation of
inhibition. Extraverts are supposed to have a slow
build-up and rapid dissipation of inhibition while the
excitatory processes in introverts are supposed to be
rapid and the inhibitory processes weak and slow.
Eysenck (1967) has suggested that differences are a
function of the level of activity in the ascending
reticular-activating system.
In terms of this theory, introverts are expected
to perform better in vigilance tasks than are extra¬
verts since the persistently heightened arousal level
of introverts facilitates vigilant attention and prevents
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performance decrements which result from inhibition
increments and consequent lowered arousal.
Most researchers have used the extraversion-
introversion dimension when trying to relate persona¬
lity traits to performance, but others have used less
well-known criteria and this sometimes makes inter-
study comparison difficult.
Halcomb and Kirk (1965) used the California
Psychological Inventory and the Wonderlic Personnel
Test and found that while subjects scoring low on
"flexibility" had higher reaction times and subjects
high on "self-control" had a slower vigilance decline,
subjects who had both "high achievement via independence"
and intelligence scores displayed no significant
performance decrement with time.
Halmiova (1965) has studied vigilance performance
in relation to a "psychobiographica!" dimension,
"strength of the nervous system". Eysenck (.1967)
suggested that a weak nervous system corresponds to
introversion. Halmiova found that strong nervous
system subjects made fewer omission and commission
errors and showed a decrease in reaction time with
time on task. These results are a contradiction of
what others have found.
Klapper and McCollach (1972) studied the effects
of two stimulant drugs (caffeine, 500 mg;
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methylphenidate, 20 mg) and two depressant drugs
(secobarbitcne, 200 mg; amylobarbitcne, 250 mg) on
31 non-patient volunteers divided into groups of
normals, neurotic triad, high Ma and Pd, or psychotic
tetrad patterns on the basis of their MMPI profiles.
One motor (pegboard) and two cognitive tasks
(addition, DSST) were used and results showed that
the neurotic triad group were affected by the
stimulants but not by the depressants, the Ma and Pd
group responded to both drug types, while the psychotic
tetrad group was sensitive to depressants and net to
stimulants.
Patkai has carried out a series of studies on
habitual "morning" and "evening" workers, comparing
day-time variations in performance and catecholamine
excretion (Patkai, 1970; 1971a, b; Patkai et al,
1967). Adrenaline excretion was h5.ghest in morning
workers in the morning while evening workers showed
constant excretion values. Morning workers perfor¬
mance, on the other hand, showed little variation
while evening workers showed a gradual improvement
through the day. Patkai (1971a) related "morning"and
"evening" types to extroversion-introversion, as
measured by Cattellfs 16PF inventory, and found a
significant correlation between introversion and
morning workers, and between extraversion and evening
workers.
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Jung (1923) has pointed out that for the extravert
"interest and attention follow objective happenings, and,
primarily, those of the immediate environment". It
follows that the extravort is more sensitive to
novelty and that repetitive stimuli will rapidly lose
their stimulating effect. The Introvert, on the
other hand, 'interposes a subjective view between the
perception of the object and his own action'. Thus
the introvert will be more affected by his motivation
and desire to do the task well, than by the
habituating effects of the stimulus.
Broadbent (1958) reported several experiments
in which extraverts, diagnosed in a variety of ways,
'were shown to perform poorly in comparison with
introverts in pi*o longed tasks. Broadbent also found
that introverts showed a greater tendency to continue
with prolonged training, even though there were no
differences in intelligence,
McGrath and his colleagues have studied individual
differences in performance. Using a battery of
seventeen tests yielding thirty different scores, low
correlations were obtained between the various vigilance
scores and the psychological test measures (McGrath et
al, 1960). Further experiments led to the conclusion
that none of the original significant correlations
appeared in the cross-validation studies and none of
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the new tests yielded significant correlations with
any of the vigilance performance scores (McGrath,
1963a, 1963b; Buckner and McGrath, 1963b).
Bakan (1959), assessing personality with the
use of the sociability scale of the Heron Inventory
(Heron, 1956), studied the interaction between
temperament and time on task. The primary task
comprised listening, for 80 minutes, to digits
presented at the rate of one per second; response
was required to the occurrence of three successive and
different odd digits which were presented at a rate of
10 per 16 minutes. Introverts performed better than
extroverts at this task. When a secondary task was
introduced, however, this difference disappeared.
Bakan interpreted the results in relation to
reinforcement theory and suggested that there was a
greater extinguishing of responses in the extravert
group. Others have suggested that an arousal theory
interpretation would be more appropriate since in a
vigilance situation extroverts may need more stimulation
to maintain a level of arousal adequate for accurate
vigilance (Stroh, 1971). A later study assessed
performance on a similar vigilance task by groups of
extroverts, introverts and 'normals® (Bakan, Belton
and Toth, 1963). The performance of normals and
extraverts, in torms of errors of omission, deteriorated
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with time on task but introverts improved from the
first to the second period and deteriorated only in
the last period. It would appear then that
differences might be considered in terms of the
superior performance of introverts rather than the
inferior performance of extraverts.
Tune (1966b) used a modification of Bakan's
task and found no difference between introverts and
extraverts in terms of errors of omission. However,
introverts were reported to make fewer errors of
commission as a result of greater caution. Other
studies have reported that extraverts made significantly
fewer errors of commission (Davies and Hockey, 1966?
Davies et al, 1969). It might be possible to explain
these results In terms of both reinforcement and arousal
theory, but Davies and his colleagues have favoured the
latter.
Davies and Hockey (1966) reported an experiment
in which the interaction of signal frequency, noise
lovel and temperament were studied in a visual checking
task. Extroverts, selected by use of the MPI, shewed
a deterioration in correct detection with time on task
at both signal frequency levels in quiet conditions
whereas introverts did not. Neither group showed
deterioration under noise conditions (95dB>).
Extraverts made fewer commission errors in quiet than
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in noise: the reverse was true in the introvert
group. Interpretation of these results was made in
torms of arousal theory and it was suggested that
noise raised the arousal level of the extrovert group
to that of the Introvert group in quiet conditions.
It was suggested that noise may encourage extraverts
to adopt a more risky decision criterion than normal,
while making introverts more cautious. Davies and
Tune (19'70) pointed out that in this study the
calculated values were based on group means rather
than on individual scores and it may be that the
meaningfulness of some of the results is doubtful,
particularly in view of the objections to the applica¬
bility of signal detection theory to vigilance data of
this sort put forward by Jerison (1967a) and others.
Jerison (1967) has argued that the application of
the signal detection model is inappropriate since values
of beta computed from vigilance data are not measures
of caution, but are artefacts due to the pooling of
observations made undex- different conditions of
attentiveness during the vigil. This point of view
will be discussed in more detail in Chapter 12.
Davies et al (1969) reported three studies which,
by again indicating that introverts and extraverts
prefer different levels of stimulation for accurate
performance, give support to the arousal theory point
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of view. Subjects were required, in the first study,
to detect the occurrence of three successive and
different odd digits under two noise conditions. The
control condition was silence (EOdB); the experimental
condition comprised continuous varied auditory
stimulation (VAS) i.e. alternating music and speech,
at a level of 80dB. While the performance of intro¬
verts was similar under both conditions, extroverts
improved with VAS, with the reduction in commission
errors being statistically significant. In the second
study the same task was performed under silent
conditions but there was the opportunity to select
periods of VAS as frequently as the subjects wished.
Extroverts requested VAS significantly more often than
did introverts. In the third study the task was
performed under VAS conditions and extroverts were
found to request periods of silence on significantly
fewer occasions than introverts. It would appear
from these results that extroverts felt that VAS
enabled them to perform the vigilance task more
effectively, while introverts felt that silence was
preferable. Thus while the introverts performed
adequately under control conditions, extraverts
appeared to need extra stimulation to maintain their
effort. An explanation in terms of an arousal
hypothesis would seem appropriate, but further
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experimentation, using a variety of intensity levels
and tasks, would have helped to clarify the degree of
variety required for the facilitation of performance
without consequent disruption.
Colquhoun (i960) tested subjects at three
different times of day (1000, 1230 and 1500 hours)
and found that introverts, as assessed by the
sociability scale of the Heron Inventory (1956), had
a high detection rate in the morning while in the
afternoon a high detection rate was associated with
extraversion. A later study confirmed these results
and also showed that afternoon performance was better
than morning performance (Colquhoun 1962a). In a
further study a significant positive correlation was
found between introversion, assessed by the Heron Scale
and speed of work in a cancellation task when subjects
were tested in isolation at 0830 hours (Colquhoun and
Corcoran, 1964). Zero correlations were found with
testing at 1330 hours, and also at 0830 hours when
subjects were tested in a group. If these results
are interpreted in terms of an arousal hypothesis then
it may be suggested that the presence of others is
sufficiently arousing for the performance of extraverts
to be affected.
Kleitman (1933) related diurnal variations in
performance and body temperature and identified 'morning'
141
and 'evening* types. Blake (1965, 1967) attempted
to clarify this relationship in terms of differences
between extroverts and introverts in performance and
body temperature variation. Blake (1965) showed
that cancellation performance varied with body
temperature at five different, times of day with a
positive correlation across subjects between performance
and body temperature at each time of day. In a later
paper it was shown that the correlation between
introversion and oral temperature gradually changed from
being significantly positive to being significantly
negative through the day (Blake, 1967). This result
was replicated in another study using a letter cancellation
task; as was the finding of a clear positive correlation
between temperature and output at ail five testing times
(Blake, 1971). Further studies, reported in the same
paper and using a variety of tasks, including vigilance,
calculations, serial reaction, card-sorting and reaction
time, produced essentially similar results.
The presence of wide individual differences in the
generation of commission errors has frequently been
noted (Bakan, 1955; Wiener, 1963), but their investiga¬
tion as the main dependent variable was first undertaken
by Krupski et al (1971). It was hypothesised that the
kind of person who makes commission errors was likely
to be impulsive and at a chronically low level of
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physiological uiousux. oxnct Impuisivi ty is one of
the components of extroversion (lysenck una Eysenck,
1963) extroversion was suggested to do positively
correlated with comnilssion errors* nosults snowed
that commission errors were related to vigilance
decrement and low eleotrodermul arousal. The
correlation between extraversion and commission errors,
although not significant, suggested there may be a
relationship, especially with the impuisivity
component.
Further evidence in support of a relationship
between the impuisivity component, rather than the
sociability component of extraversion, and performance
pattern has been provided by Thackray and his
colleagues (Thackray et al, 1973, 1974). In the
earlier experiment, individuals who had rated them¬
selves as highly distractable in their daily lives
were found to be unable to sustain attention during a
monotonous task, while self-rated low distractability
subjects sustained attention with no decrement. In
the latter experiment extruverted subjects showed
increasing lapses of attention while introverts did
not and impuisivity was the component responsible for
the decrement. It must be pointed out that in neither
of these studies was shown any relationship between
commission errors and any of the personality variables.
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The two dimensions of L arid N have been discussed
and used extensively as a research tool. More recently
it has been suggested that there exists a "set of
correlated behaviour variables indicative of predis¬
position to psychotic breakdown, demonstrable as a
continuous variable in the normal population and
independent of L and N" (Eysenck and Eysenck, 1968b).
Eysenck and Eysenck (1968c) suggested that "P
(Psychoticism) might be a personality variable of
interest in connection with many experimental
investigations: that it may determine differential
performance either alone, or in conjunction with E
and/or N; and the experimental study of P might throw
much needed light on the nature and meaning of
psychoticism as a personality variable".
The value of the PEN Inventory has been investiga¬
ted both as a clinical and as a research tool.
McPherson et al (1974) found that P scale scores
did not discriminate between 77 psychotics, 32 neutorics
and 112 normals. However, within the psychotic group
those patients who had delusions of * disintegration*
thought disorder and affective flattening had
significantly higher scores than those psychotics who
did not.
Davis (1974), having used the PEN Inventory with
over 100 patients, suggested that P is not orthogonal
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to E and N, that only 5 Items meet the Eysenck
and Eysenck (1968a) criteria for use as a scale and
that the P scale is simply a broader measure of
emotionality than N.
Claridge and Birchall (1973) and Claridge and
Chappa (1973) examined the P scale in relation to
the two-flash threshold and electrodermal activity
and concluded that there is a distinctive and
unstable kind of central nervous system organisation
underlying "psychoticism" which at the lower end of
the continuum falls within normal personality
dimensions but which at the upper end can be seen in
the psychotic disorders.
Stroh (1970) has used the PEN Inventory in the
study of the performance of a large number of subjects
on a visual vigilance task. Correlational analysis
revealed no significant relationship between vigilance
performance and either E or N, but there was a
significant inverse relationship between P and d'.
That it is oversimplifying to generalise about
the effect of stimulant or depressant drugs on
people as a whole, or on different groups, is evident,
in view of the multiplicity and variety of effects
which a single drug may have. Koestler reported
different effects obtained using LSD and mescaline
in groups of subjects from the West Coast and the East
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Coast of .America (boostler, 1961). The formor group
experienced a great variety of subjective effects
while the letter group reported few. Such differences
emphasise the importance of personality and environment
on the effects of a drug.
A complicating factor is that drugs considered
to have a certain type of action do not always have it
so predictably. For example, barbiturates generally
depress activity yet under some circumstances doses
which normally depress activity may stimulate it (Hill
at al, .1957) and in very small doses the effects may be
predominantly stimulant (Read et. al, I960). When drug
combinations are used, a technique which has been
employed in psychiatry, it has been found that ampheta¬
mines can counteract the deleterious effects of
cyclobarbitone and that a mixture can produce effects
which could not be obtained by either drug separately
(Steinberg, 1961, 1964; Steinberg and Rushton, 1963).
Paradoxical effects have been noted in clinical
situations as well, and recently there has been
discussion in the British Medical Journal on the
•effects on patients of benzodiazepines prescribed
for anxiety and depression resulting from situations
of interpersonal tension. There have been several
reported instances of aggression with a very young
child or marital partner usually being the catalyst
(Lynch et al, 1975).
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As none of the above reports studied, groups
selected for differences such as personality type,
the need for caution in the construction of hypotheses
and the interpretation of results is evident
(Trouton and Eysenck, I960).
A theory postulating a greater amount of cortical
control for introverts and a greater susceptibility to
depressant drugs of extraverts due to the reduction of
cortical control was first suggested by McDouga.il (1929).
Eysenck (i960) extended McDougall's suggestion
when he stated "depressant drugs increase cortical
inhibition, decrease cortical excitation and thereby
produce extroverted behaviour patterns. Stimulant
drugs decrease cortical inhibition, increase cortical
excitation and thereby produce introverted behaviour
patterns".
Studies in which the differential effects of
alcohol on performance has been examined have shown
greater effects in extraverts. Drew, Colquhoun and
Long (1953) fcund that in "a skill resembling driving"
extraverts did not change either control movements or
speed very much, that they were less consistent in
control movements and that they showed large increases
in error when under the influence of alcohol.
Introverts, on the other hand, changed speed considerably,
increased control movements and made significantly fewer
errors.
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Jones (1974) tested extroverts and introverts on
Jets X end XI of Raven's Progressiva Matrices. On Set
I no significant differences were found between the
groups. At this stage both groups v/.oce on the
ascending limb of the blood alcohol curve. On Set II,
however, introverts scored better than extroverts while
on the descending limb of the blood alcohol curve
under placebo conditions extraverta performed better
than introverts.
Dinard and Defayolle (1972) studied the
differences in performance patterns between extroverts
~nd introverts, as defined by Lysenck, on nocturnal
vigilance tasks. Although very small groups were used
the introverts performed significantly better than
extraverts and maintained their detection levels through
the night. However, in a variety of other tasks
extraverts performed better, making fewer errors and
faster reactions. Librium appeared to have a stimulant
action on the vigilance of stable introverts and
neurotic extraverts shortening reaction time and
reducing the number of omission errors. The reverse
pattern occurred in stable extraverts and neurotic
introverts. Librium appeared to make overall
performance patterns more homogeneous by attenuating
the inter-individual differences established in the
absence of treatment.
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The effect.s of a stimulant, caffeine, en
vigilance porformuncr in extrrverts rf introverts
have been studied (Keistor and McLauchlin, 1972).
it was hypothesised that the stimulant v.'ould "decrease
cortical inhibition, increase cornice! xcitation and
thereby produce introverted behaviour patternsM. The
effect of the caffeine would bo to maintain the continued
efficiency characteristic of the introvert thereby
inhibiting the performance decrement usually expected
under placebo conditions in the extrovert. The task
was similar to that used by Baker. (1959). As hypo¬
thesised under the no-drug condition, the extroverts
showed a decrement from the first to the last third
of the task, while the introverts o'id not, and under
the effects of caffeine both extroverts and introverts
showed no decrement between the first and last third
of the task.
Generally it seems then that oxtraverts make more
errors of omission and show a greater decrement with
time on task than c'o introverts. It nay be, however,
that consideration should be given to the * abnormal'
response pattern of introverts since in not showing a
decrement with time on task they appeared in one study
to perform differently from normals (Bukan et al, 1963).
Intervening factors may affect this simple
differentiation. Noise (Davies and Hockey, 1966;
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Davies et al, 1969) a secondary task (Bakan, 1959),
caffeine (Keister and McLaughlin, 1972) and
chlordlazepoxide (Dinard and Defayolle, 1972) have
abolished differences in response pattern and it has
been suggested that these factors have served to
raise the arousal of extroverts to a level similar
to that of introverts under the monotonous conditions
of the basic vigilance task.
The relationship between errors of commission
and temperament is less clear. Hypotheses derived
from Eysenck's theory have suggested that there
should be a positive correlation between commission
errors and extraversion. TJhile there has been some
support for this suggestion (Tune, 1966b) results which
have indicated the opposite (Davies and Hockey, 1966;
Davies et al, 1969) or which have been inconclusive
(Krupski et al, 1971; Thackray et al, 1973, 1974)
have also been reported.
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CHAPTER 8
A RETROSPECTIVE ANALYSIS OF PERFORMANCE
IN TWO AGE GROUPS
Since the Eysenck Personality Inventory, Form A,
had been administered routinely to all subjects
participating in experiments in the psychopharmacology
laboratory, a "post-hoc" analysis of part of the data
from two experiments described earlier was undertaken.
It is recognised that great caution must be taken in
extrapolation from such analyses, especially where only
small numbers of subjects are used, and the aim was
solely to obtain illumination on some of the factors
possibly involved in relation to heterogeneous
responsivity.
The data to be re-analysed was generated by the
two groups which had received the 10 mg dose of
mesoridazine. The first group, comprising male young
adults, received mesoridazine nightly for two weeks and
were also studied over a two week withdrawal period.
The second group, comprising male and female middle-
aged subjects, received the drug for three weeks and
were studied over three weeks of withdrawal. The two
groups are not strictly comparable, therefore, and
neither was this the intention. However, if a
dissimilarity of response pattern between personality
type was indicated and if this difference was consistent
across age groups then if such an effect was replicable,
the finding would be of relevance in the clinical
application of the drug.
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Procedure
There were six subjects in the young adults'
group. The three with the highest extraversion
scale scores were deemed extraverts and the other
three subjects were called introverts. In the
older group, 'which contained seven subjects, the
three highest E scale scorers were allocated to the
extraversion group and the lowest three to the
introvert group. The scores of the fourth highest
E scale scorer were not included. The comparison
is therefore between higher and lower scorers on the
E scale rather than 'extraverts' and 'introverts'.
E scale scores were 22, 22 and 16 for the high
extraversion group and 9, 12 and 14 for the lower
extraversion group of young adults, and 16, 17 and 18
for the higher and 8. 10 and 11 for the lower extra-
version groups of older subjects.
Results
The extraverts tended to be less affected by
the drug than the introverts who, in both age groups,
showed at least an initial deterioration in perform¬
ance on several of the tests when first administered
the drug.
In the vigilance task, correct detections by
the extraverts of both age groups increased on
receiving the drug, while in both groups of introverts
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the detection rate fell. In the older age group
this difference reached statistical significance
(p< 0.002) (Table 16). Similarly, in both age
groups, false positive detections showed an onto-
drug decline in extraverts and a rise in introverts.
Consequently the signal detection theory transforma¬
tions d' and beta showed differences between the
personality types across the age groups with onto-
drug increases in both d' and beta for both groups
of extraverts and corresponding decreases for the
introverts with the exception of d* in the older age
group (Tables 15-17).
A similar pattern of onto-drug improvement in
extraverts and deterioration in introverts was
evident on the manual dexterity task. In both age
groups overall performance was significantly better
in the former (Tables ]_8 and 19).
While the performance level of the introvert
groups was higher overall on the digit symbol
substitution task the degree of disruption that
occurred when mesoridazine was administered was
relatively greater (Figures 14,15). These differences
reached statistical significance only in the older
age group (Tables 20 and 21).
In the card-sorting decision time task both
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VIGILANCE IN YOUNGER SUBJECTS
Correct Detections
Weeks 1 2345
(Baseline) (D]_) (Dg) (W^ (WQ)
Groups
High E 21.22 22.44 20.78 17.56 19.89
Low E 25.22 20.44 20.44 17.56 19.33
False Positive Detections
Groups
High E 7.89 4.22 2.44 2.00 1.22
Low E 2.00 3.56 2.00 1.78 1.33
11
Groups
High E 2.792 3.140 3.244 3.130 3.540
Low E 3.693 3.144 3.357 3.120 3.374
(beta) (Log transformation)
Groups
High E 3.88 4.38 5.14 5.25 5.75
Low E 5.49 4.91 5.39 5.22 6.01
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VIGILANCE IN OLDER SUBJECTS
Correct Detections
Weeks i 2 3 4 5 6 7
(Placebo) (D^ {Dq) (D1&) (W?) (Wg) (W15)
Groups
High E 24.67 27.56 24.00 26.22 26.67 26.56 24.56
Low E 18.33 15.67 15.56 19.00 17.11 16.33 11.44
Source of Variation DF SS MS VR
Groups 1 2876.22 2376.22 75.833
Weeks 6 263.65 43.94 1.159
Sessions 2 1.73 0.87 0.023
Groups Weeks 6 160.89 26.81 0.707
Groups Sessions 2 46.03 23.01 0.607
Weeks Sessions 12 564.83 47.07 1.241
Groups Weeks Sessions 12 238.54 19.88 0.524







VIGILANCE IN OLDER SUBJECTS
False Positive Detections
Weeks 1 2 3 4 5 6 7
Groups
High E 32.1 22.0 19.6 17.7 26.1 18.3 11.4
Low E 18.2 28.7 14.6 10.0 10.4 4.3 5.6
11
Weeks 1 2. 3 4 5 6 7
Groups
High E 2.315 2.653 2.673 2.748 2.688 2.917 3.030
Low E 2.567 2.702 2.656 2.599 2.817 3.048 2.840
(beta) (Log transformation)
Weeks 1 2 3 4 5 6 7
Groups
High E 2.65 2.75 3.03 3.06 3.00 3.74 3.59
Low E 2.82 2.60 3.08 3.51 3.64 4.34 4.12
TABLE 18
MANUAL DEXTERITY IN YOUNGER SUBJECTS
Weeks 1 2
Groups
High E 39.17 40.89
Low E 36.93 35.25






































Source of Variation DF SS MS VR
Groups 1 420.75 420.75 9.264**
Weeks 6 110.16 18.36 0.404
Sessions 2 85.22 42.61 0.938
Groups Weeks 6 28.43 4.74 0.104
Groups Sessions 2 0.11 0.06 0.001
Weeks Sessions 12 11,08 0.93 0.020
Groups Weeks Sessions3 12 12.11 1.01 0.022
Residual 84 3815.11 45.43
TOTAL 125 4482.97
TABLE 20
DIGIT SYMBOL SUBSTITUTION IN YOUNGER SUBJECTS
Weeks 1 2 3 4 5
Groups
High E 205.7 200.6 196.0 205.1 218.1
Low E 210.9 209.8 196.2 215.9 226.4
TABLE 21
DIGIT SYMBOL SUBSTITUTION IN OLDER SUBJECTS
Weeks 1 2
Groups
High E 184.7 193.6
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High E 13.09 13.77
Low E 13.33 13.94
Four Categories
Groups
High E 18.06 18.04
Low E 18.03 18.64
Eight Categories
Groups
High E 23.17 23.04
Low E 23.34 20.11
5
13.40 12.67 14.78 14.37 14.33
14.87 17.39 14.50 15.38 12.54
16.73 15.57 19.59 17.40 17.51
20 <21 19.91 13.79 19.06 17.71
21.90 22.39 22.69 22.58 21.79
22.89 23.47 20.99 21.28 19.73
the drug, in comparison with baseline, and both groups
of introverts showed a decline at all three different
levels of complexity, although these differences were
significant statistically only in the younger age
group (Figures 14,15 Tables 22,24).
The effect of the drug on subjective feeling
states appeared to be greater on introverts as well.
Figure 16 shows that in the older age group, while
there was little initial difference in the effect of
mesoridazine on self-rated subjective concentration,
the introverts continued to be affected throughout
the drug period, in terms of frequency of fluctuations
greater than two standard deviations from the mean,
and that this effect continued into withdrawal.
Discussion
This 'post-hoc' analysis of data gathered in
earlier experiments yielded information of interest on
several grounds. First, the consistent difference
of response patterns between extraverts and 'introverts',
across age groups, with the administration of mesori-
dazine occurred on almost all the parameters. Despite
the small numbers involved statistically, significant
differences were obtained on several of the comparisons,
and notably on the manual dexterity and vigilance tasks.
It had been concluded, especially in the study of
the effects of mesoridazine on subjects in the older age
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group, that the drug had little disruptive effect on
performance, even with continued administration and
abrupt withdrawal. More detailed examination of the
data has suggested, however, when the subjects are
divided into groups on„the basis of an extensively
documented typology, that not" onl-y^rfiay the dSrug have
an initially deleterious effect* on performance but.
that disruption may in some cases increase with
continued administration. It is possible, also,
that abrupt withdrawal might, in some instances, cause
a deterioration where no decrement had occurred on
initial administration.
Averaging of subjen+s' performance scores is
intended to give a general picture of the general trend
of change with repeated ^-testing under different
conditions.,-., These data are sometimes adequate but
•-*<-;.,%v >;v .. a - - / •. • <«. v-
when the effects of a drug: are. being assessed, greater
caution is needed since, while the majority may not be
affected, there may be some who are affected to the
extent of being at risk in some situations, e.g. driving.
This 'post-hoc' analysis suggested that some people may
be effected more than others, both objectively and
subjectively, and that the extent of the effects may be
related to personality type. However, retrospective
analysis of data from such small groups is of little
value unless the results can be replicated using larger
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groups of subjects. Consequently a larger st
was planned and this is described in chapter 9
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CHAPTER 9
. corp.yiiscM or nr fffcts or r r: rio.v/ii:-
01! IT GROUPS OF CUD":! SUBJECTS
Introduction
A further study was designed as a result of the
possibility that mesoridazine has differential effects
on different personality types. It was predicted
that if there were differences between groups examined
on a 'post-hoc' basis, and that if these differences
were consistent across subjects of different ages,
then the differences should be greater in subjects
selected for their polarised scores on the same
parameter. The hypotheses were put forward that
introverts would be affected to a greater extent than
would extraverts of the same age group on both a
battery of psychomotor performance tests and self-
rated feeling states, and both Initially and with
continued administration.
Subjects
A large number of individuals, all over the age
of fifty and known to be willing to be subjects in
studies in either the sleep or performance laboratory,
were sent a study description. If willing to
volunteer for this study, they were asked to complete
the Eysenck Personality Inventory, Form A. All
subjects chosen had scored at least one and a half
standard deviations above or below the mean. The
extravert group had a mean age of 56 years and a mean
E scale score of 16.75 (S.D. =2.71; range ■ 14-21)
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and the introvert group had a mean age of 58 years
and a mean E scale score of 6.75 (S.D. = 2.12;
range = 4-9). The N and L scale scores for the two
groups were not significantly different. The extra-
vert group had a mean N scale score of 8.5 (S.D. «
4.63) and an L scale mean of 2.63 (S.D. - 1.41);
the N scale mean for the introvert group was 7.5
(S.D. « 4.84) and the L scale mean score was 3.13
(S.D. » 1.96). There were eight subjects in each
group. The extravert group contained five women
and three nk.n; the introvert group contained three
women and five men. None had taken CNS drugs in the
preceding months and all agreed to refrain from taking
alcohol for the period of the study.
Procedure
Subjects attended the laboratory weekly over a
period of six weeks. The first attendance was for
orientation and practice and scores were not included
in the analysis. Testing weeks 1 and 2 provided
placebo baseline scores. The active drug was
administered for the first time the night before test
day 3 and by test day 4 the subjects had had eight
nights of mesoridazine (10 mg). The subjects continued
to receive the drug capsules for another six nights
before they were substituted by matched placebo controls.
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Thus on test day 5 the subjects had received placebo
again for the first time the night before testing,
and a measure of any early withdrawal effects would
be obtained.
Subjects reported to the laboratory at 0915 hours
on each test day and the three testing sessions,
following the "two hours on - two hours off" schedule,
started at 0930, 1330 and 1730 hours.












In the auditory vigilance task subjects were
instructed to respond more fully than was required in
the other studies. The task was the same as described
in the methodology (Chapter 3) i.e. signals occurred
every two seconds and lasted 500 msec, while target
signals occurred infrequently and lasted 400 msec.
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Detection of a target signal was recorded, first, by
pressing an identifier button and, second, by pressing
one of the three confidence buttons, which corresponded
to the opinions - 'very sure', 'reasonably sure' and
'not at all sure'. Binford and Loeb (1966) studied
response patterns during a vigilance task in a group
which simply reported whether or not they thought a
signal had occurred and in a group allowed three
categories of response confidence. They reported that
correct detections improved only slightly over 9 sessions
while commission errors decreased, with the multiple
criterion group making consistently fewer errors.
Using signal detection theory analysis, they concluded
that there was a gradual decrease in the discrimin-
ability of the stimulus and an increase in the level of
caution employed by the subjects, thus indicating a
reduction in confusion about the characteristics of
the signal with repeated testing.
A confidence level rating method has been used
in both auditory and visual vigilance tasks in the
detection of a target signal (Broadbent and Gregory,
1963a). It was concluded that the ratio of detections
to false positive detections became less as responses
of lower confidence levels were included, and that
there was little change in d' during the session, while
increased with the most cautious criterion but not
with the riskiest criterion.
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The Logical Reasoning task was included, for the
first time, since it was felt that none of the other
tasks in the battery adequately measured intellectual
agility. The DSST task measures concentration and
memory, while the card-sorting task measures informa¬
tion processing, at varying levels of complexity, but
is straightforward and subject-paced. It was considered
that an experimenter-paced test of correct and incorrect
syllogism recognition might detect, any drug-induced
impairment of intellectual function. Forty slides
of simple logical propositions were projected onto a
large screen so that the words were clearly legible to
all subjects. The 40 slides were projected onto the
screen for 5 seconds each by an automatic projector,
which had been cued to pause for five seconds after the
twentieth slide. The first twenty slides contained
statements including the word 'follows', e.g.
A follows B BA
A follows B AB
B is followed by A BA
B is followed by A AB
The subject's task was to decide whether the statements
were logically consistent. The second block of twenty
slides followed a similar pattern but the word 'follow'
was substituted by 'precede'.
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This form of reasoning task was used in
preference to others since any impairment of this
faculty is more likely to bo detected in an experimenter-
paced task. Furthermore, the task requirements are
fairly simple and a long-term practice effect is
unlikely to occur, while the rearrangement after each
session of the presentation order within each twenty
slide block precludes the possibility of a high number
of correct responses as a result of a response set
rather than examination of and response to each slide
individually.
A second placebo baseline test day was included
in this design to establish whether repeated testing
under placebo conditions resulted in an improvement
in performance in a way similar to that reported in
Chapter 4 in young adults. With only one baseline
record a lack of change from baseline could be inter¬
preted as either a lack of drug effect or as an
inhibition of improvement. With two baseline records,
however, it might be possible to draw conclusions about
a drug's effects on the basis of the degree of
difference between the two baselines. Thus an improve¬
ment in performance from the first to the second
baseline followed by a continued improvement with the
introduction of the drug might indicate that the drug
does not have a noticeably deleterious effect while a
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pattern of either no change or decrement might
indicate that tho drug has either an inhibitory or
more deleterious effect.
During the second placebo test day, subjects
completed two further personality inventories. The
Eysenck Personality Inventory, Form B, and the PQ
inventory were administered in order to assess test-
retest reliability in the two groups and to examine
tho assertion that the 'Psychoticism' scale is of
experimental value (Eysenck and Eysenck, 1968s:
Claridge and Birchall, 1973; Claridge and Chappa,
1973* Stroh, 1970). The PQ Inventory, a development
of the PEN Inventory, has several different forms and
an example of the version used is enclosed in
Appendix 1.
Results
Analysis of variance revealed no statistically
significant differences between the correct detection
rates of the two groups. Examination of the overall
mean scores by week revealed that the extravert group
detected more signals after the first week, with a
slight improvement on taking the drug and also on its
withdrawal, while the introvert group showed an onto-
drug decrement which disappeared on withdrawal
(Table 25Figure 17). Examination of the morning
session data showed a decrement, with the introduction
163
FIGURE 17
THE EFFECT OF MESORIOAZINE ON TWO GROUPS OF OLDER SUBJECTS
CORRECT IDENTIFICATION
o High extraversion n=8












THE EFFECTS OF MESORIDAZINE ON TWO GROUPS OF OLDER SUBJECTS
MANUAL DEXTERITY
° High extraversion n = 8

















SESSIONS 1 o Qo Mean S.D.
Groups Weeks
High E I 2.6.87 2^.75 23.50 24.71 8.7
2 27.11 24.00 2^.75 25.29 8.7
3 26.25 24.63 26.63 25.83 8.7
4 26.50 24.2.5 26. .11 25.63 10.7
5 26.00 28.37 24.37 2,6.25 9.4
Low E 1 25.25 25.11 25.11 25.17 10.1
2 25.87 22.62 21.87 23.46 8.4
3 22.50 24.87 22.62 23.33 7.8
4 21.75 22.75 26.00 23.50 9.5
5 25.00 24.37 23.11 24.17 7.7
of the drug, in both groups but the impairment was
relatively larger and increased in the introvert group,
disappearing only on withdrawn!.
More detailed examination of the correct detection
vigilance data, by dividing the one hour task into .15
minute sections and scoring the moan correct detections
in each section in order to assess any change in
response pattern through the session, indicated that
the performance of both groups deteriorated with time
on task under baseline conditions (Tab!026)• On
the first baseline test day the overall mean score of
the introvert group was slightly better but this
pattern was reversed on the second baseline test day.
Examination of these data by session revealed no
significant pattern of difference. Drug administration
appeared to have little effect on overall mean detection
scores in either group, with the introvert group
continuing to show more deleterioration through the
sessions. Withdrawal produced an improvement in
detection rates in both groups (Table 25)• Examination
of the morning session data revealed that the extravert
group was less affected by the introduction of the drug.
Withdrawal showed an improvement in detections,
especially in the earlier part of the session, but a
decrement did occur in the last quarter where improve¬
ment had been the pattern in previous v/eeks. The
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introvert group showed an onto-drug decline in
detection in the morning session, especially in the
first part of the session (Table 28). This decrement
had disappeared by midday. A similar, but less
marked, decrement was evident after eight days on the
drug, but this was abolished with withdrawal. In the
last quarter of the withdrawal test day morning session
the introvert group also showed a progressive decline
in detections through the session where the previous
pattern was one of late improvement. It may be,
therefore, that withdrawal of the drug improves alert¬
ness but impairs the ability to sustain attention and
improve performance in anticipation of the end of the
task.
The correct detection confidence level chosen by
subjects in both groups tended to increase with repeated
testing. In both groups, on both baseline days, there
was a percentage increase in high confidence detections
through the day, with subjects being relatively more
confident in their detections in the later sessions of
the second baseline test day (Table 29).
Introduction of the drug did not impair the percentage
of high confidence detections in either group, indeed
there was an increase, notably in the morning session
in both groups. The pattern of increasing confidence
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High £ 1 7.250 7.250 7.000 6.750 8.500
2 6.750 7.375 5.875 6.750 6.375
3 6.250 5.875 6.375 6.125 6.250
4 6.625 6.500 6.500 6.875 4.875
Low E 1 7.375 7.375 5.875 6.500 8.000
2 6.125 6.000 6.500 6.250 6.250
3 6.750 5.500 4.375 4.250 5.875
4 5.250 6.000 5.750 5.750 4.875
TABLE 29
VIGI LAI-ICE i CORRECT DETECTIONS
Detections at the highest confidence level
as a percentage of total detections
Morning Session
Weeks 1 2 3 4 5
Groups
High E 48 47 59 74 48
Low E 48 49 56 66 64
Midday Session
High E 49 63 63 70 76
Low E 53 53 61 67 67
Afternoon Session
High E 53 61 75 76 73
Low E 56 60 65 59 64
remained most noticeable in the morning session.
The general pattern of increasing confidence in the
correctness of correct detections was disrupted by the
withdrawal of mesoridazine. In the midday and after¬
noon sessions there was little difference from
confidence levels while on the drug and in the morning
session there was a decrease in percentage high
confidence detections, especially in the extrovert
group which showed a decline from 74/' to
False positive detections declined with repeated
testing in introverts. There was a slight onto-drug
increase in commission errors in the extrovert group
but this was not statistically significant and +he
pattern of responding was essentially similar in the
two groups, although the level was significantly higher
in the extravert group (Table 30 Figure 17). However,
on the morning after first taking the drug the extravert
group made more commission errors than at any other time
in the study, 'while the introvert group showed a decline,
which persisted through the day.
Examination of the false positive detection data
by quarter-hour showed that there was little decline in
detection levels with time on task in either group under
placebo conditions (Tableg The extravert group
responded at a higher rate on both baseline days and
this pattern was not affected by mesoridazine or its
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TABLE 30
VIGILANCE: FALSE POSITIVE DETECTTONS
SESSION
Weeks 1-L n 3 Mean
Groups
High E I 42.9 27.5 26.7 32.4
O 40.4 28.7 33.6 34.1
o
o 44.9 29.6 33.5 36.0
4 24.2 22. 1 26.5 24.3
p;
o 21.1 25.9 23.6 23.5
Low n i 30.6 23.5 24 .0 26.0
o 29.0 26.5 22. 1 25.9
Q 24. 2 17.2 13.9 18.5
4 20.9 17.5 16.7 18.4
5 13.1 14.7 17.4 15.1
Source of Variation DF SS MS VR
Groups 1 5217 5217 5.036*
Weeks 4 4473 1118 1.079
Sessions 2 1659 830 0.801
Groups Weeks 4 1077 269 0.260
Groups Sessions 2 193 97 0.093
Weeks Sessions 8 1689 211 0.204
Groups Weeks Sessions 8 547 68 0.066
Residual 210 217553 1036
TOTAL 239 232408
TABLE 31
VIGILANCE: FALSE POSITIVE DETECTIONS
Mean score by quarter--hour
Weeks 1 2 3 4 5
Groups
High E 1 8.75 9.43 9.33 6.96 7.69
2 7.67 8.17 8.58 5.29 6.00
3 7.30 7.50 9.00 4.71 5.00
4 8.67 9.17 9.19 6.67 4.75
Low E iL 5.96 5.33 5.79 4.50 4.67
9 5.33 6.17 5.71 5.19 3. 11
3 5.03 5.71 5.11 4.46 3.04
4 5.54 6.37 5.54 5.96 4.30
TABLE 32
Source of Variation DF SS MS VR
Groups 1 1292.70 1292.70 17.439***
Weeks A 969.55 242.39 3.270**
Sessions r\ 369.00 184.50 2.489*
Division 3 207.85 69.30 0.935
Groups Weeks A 174.19 43.56 0.588
Groups Sessions p 46.19 23.11 0.313
Weeks Sessions 8 453.66 56.71 0.765
Groups Division 47.15 ^5.73 0.212
Weeks Division .1.2 CO•CO 7.75 0.105
Sessions Division 6 166.55 27.76 0.374
Groups Weeks Sessions 8 166.19 20.78 0.280
Groups Weeks Division 12 83.05 6.93 0.093
Groups Sessions
Division 6 64.08 10.68 0.144
Weeks Sessions
Division 24 309.66 12.00 0.174
Groups Weeks Session
Division 24 324.11 13.51 0.183
Residual 840 62266.69 74.13
TOTAL 959 67033.63
withdrawal. The difference in response level between
the groups was statistically significant (p < 0.001).
Administration of the drug was associated with an
increase in responses in the extravert group and a
concomitant decline in the introvert group. There
was a reduction in commission errors by both of the
groups in the second, drug week, this was substantial
in the former group, while scores increased in the
extravert group and decreased in the introvert ctroup
on the withdrawal tost day.
There were no differences between the two groups
on the manual dexterity task, even on the morning after
•first administration and after withdrawal (Table 33
Figure 18)* Throughout, the extravert group were
slightly quicker, but there was greater inter-subject
variability; both groups improved through the day and
from week to week, but these changes were not
statistically significant.
The extravert group was significantly slower on the
DSST (p^LO.OOl) (Table ^Figure is). There was a non¬
significant overall mean onto-drug decline in perfor¬
mance in this group and a similar occurrence on withdrawal.
Examination of the data by sessions indicated that the
onto-drug decrement occurred in the midday and afternoon
sessions and that in the morning session there was a
slight improvement over both baseline morning session






























































High E 1 170.63 177.87 169.63 172.71 + 24.5
2 181.00 191.75 191.11 187.97 + 28.2
3 183.37 185,00 184.75 184.04 24.4
4 186.no 188.75 186.87 136.87 ± 22'6
5 191.60 187,63 173.75 183.96 + 33-9
Low E 1 181.60 186,75 192.25 186.83 + 24.2
0 188.13 139.35 205.87 194.43 ± 28.9
3 201.75 199.02 198.75 199.83 * 28.8
4 209.50 208.87 196.11 204.83 ± 31.1
5 211.37 199.75 209.00 206.71 ±. 31.1
Source of Variation
Groups 1 14260.4 14260.4 16.343^
Weeks 4 8120.7 2030.2 2.326
Sessions 2 5"*.7 28.9 0.033
Groups Weeks 4 1707.6 426.9 0.489
Groups Sessions 2 809.4 404.7 0.464
Weeks Sessions 8 3285.8 410.7 0.471
Groups Weeks Sessions 8 2013.9 251.7 0.288
Residual 210 183256.0 872.6
TOTAL 239 :213511.4
affect performance in the morning session either but
performance was relatively poorer on both of the later
sessions. The introvert group also showed a pattern
of slight onto-drug morning session improvement and
afternoon session decrement but in this instance the
effect persisted into the second drug week.
Withdrawal had little effect.
The extravert group made significantly more
errors in the logical reasoning task (p < 0.05)
(Table 35). The general pattern, in both groups,
showed a decline in errors with repeated testing, but
there was a slight and non-significant increase in
errors on the morning after first taking the drug.
This effect did not persist until the midday session.
Withdrawal had little effect on extraverts and did not
inhibit the gradual, but non-significant, decrease in
errors by the introvert group.
There were no statistically significant differences
between the groups on the card-sorting task. Overall
mean scores were higher after the extraverts went onto
the drug, at all levels of complexity. The same was
true for the introverts at the two simpler levels
(Figure 19, Tables 36, 37). Withdrawal of the drug
was associated with a slight improvement in the
performance of the extraverts and a slight deterioration
in the performance of the introverts.
168.
































SESSIONS I 2 NJ Mean
Groups
High E 1 4.75 6.00 3.13 4.63
2 2.75 2.87 2.75 2.79
3 3.00 2.12 2.12 2.43
4 2.12 1.00 1.25 1.46
5 1.87 2.25 1.37 1.83
Low E 1 2.25 1.62 1.50 1.79
2 0.75 3.75 0.50 1.67
3 1.50 2.00 1.00 1.50
4 0.87 0.87 2.50 1.42
5 0.50 0.50 0.50 0.50
Source of Variation DF SS MS VR
Groups 1 93.75 93.75 5.679*
Weeks 4 12.1.21 30.30 1.836
Session s 2 16.43 8.22 0.497
Groups Weeks 4 49.21 12.30 0.745
Groups Sessions 2 7.07 3.54 0.214
Weeks Sessions 8 44.63 5.58 0.338
Groups Weeks Sessions 8 50.97 6.37 0.386






Category 1 2 3
Groups Weeks
High E 1 9.55 16.10 18.45
2 12.06 16.41 21.44
3 10.89 17.84 20.49
4 11.44 17.41 21.06
5 12.74 17.22 20.32
Low E 1 10.85 16.45 21.26
2 13.35 18.37 21.25
3 12.45 17.55 20.54
4 12.94 17.22 18.03
5 13.91 17.06 20.64
Middav Session
High E 1 10.83 17.56 18.71
2 13.71 18.54 19.51
3 13.17 16.19 19.07
4 13.69 18.30 21.11
5 11.82 16.66 19.19
Low E 1 11.81 17.00 19.31
2 13.36 16.61 18.65
3 11.73 17.00 18.85
4 11.77 16.76 19.51
5 12.54 17.86 18.22
TABLE 37
CARD-- SORTING: DECISION TIME
Afternoon Session
Category 1 O 2j
Groups Weeks
High E 1 12.56 17.22 19. 36
2 11.30 16.40 19. 42
3 12.67 16.39 IB.
A 12.54 18.60 21. 09
5 11.93 15.94 20. 09
Low E i 11.22 15.76 17. 36
p 12.97 16.96 18. 86
o 12.76 16.57 20. A A
11.30 16.55 18. 69
5 12.12 16.19 20. 37
Week Mean Score
High E 1 10.98 16.96 18. 84
2 12.36 17.13 20. 11
3 12.25 16.80 19. 23
4 12.55 18.10 21. 90
5 12.16 16.61 19. 87
Low E 1 11.30 16.40 19. 31
2 13.23 17.32 19. 59
3 12.31 17.04 19. 94
4 12.00 16.85 18. 74
5 12.86 17.04 19. 74
The presentation of the self-rated feeling statei —'
data takes two forms. In the first, the data were
calculated by taking the mean of each subject's drug
and withdrawal day deviations from his baseline mean,
. s described in the methodology. Using this approach,
slap quality was rated as better than under placebo
conditions by both groups (Figure 20)- Withdrawn!
had a deleterious effect initially, especially- for the
introvert group,, but this effect, quickly disappeared.
Morning vitality was reported by both groups to be
impaired during the a.drn.inistrntion of the drug,
especially in the second week, but this disruption
disappeared on withdraw 1 (Figure 2l) • Mesor.idnzine
had little effect on self-rated anxiety and concentra¬
tion in either group for the period of the study
(Figures 22, 23).
Examination of the raw data, however, led to the
conclusion that there was wide inter-subject variability,
under placebo baseline conditions, in the estimation of
self-rated feelings both from day-to-day and from week-
to-week. Some reported little fluctuation while others
reported good sleep one night and very poor sleep the
following night. Calculation of post baseline
fluctuations based solely on baseline means tends to
give disproportionate emphasis to the reports of the
latter type of subject, with the paradoxical possibility
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FIGURE 20
MESORIDAZINE: SELF-RATED SLEEP QUALITY IN TWO GROUPS OF OLDER SUBJECTS
Days since drug first taken
MESORIDAZINE: SELF-RATED MORNING VITALITY IN TWO GROUPS OF OLDER SUBJECTS
2 A 6 8 10 12 U 16 18 20 22
Days since drug first taken
FIGURE 21
FIGURE 22
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SELF RATED SLEEP QUALITY
Week by week comparison
Source of Variationt DF SS MS VR
Groups 1 115749 115749 3.505
Weeks 5 716496 143299 4.339***
Days 6 179471 29912 0.906
Groups Weeks 5 368451 73690 2.231*
Groups Days 6 203579 33930 1.027
Weeks Days 30 467616 15587 0.473
Groups Weeks Days 30 547765 18259 0.553
Residual 588 19420016 33027
TOTAL 671 22019136











DF SS MS VR
1 312909 312909 7.970***
1 480973 480973 12.251***
13 241336 18564 0.473
1 102284 102284 2.605
13 281351 21642 0.551
13 275095 21162 0.539




SELF RATED MORNING VITALITY
Second and third placebo weeks compared with drug weeks
Source of Variation DF SS MS VR
Groups 1 49335 49335 1.520
Condition 1 785197 785197 24.191***
Days 13 426565 32813 1.011
Groups Condition 1 125427 125427 3.864*
Groups Days 13 164881 12683 0.391
Condition Days 13 380069 29236 0.901
Groups Condition Days 13 220059 16928 0.522
Residual 392 12723850 32459
TOTAL 447 14875379
that such a report night not be any larger than
occurred under baseline conditions end oven then night
obliterate a relatively large fluctuation reported by
the former type of subject.
In order to assess a more equitable distribution
of reported disruption, the same self-rated feeling data
are presented in another form, A second transformation
of the data was carried out. The baseline mean and
standard deviation were calculated for each subject and
the post-baseline fluctuations were calculated as per¬
centages of the baseline standard deviation. Thus a
subject who reported little fluctuation during baseline
would have a small standard deviation and post-base.line
changes, which might be small in relation to the reports
of others but which were large in comparison with base¬
line fluctuations, would be given the relative emphasis
they warranted. The swamping effect of the reports of
subjects with large fluctuations, on the other hand,
would be diminished since post-baseline fluctuations
would be reduced when calculated as a percentage of their
large baseline standard deviations.
Examination of self-rated sleep quality in this
way showed that while the introvert group reported little
change with the introduction of the drug, they did
experience a slightly deleterious effect on initial
withdrawal (Figure 25)* The extravert group, on the
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other hond, reported an improvement in sleep quality,
especially initially, which disappe .-.red on withdrawal
without noticeable disruption (Figure 24/. Statistical
comparison over the whole study revealed a Groups X
b'oeks interaction (p< 0.05) and comparison of the
second and third placebo weeks with the two drug weeks
confirmed the difference in :e ported sleep quality
between the two groups while receiving thr drug
(Table 38).
Morning vitality was reoorted to be reduced onJ i
receiving the drug by both groups. This effect was
greater in the second drug week and the- effect was
overall greater in the extravert group (Figures 26, 27).
There was a significant Groups X Conditions interaction
(p< 0.05) (Table 39). Withdrawal caused little
disruption in either group but there v/as a tendency for
the extraverts to rate their vitality positively and for
the introverts to rate negatively,
Mesoridazine and its withdrawal had little effect
on self-rated anxiety in either group (Figures 28, 29),
Indeed three of the four highest mean ratings of anxiety
for both groups in the whole experiment occurred at the
start of the study and are probably associated with
attendance at the laboratory for the first time.
Mesoridazine and its withdrawal had no observable
effect on concentration in the introvert group (Figure 31)#
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FIGURE 24 Feeling state rated as a percentage of
baseline standard deviation.
MESORIOAZINE: SELF-RATED SLEEP QUALITY
IN 8 OLDER EXTRAVERTS
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In the extravert group, however, there was an initial,
but non-significant focilitatory offeci, which
disappeared in the second drug week (Figure 30/.
Discussion
There were significant differences between the
oxt:.averts and introverts on several of the measures
used. Only on the manual dexterity • nd card-sorting
tasks were nc differences found and examineticn of the
cluta revealed similarities between response p. t.terns in
this study and the 'post-hoc1 analysis reported earlier.
In both studios extroverts showed a slight onto-drug
improvement in vigilance correct detections, while
introverts' accuracy slightly declined. The deteriora¬
tion in the introvert group continued into the second
drug test day and declined only on withdrawal. Overall
accuracy was greater in the extrovert group, a pattern
also found in tho previous study, and this was seen
to result from tho decline in the number of detections
with time on task in the introvert group since the
detection rates in the early part of the sessions did
not differ. This finding is in contradiction to the
reports of others. Generally, decrements with time
on t sk have been found in extrovert groups. However,
in this study, on both baseline days, a greater first to
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FIGURE 31
During baseline and drug administration, morning
session accuracy of detection decreased through the
first three quarters of the task and increased again
in the last quarter in both, groups. This 'end-spurt'
rheeoncnon, which has also been reported by others,
occurred even though the sub jcots were deprived of
their watches# On the test day following withdrawal,
however, this pattern did not occur. Doth groups
showed a prooressive decline from £5.r~t to last
quarter, with higher than usual initial detections.
"r-'-
may bo, therefore, that the withdraw:-.! of mesoridazine
improved alertness but inhibited the ability to maintain
■attention over a sustained period of time.
The possibility that detection may have been
disrupted on the morning after a placebo first replaced
the active drug is supported, in the extravert group at
least, by the evidence that the confidence the subjects
placed in their detection accuracy was diminished.
False positive detections again showed a decline
vrith repeated testing and were at a higher level in the
extravert group. Introduction of the drug increased
errors by the extravert group, especially in the morning
session, while errors by the introvert group declined.
Thus mesoridazine increased response rate in the former
group and decreased it. in the latter.
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In the retrospective analysis described in
Chapter 8, both groups v/ere rcoc rted to improve on the
manual dexterity tack with repeated testing; the
extrovert group being quicker throughout and showing
«n onto-drug improvement, while the introvert group
showed u concomitant decrement. In this study, both
groups again shewed progressive improvement, and the
extroverts were again quicker, but .introduction of the
drug hud no effect on wither group, even in the morning
session.
The extrovert group were again slower on the digit
symbol substitution task. Both groups showed .n onto-
drug morning session improvement in performance which
disappeared later in the day. The introvert group
showed a similar deterioration through the day when
tested after having received the drug for eight days.
While the introduction of mesoridazine did result
in a reduction in the correct detection rate in the
introvert group the general ont<>~drug deterioration
which was reported in the 'post-hoc1 analysis was not
evident in this study. The pattern of response was
often similar in the two groups and the significant
differences in the statistical analyses refer more to
the differences in level of response between the two
groups. The extrovert group had more correct and
false positive detections in the vigilance task and
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were quicker in the manual dexterity task but the lack
of significant statistical inters.ct 1 ens implies that
the introduction and withdrawal of the drug had little
disruptive effect.
It was evident, however, that the drug was not
without effect because both groi.ros of sub' -ata rated
their feelings while taking the drug as significantly
different from their feelings under pi?cob''" baseline
conditions. Tt was suggested, in the introduction,
that the introvert group wonId report greater
subjective disruption while taking the drug then
would the extravert group, Th"* reverse was true.
The introvert group did report d5.srupt5.cn of morning
vitality and a transient withdrawal effect, on sleep
quality, but clearly the greater disruption occurred
in the ext.ravert group. Although sleep quality was
improved, morning vitality was also clearly affected
and this disruption disappeared only on withdrawal of
mesoridazlne.
In the conclusion of Chapter 8 it was suggested
that the exercise of caution in the interpretation of
the extent of a drug's effect is essential. The
possibility of the need for such caution had been
suggested by the retrospective analysis of part of the
data from the studies described in Chapters 4 and 6.
Thus, while the results of the main studies had
indicated that the introduction of mesoridazine had
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little effect on performance, the division of the
subjects into groups on the bo sis of persona.15.ty.
tune had suggested lifforenti'1 response patterns.j t _> .1
Consequently, it v/?.s predicted that the performance
f individuals having low scores on the E scale of
lha Eysenck Personality inventory would be more
affected by the introduction of mosor.idazine than
would the performance o~ individuals ••■/ith high E
scale scores. This study no4- only foiled to support
that hypothesis but, in sons instances, implied the
opposite. In the extrovert group the disruption
of morning vitality, especially with continued
administration of rnesoridszina, coupled with the
positive assessment of sleep quality, indicated a
possible hazard since although the subject had had
subjectively better sleep, he was also less alert.
The lack of a drug-induced effect on performance on
the battery of tests does not preclude the possibility
of a deleterious effect on skilled performance since
in a performance laboratory a subject may be able to
compensate for a drug's effects by increasing effort
when this would not be possible in a 'real-life*
situation. This problem will be discussed in
Chapter 12.
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Eysenck Personality Seal,. Tost-retest Scores
As describe-' : rlior, '-•-'"■iocts frr this study were
selected en the err: orion that their scores were, at
least, one and a half standard deviations above or
L ien/ the mean of the total group tested, on Form A
of .he F.P.I. The mean L scale score cf the extrovert
group wac 16.75 {stanch.rd deviation 2.71) and of the
introvert group 6.75 (h.P. 2.12). Cn the third
attendance at the performance laboratory, which was the
second placebo baseline test day, all the subjects were
asked to complete Form E of the F.P.I, and the PQ
Inventory. Or. this occasion the E scale scores were
only slightly different from before for the extrovert
group (16.75 mean, 2.55 S.D.) but were increased for
the introvert group (mean 12.25, S.D. 2.55}. The E
scale scores for the extraverts and introverts on the
PQ Inventory were 14.38 (S.D. 6.00) and 9.25 (S.D.
4.60) respectively. Thus while there was similarity
between the E scale scores in the extravert group (r s
.71) there was an increase from test to retest in the
introvert group which was contributed to by every
subject in the group. There was no accompanying change
in cither the N scale or I, scale scores. On the
former there was a slight increase from 7.50 (S.D. 4.84)
to 9.88 (S.D. 3.09) and on the latter a decrease from
3.13 (S.D. 1.96) to 0.88 (S.D. 0.99).
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It ha« boon suggested that axtraversion is a
highly desirable social 'arc.it (Goreman, 1968). If
ouch i socially con tv'rion-^ ' need for approval does
exist then it may be supposed that it will be more in
evidence in social situations. Thus a subject is more
liholy to adop4* a strategy emph '..lining his, social
desirability when completing n inventory in on
■nvironment in which there are other pc-^p1., including
the person whom the subject assumes a rill be assessing
his answers, than when he is lone in his own home.
An explanation o-r the int.rovert to smbivcrt change
in the introvert group in terms of such a hypothesis can
only be tentative since such a change was not predicted
or expected and no scale or inventory designed to
specifically assess social desirability was included.
Furthermore, the hazards of 1 post-hoc1 extrapolation
are well appreciated.
However, a correlation between introversion and
social desirability scale scorer has been reported
(Farley, 1966: Gorman, 1968) and it has been suggested
that socio-cultural differences are of importance
(Stanley, 1973).
The PO Inventory
It has been suggested that 'psychoticism*, as
measured by the P scale of the PEN Inventory, is a
parameter of experimental value (Eysenck and Eysenck:,
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1968c), Th i s "? ssortien h" s bo^n cxamir-ed and 5.t s
v?lue both supper*'"'c' (C! rcic^o.-. r .' f:v- >-,n f 1973?
Cloridge and Birchoil. 1978; 8+roh, 1970) and
questJ.oped (McPherson et ?. 1, 1974? Davis. 1974),
Although it has c Iways boon an implicit
.aosumotion in Eysencb* s thoor'' that p ycho 15. c x sm
forms v dimenr. ton cf pernor a. lity • dditiori' 1 to extra-
version and nournfi.oisn (i"y ' rt'-. 1957.) -'.'.ho P scale
of th^ PF1T inventory mure son' r the first tin mod tc
measure this dimension end there- have been revere],
versions of th° inventor^*. Th<" vrr5 r r emp] eyed in
this study was current in March 1974 end norm."tive data
for subjects ver the *nr of 59 years was ^imit"-d
(S.B.G. Eysenck, person*: 1 communication).
The mean P scale score for men aged. 50-70 years
was 2.56 (S.D. 2.49) and for women in the same age
range was 2.45 (S.D. 2.45). This difference was not
statistically significant. The 9 scale score range
in this study was 0 to 74 and the 16 subjects were
divided into high and low P rccrers. The high P group
had a mean higher then the normative data mean (mean a
7.25, S.D. 6.82? range 4 to 24) and the lew P group
had a mean lower than the norm (mean « 0.88, S.P. 0.64?
range 0 to 2). There was no statistical difference
between the E, N and L scale scores cf the two groups.
The high P scale score group comprised six women and
179
two men; the low P group contained two women and six
men.
Results
Analysis of variance revealed no significant
differences between the two groups* correct detection
rates in the vigilance task. Examination of the data
indicated that there was an onto-drug decrement in the
low P group, especially in the morning session u>nd with
increasing time on task. This effect hid disappeared
by the afternoon session.
There was a significantly higher false positive
detection rate in the high P group (p< 0.002). There
was an onto-drug increase in commission errors in the
high P group and a concomitant decrease in the low P
group, which was especially clear in the morning
session. There was no evidence, however, that either
continued administration or withdrawal of mesoridazine
hid any effect on the expected decline of commission
errors with repeated testing.
Performance on the manual dexterity task was not
significantly affected by the drug. There was an onto-
drug deterioration in the high P group but there was
little inhibition of the pattern of improvement
expected with repeated testing.
The high P group were significantly slower
overall on the digit symbol substitution task (p< 0.002).
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Throughout the study they showed little improvement
in performance level. The low P group, on the other
hand, improved through the study, noticeably in the
morning sessions, but there was a suggestion of
deterioration in the afternoon sessions of the second
drug and withdrawal test days.
In the card-sorting task the low P group had
significantly shorter decision times than did the high
P group (p< 0.002). There was no interaction at any
level of complexity, however, but there was an
indication of an onto-drug morning session decrement
in the high P groun and improvement in the low P group.
The clearest indication of any difference in
reaction to the introduction and withdrawal of the drug
appeared in the self-rating data. In the first week
of taking the drug both groups reported an improvement
in sleep quality. This effect disappeared for the high
P groun with continued administration, and withdrawal had
no noticeable effect. For the low P group, however,
continued administration brought a continued improvement
in sleen quality, which quickly disappeared on with¬
drawal of the drug.
The drug had little initial effect on morning
vitality and although the high P group reported feeling
less alert th m the low P group, the effect did not
become noticeable until the second week of
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administration. The former group reported feeling
more impaired during the second drug week than they
did in the first week of the drug, but their reports
did not exceed one standard deviation of the baseline
mean. In the latter group, however, the deterioration
of morning vitality In the second drug week was
reported to be more than twice the baseline standard
deviation and this difference was statistically
significant (p<0.02).
Discussion
There were differences in the level of performance
of subjects divided into two groups on the basis of
scores either above or below the mean normative P scale
score, as assessed on the PQ inventory. The intro¬
duction of rnosoridazine did not have a significant
effect on performance patterns and neither did its
withdrawal. The drug, however, did improve sleep
quality and impair morning vitality in both grouos.
In the high P group tho benefits were in the first
week of taking the drug since sleep quality improved
while alertness was only slightly affected. The
sleep quality of the low P group improved with
continued administration but waking drowsiness
increased as well and although the subjects managed to
overcome their substantial feelings of reduced
alertness in the performance laboratory, their ability
to cope in •real-life* might not be so effective.
182
although the use o i. oilO r 3Cjiu liuu Uj-X i. crentxated
between subjects on both subjocxivo and objective
purupeters, end could possibly bo described as of
experimental value on this basis, much more extensive
assessment in both normal and abnormal subject groups
is needed before doubts .b>>ut its us- fulness will be
dispelled. In its present f worn, th ; PQ inventory is
open to criticism on s -vera! issues, including she
Validity of its construction according to the criteria
laid down by the inventory's creators (Davis, !9'M)
and the seal- 1 ; ability xo differentiate between normal
.aid psychotic groups (i icPherson at ul, 197-1;.
In the rfl and the P<4 inventories the me ens fox*
the - and 14 scales are approximately the median of the
range and the population is roughly equally distributed
on either side. On the P scale, however, the mean is
very heavily skewed towards the lower- end of the range
and is increasingly skewed with increasing ago,
especially in men. This v/oula bo acceptable if it
could be shown that there was a correlation between
increasing P and increasing psychcticism but this has
not been done (McPherson et al, 1974) and several
subjects in this study had P scores well in excess of
the mean yet none manifested any symptoms of psychiatric
illness when interviewed by a consultant psychiatrist.
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7+ i known *hat *r a iwst 5.7 dnyelnpod 5.7 7
5 nul a~* ^nvl t*1*^nmont 5 ■'■7 us^f'3^ no—,e an^ validity in
no+.hnr environment nav bo limited. Thus tho EPI was
constructed in Br5.tain and its validity in Iran may not
^o clear unless a specially constructed Persian version
is employed (Hosseini et. "*1. 1971). Little considera¬
tion has been given, however, to intra-culture1
5ifforonces, It is intua.tl.vely clear that o^fen within
Britain there will be Inter—personal lifforencos in
response to questionnaires ivhich will result not so
•ouch "From personalit" differences as f^om differences
in early training and in oresent environment. In .a
looseIv constructed questionnaire excessive rioiditv
in scoring paradoxical, hut perfectly honest, responses
nay lead to a miscategorization of the subject. Thus
in the PD inventory there are several questions,
especially in the P and L scales, which might reasonably
be answered in different ways. Middle-aged subjects
from a Scottish Presbyterian home are very likely to
respond differently from a young adult with a poor
home background and to indicate that they do not have
bad habits, were never cheeky to their parents, would
not dodge paying taxes and would always wash before a
meal (see Appendix It questions 21, 57, 76 and 61
respectively), Similarly, several items on the P
scale might be answered, 'wrongly* and it is less likely
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that .an affirmative answer "/111 be abto ined to the
question 'Do you boo1: un your house carefully at
night?* in a rural re a ■ than in London. In the no
circumstances the relevance of this question and
others, including the usefulness of insurance schemes
ad marriage and whether one arrives early or an time




EXPERIMENTAL COMPARISON OF NITRAZEPAM
AND HORLXCKS
A Comparison of the Effects of Nitrazepam and Horlicks
on Older Subjects
Introduction
The characteristics of sleep change with age
(Williams et al, 1974), and the most obvious effect is
increasingly broken sleep with increasing age (Feinberg,
1968). It is a popular belief, however, that we all
need 7 or 8 hours sleep a night and that if we do not
achieve this then medical help is needed. Consequently
there have been several reports of increasing consumption
of sleeping pills concomitant with increasing complaints
of insomnia in oldex- people (Weiss et al, 1962; Johns
et al, 1971).
There have been reports, as well, of the disruptive
effects of hypnotic drugs on sleep patterns during both
administration and withdrawal (Oswald et al, 1973) and
on objectively and subjectively assessed psychological
function (Malpas et al, 1970; Bond and Lader, 1972,
1973). Oswald et al (1973) described the effect of
nitrazepam as diminishing restlessness, but also
reducing REM sleep and stages 3-4 NREM with continued
administration. If the function of sleep is to be
considered important in relation to synthetic processes
for both growth and renewal (Oswald, 1969a, 1970b)
then disruption of the normal stage distribution may
be detrimental. Fui-thermore, studies comparing
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different hypnotics have concluded that some drugs
cause more disruption in waking behaviour than others,
but almost all have shown some disruption of one facet
or another. Thus, Haider (1968) described greater
subjective disruption with amylobarbitone (200 mg) than
with nitrazepam (10 mg), but the reverse effect
occurred on objective performance when butobarbitone
(100 mg) and nitrazepam (5 mg) were compared (Bond and
Lader, .1972). Such "behavioural toxicity" is as
important to evaluate as physiological toxicity since
poor reaction and judgement can be as dangerous as renal
damage. Miller (1962) was one of the first to appreciate
this problem and test subjects, given a variety of
chronically administered drugs including meprobamate
and chlordiazepoxide, on a battery of tests of skills
required in normal daily life.
Since many hypnotics disrupt both the normal
distribution of sleep stages through the night and
daytime skills, research continues to attempt to
isolate preparations that can improve sleep quality
without distorting the other facets of our life. While
no drug can do this, some products, including Horlicks,
have been credited this power for several generations.
Laird and Drexel (1934) reported that after a meal
of cornflakes and milk, young adults' nocturnal sleep
was less restless than after a heavy meal, and
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Southwell et al (1972) have reported that sleep after
Horlicks was less disturbed at the end of night for
young adults. These studies measured only body
movement frequency and discrimination between move¬
ments during sleep and during episodes of wakefulness
was not possible. An added disadvantage was their
use of only young adults whose sleep often leaves
little scope for improvement.
Brezinova and Oswald (1972) hypothesised that
sleep after Horlicks would be of greater duration and
less broken, especially in older subjects. Using
electroencephalography, they found that in a group of
ten young adults restlessness towards the end of the
night was diminished after Horlicks. In eight middle
aged subjects, Horlicks reduced the number of periods
of wakefulness especially in the later part of the
night and also prolonged sleep duration. Repeated
administration increased these effects and this result
is in contrast to the effects of hypnotic drugs which
generally became less effective with serial
administration.
The present study was designed to compare effect
of prolonged administration of nitrazepam and Horlicks
in a group of middle-aged men and women, with the




Subjects for this study were middle-aged
volunteers recruited through personal contact. The
minimum age limit was 45 years. Preference was
given to subjects who were in good physical health
and who considered themselves poor sleepers but who
had not used either sleeping or nerve pills in the
previous months.
Selection of subjects had to bo effected care¬
fully since the study spanned nine months for each
volunteer. During this period, except for six weeks
in the middle, the subjects were required to abstain
from alcohol and maintain regular hours.
Subjects were invited to participate in two
concurrent studies. One involved sleeping in the
laboratory at intervals over the nine months' period
for electroencephalographic recording, and the other
involved attending the performance laboratory on 10
occasions. Ten subjects participated in the sleep
study while 8 agreed to participate in the performance
study as well. There was an even sex split.
Attendance at the sleep laboratory was required
on sixty nights as described belows -
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Weeks 1 .and 2 a total of 8 nights
If 3 " 4 free
?f 5 " 6 a total of 7 nights
ff 7, 8, 9 and 10 free
ff 11 and 12 a total of 8 nights
ft 13 " 14 free
ff 15 " 16 a total of 7 nights
ff 17 to 22 interval for holidays
II 23 and 24 a total of ou nights
f! 25 " 26 free
tf 2.7 M 28 a total of 7 nights
t? 29 4* /-s OOL. O o /L free
ff '"1 «•>
oo and 34 a total of 8 nights
ff 35 " 36 free
ff 37 " 38 a total of 7 nights
At bedtime during weeks 5-14 and 27-36 volunteers
took either nitrazepam (Mogadon) or Horlicks food drink.
Those who took nitrazepam in weeks 5 to 14 were given
the drink in weeks 27 to 36 and vice versa. The pill
or the drink were taken at home as well as in the
laboratory and subjects were instructed to take the
preparations half an hour before retiring to bed and to




Volunteers for the performance study were asked
to attend the laboratory on 10 occasions by day between



















In the course of each test day, the subjects had
three testing sessions starting at 0830, 1230 and 1630 hours





3. Digit symbol substitution (10 minute version)
4. Card-sorting.
The present author was not principally involved in
the sleep study but since the sleep and performance
studies were planned to run together and employ the
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same subjects the results of both will be reported,
but only briefly in the case of the former and only
for the sake of continuity and completeness.
Results
The methods of analysis employed were:-
(a) Analysis of variance on the raw data.
(b) A transformation of the data by which drugs'
scores were calculated by subtraction from the
relevant baseline scores. Thus when the subjects
were soon to receive Horlicks the baseline whole
day mean correct vigilance detection score was
17 detections. Having received Hor.licks for
the first time the previous night, the mean
detection score fell to 14.5. This has been
plotted on Figure as a mean deviation from
placebo .f -2,5. After consumption of Horlicks
daily for six weeks, mean vigi.lance performance
score for the whole day was 18.83 detections.
This has been represented on Figure 32 as an
improvement of +1.33 over baseline. This
technique, similar to that used in the previous
study, allowed comparison of the relative effects
of nitrazepam and Horlicks when baseline
performance scores differed.
(c) The technique used for analysis of the self-rated




Analysis of variance revealed no significant
differences between the effects of nitrazepam and
Horlicks on vigilance in the group of eight older
adults. Both preparations wore associated with some
depression of accuracy of detection on the day
following the first administration but this effect,
if real, had disappeared after six weeks taking
nitrazepam and an improvement over baseline occurred
with Horlicks (Figuro32/. Examination of the
morning session scores indicated a slight impairment
after first taking Horlicks and nitrazepam, but after
six weeks this had disappeared.
Commission errors were slightly increased but
not significantly so, after taking Horlicks while
continued Horlicks and the taking of nitrazepam did
little to affect the pattern of responding expected
as a result of repeated testing (Figure 33).
2. Manual dexterity
Analysis of variance revealed significant
differences, on the manual dexterity task, between
scores after Horlicks and after nitrazepam (p<0.05).
The interaction was not significant (Table 43).
Examination of the transformed data (Figure 33)
showed that nitrazepam initially hindered performance
and that this effect, in comparison with baseline,
disappeared with continuous administration.
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FIGURE 32





























3. Digit symbol substitution
Statistically there was no difference between
the effects of nitrazepam and Horlicks on this task
but Figure 33 indicates that performance was rather
poorer after nitrazepam than after Horlicks, both
initially and after prolonged administration; there
was no decrement, however, in comparison with
baseline.
4. Card-sorting: decision-time
Yet again there were no significant differences
between the effects of the two preparations.
Whole day mean scores for the three levels of
complexity differed only slightly from baseline
(Figure 34). Mean morning session scores followed
the same trends but the inter-preparation differences
were more pronounced, with Horlicks having a deleterious
effect at each level of complexity initially in
comparison both with baseline and with nitrazepam.
This decrement did not disappear at the intermediate
level with continued administration.
5. Sleep EEG
Both preparations reduced intervening wakefulness
over the first seven hours of sleep. Nitrazepam had
a greater effect than Horlicks on this parameter but it
also reduced REM sleep in the first 3 hours of sleep and
caused a large increase in intervening wakefulness on
withdrawal.
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WHOLE DAY (MEAN OF 3 SESSIONS)










Source of Variation DF SS MS VR
Blocks 1 194.25 194.25 4.485*
Conditions 2 10.90 5.45 0.126
Sessions 2 89.47 44.73 1.033
Blocks Conditions 2 28.85 14.43 0.333
Blocks Sessions 2 1.93 0.96 0.022
Conditions Sessions 4 2.18 0.55 0.013
Blocks Conditions Sessions 4 3.66 0.92 0.021
Residual 126 5457.10 43.31
TOTAL 143 5788.35
It was predicted, from an earlier study, that
Horlicks would have a greater effect on Intervening
wakefulness in the second part of the night with
continued administration than would nitrazepam.
The prediction was supported and indeed it was the
lowest mean level of intervening wakefulness of the
whole study. Thus while it appeared that nitrazepam
was relatively short acting, in that its principal
effect on wakefulness is in the first part of the
night anc! there is also an immediately disruptive
effect on wakefulness and sleep quality on its with¬
drawal, the effects of Horlicks took longer to appear
and disappear.
Discussion
There was a significant difference between the
effects of nitrazepam and Horlicks on only one of the
seven measures of the test battery. This one -
manual dexterity - only just reached significance, but
the difference was in the predicted direction. The
other measure which showed results in the predicted
direction was digit symbol substitution. The other
five measures, in the vigilance and card-sorting tasks,
all suggested, although the differences were not
significant, that Horlicks had a greater deleterious
effect on performance with initial administration than
did nitrazepam. This effect was accentuated in the
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morning session. With continued administration this
effect disappeared and performance, with the exception
cf intermediate-complexity card-sorting, appeared to be
bettor, although not significantly so, than on either
baseline or nitrazepam.
Nothing was previously known about the possible
effects of Horlicks on performance measures and the
hypothesis was derived from two different, types of
source. The first was the beneficial effects that
Horlicks appeared to have on sleep, without any
concomitant disruption of the sleep stages'
distribution (Brezinova and Oswald, 1972), and with
the reduction in the number of body movements
(Southwell et al, 1972). The second typo of source
has regard to the disruptive effects that nitrazepam
has been reported to have on sleep stages, at least
initially (Lehmann and Ban, 1968: Lob et al, 1968:
Haider and Oswald, 1971), This disruption may take
up to a month to return towards normal sleep,
especially after a drug overdose (Haider and Oswald,
1970, 1971), Such evidence has support in performance
studies. Several researchers have reported disruption
on a wide variety of tests, even after the administra¬
tion of a single dose (Bond and Lader, 1972; Haider,
1968; Malpas et al 1970).
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On oil measures, except complex card-sorting,
performance did not deteriorate with continued
administration of nitrazepam. Indeed, in comparison
with baseline anv decrement had d5sanoearod and* L i.
performance was at least marginally improved on all
measures except mean vigilance correct detections.
Although the effect was not statistically
significant, Horlicks caused greater disruption on
five of the seven measures, especially in the morning
session. The extent of the disruption may be under¬
estimated since other researchers and the previous
study have shown that repeated testing produces
improvement in performance in most tests. This
improvement may not be detectable unless a group
receiving only placebo is included, since this is the
only way that the progress of drug receiving groups
can be monitored for the existence of a drug induced
inhibition of improvement. Should older subjects
improve with practice in the way that young adults do
anything less than an improvement over baseline must
be considered a decrement with additional negative
weighting given to performance levels poorer than
baseline.
In the light of such admittedly theoretical
weighting it might bo suggested that the initially
disruptive effects of Horlicks disappear with
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prolonged administration while even after six weeks
nitrazepam may have a deleterious effect since on




A STUDY OF THE EFFECTS OF TEMAZF.PAM ON SLEEP
A study of ' h ? effect -: of Tomazopam on the sleep of
older subjects
The benzodiazepine group of 'rugs have found
extensive use in clinical practice in the treatment
of insomnia. Not only have they been found to be
effective therapeutically, they have the added merit,
of being particularly safe in overdose (Oswald et al,
1973).
In a sleep study of the new benzodiazepine,
temazepam, Maggini et al (1969) found that, in a
patient population the drug had little effect on
sleep. Other benz ;diazepinc-s, however, have been
found to disrupt sleep patterns. Oswald and Priest
(1.965) found that nitrazepam reduced REM sleep in
normal volunteers, with withdrawal causing REM rebound
and reduced REM onset latency. Other studies have
supported these findings (Lehmann and E n, 1968;
Haider and Oswald, 1971) and it has also been shewn
that nitrazepam, in common with some barbiturates,
reduces the frequency of rapid eye movements per unit
time during REM sleep, with a rebound increase above
normal after withdrawal (Lewis, 1968).
The effects of chlordiazepoxide on sleep have
been investigated at different dose levels. Hartmann
(1967) using 100 mg chlordiazepoxide found increased
REM onset latency and decreased REM percentage over
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the night. A later study using a lower dose (50 mg)
administered daily for one month found no initial
effect but a decrease in both REM and NREM stages 3
and A appeared after a few days and remained until
withdrawal (Hartmann and Cravens, 1973).
Kales, Kales, Soharf and Tan (1970) have
reported that, another benzodiazepine hypnotic,
flurazepam, hod little effect on REM sleep but.
significantly reduced NREM stage 4 with a 30 mg dose,
while 60 mg caused a significant reduction in REM
duration and an onset delay. However, single
smaller dose (15 mg) has been reported, to have only
the beneficial effects of reducing sleep onset
latency and wakefulness and increasing sleep duration
(Johns and Masterton, 1974).
A. new benzodiazepine, flunidazepam, has been
shown to reduce REM percentage when first administered
(Oswald et al, 1973). After three weeks' administra¬
tion, REM sleep iri the second 3 hours of the night
showed an excess over baseline, while the initial
decrease of NREM stages 3 and 4 continued until
withdrawal.
Maggini et al (1969) reported that changes in
REM and NREM stages 3 and 4 did not appear to occur
with temazepam. The main effect^ appeared to be an
increase in sleep duration and a decrease in sleep
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onset latency. The purpose of this study was to
examine whether or not sleep disruption resulted from
chronic ndministration.
Subj nets
Three volunteer male subjects in the age range
50-60 years were used. Their general health was
assessed by a physician. Two had had depressive
illness in the recent past. One of the two was
subsequently discovered to have late onset epilepsy
of vascular origin for which ho was taking an anti¬
convulsant drug, but no medication was being taken
by either of the other volunteers. All agreed to
refrain from alcohol throughout the study.
Procedure
Temazepam (00 mg nocte) was administered in the
form of Scherer capsules for ten consecutive nights.
The capsules 'were taken approximately 15 minutes
before retiring to bed.
There was a .14 day placebo capsule baseline period
before the drug period, and a similar period of placebo
administration after the withdrawal of the drug.
The subjects reported to the laboratory at 2130
hours and were in bed with the lights out, by 2230
hours. They were instructed to be in bed on non-
laboratory nights by 2300 hours, at the latest. As
all three subjects were in full employment, they were
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not. able to sleep to spontaneous wakening; they had
to be wakened in the morning in time to have breakfast
end arrive at work in time, but. they did not rise any
earlier than they would normally have done.
Sloop recording
The method of recording sleep was similar to
that described by Haider and Oswald (1971). The
analysis of the records was according to international
criteria {Rechtsohoffen and Kales, "968).
There were two adaptation nights, three non-
consecutive placebo baseline nights, three recordings
during the drug period (nights 1, 2 and 9) and throe
during withdrawal (nights 2, 3 and 12).
Subjective feeling states
Every morning on rising the subjects completed
visual analogue scales to indicate hew they felt they
had slept and how wide awake they felt. In the
evening, before retiring, they assessed, in a similar
manner, their mood and anxiety level during the day.
All. four scales were completed on each of the 38 days
of the study.
Results
Total sleep time (Figure 35). During the baseline
period about 85$ cf the time in bed was spent asleep.
Or administration of temazepam, the proportion of time
spent asleep rose to 95$ but after nine days on the drug
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the total 5loop time had returned *<* pro-drug
values. Drug withdrawal resulted in an immediate
decrease in total sloop time. On withdrawal night 3
the proportion of time in hod spent asleep was only
63$. This mean figure was skewed since one subject
slept for only 519 minutes out of en available 510
minutes but the other two subjects had shortened
sleep durations as well. By the 10th withdrawal
niaht all three subjests had returned to baseline
sleep duration levels,
?. Delay to sleep onset. The sleep onset latency
reflected very much the chancres noted in total sleep
time. The subjects went to sleep more quickly when
on the drug. Though there was a withdrawal effect
which had disappeared, by the 19th withdrawal day,
this had to be seen in the light of one subject on
withdrawal night 3 taking 193 rn5.nut.es to no to sleep.
3. Sleep disturbance. This was assessed, by noting
the number of shifts from any stage of sleep to stage 1
(drowsiness) cr stage 0 (awake). Since there were
variations in total sleep tine, the parameter was
measured over tho first six hours of sleep. There
was no notable change except for e. slight decrease in
sleep disturbance towards the end of the first drug
night. Withdrawal of temazepam increased sleep
disturbance, especially on night 12. However, this
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could have been duo co the subjects not having bean in
the laboratory for several nights previously.
wU.ge I o-oejo (Figure 36/. 7emucupula reduced
the amount of stage 1 sleep over the whole night for
the whole of the drug period. Withdrawal did not
produce a marked rebound, although there was a tendency
for there to be more stage 1 in the early pare than in
v.ne race part or tha nrght.
o. t/cucie d 0^0cp. xhrs sreop stage was unartered
by ertner administration or withdrawal or temazepam.
O 1 _ 1 ! o . • > T
O• oXO\'J IVuVC 3 Op \ S*CcdQt?S vd cliiC s- ) • 1 fcHudZtjpdni
caused little change in the percentage of stages 3 and
4 in the night, even in withdrawal. However, on the
first night of drug administration there did appear to
be a slight increase in the amount of slow wave sleep
in the first 3 hours of sleep (Figure 37/.
7. REM sleep. The overall proportion of REM sleep
in the night remained similar to baseline levels both
on administration and withdrawal. Consideration of
the distribution of REM sleep over the first six hours
of sleep reveals an internal compensation while taking
teraazepam. Thus, on the first night of drug ingestion
there was a very small percentage cf REM sleep in the
first hour in relation to the amount of REM sleep
occurring in the first hour on the baseline nights.
Later on in the night, however, the percentage of REM
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stoop r^se t-- o teve1 higher than that which occurred
at the equivalent time on the bane.lino niahts
(Figure 38) • Tn the sixth hour '-•f stoop th^ REM
sleep percent ape was 160% of" baseline levels. On
•'-.he second and ninth drug nights there "/a* a similar
pattern of lev/or than baseline R"M percent--pe in the
first hour of sleep and higher then baselino percentage
in the sixth hour cf steep. Indeed en the nin+h drug
night the RrM percent ego in the sixth h~tvr of sleep was
24Of' higher than baseline.
'Vithdrawal of temazooam had nn rl.oar effect on
PPM sleep. On the throe recorded wlt.hdrawo.1 nights
there wore alternating periods of increase and decrease,
in rotation to baseline. On the second withdrawal
night, overall night mean REM percentage was ov»r 180%
higher than under baseline conditions, but the hour by
hour ROM percentage ranged from 360% of baseline in the
second and third hours of sleep. Similarly, on the
third withdrawal night, hour by hour REM percentage
ranged from 190% of baseline in the second and fifth
hours of sleep to 40% of baseline in the sixth hour,
and on the twelfth 'withdrawal night the percentage
ranged from 20% in the second hour to 240% in the sixth
hour. On the two last-mentioned nights, however, the
overall night mean REM percentages were only 120% of
baseline overall night moan REM percentage.
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8. lubjoc-':tuc FvL •• . Thos dat .» aoro
analysed by calculating the bago 1.1 no moan ind standard
deviation for each subject and than plotting post*-
baseline fluctuations from the baseline noan as
percentages of the baseline si and ard 'aviation. Thus
a subject who reportod little fluctuation "luring
baseline would have a small standard deviation and
post-baseline changes, which might be snail ' a relation
to the reports of others but which wrc large in
relation to ho online fluctu t'- ns, would. b • given the
relative weighting they warranted. The sv/o raping
effect of the reports of subject" with larg fluctua¬
tions, on -'-he- ether hand, would bo diminished since
post-basoline fluctuations would bo reduced when
calculated as a percentage f their large baseline
standard deviations.
(1) f'oop uT. 11--y (Figure- 39. -Tenia z op am
initially improved sloop quality but this
effect disappeared quickly. Withdrawal, on
the other h; rid. brought, about marked feelings
of worsened sleep. These feelings were most
evident in the first three days but continued
until the end of the study.
(2) raa-Titno ult..lttu (Figure 4<j, At no
point did the subjects report feeling more
lively in the morning after temazopam than they
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cli ' hiring th : -1 :c b baseline ; eriod.
In do -J both starting ond stepping the -Jrug
induced noticeable feelings of increased
drowsiness, particul arly on the second day of
administration and the second and third days
of rlth irav/al.
(3) Anxiety (figur* 4l). Tom ■zepnm reduced
feelings of anxiety, especially Initially.
The most mari vl effects appeared /ith the
withdrawal • 7 the drug. \gi'nation increanod
noticeably by the second lay an .1 remained
evident for the remainder of the study.
(-i) t'oo 1 (figure 42) ♦ Initial irug-induced
elevation of mood quietly disappeared and
withdrawn1 of terna2opam led to reports if
depression, which ron chad a pool: 0.1 the third
withdrawal day. Despite a subsequent reduction
in the degree of depression an offact persisted
for at least 14 days.
Discussion
^t a dose of 2D ng temazepam initially increased
sleep duration and lacreased sleep onset latency.
Apart from a reduction of stage 1 sleep, which persisted
for the whole of the drug period, sleep stages, in terms
of overall night mean percentages, wore not gre ally
altered. However, there were changes in the distribution
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of son: of Lho stages in the night. 0; tho first two
hrug night.-;,, f >x example, ahor- was ; I over than base-
iine percontng■: " 1 7r si,::; in th - rly part f the
night. md. high03- than b :e 1 inn .rrun' in the later
part of tho night. FluniJazopam has been reportod to
have a similrr off •ct (Oowal ' ' 1, 1973). Similarly
on the second 'rug nigh1' there vein higher than
baseline arrvnnt f stages 3 - 4 sleep in the first
three hours of sleep and a lower than baseline amount
in the s^eon-:1 threee hours a" sleep.
Although tors a zop am vrl'.ially irvpr -v.A sleep, in
terms of increased duration, and reduced, restlessness,
this a'van-': ago he1 'is, pp: ■.rod by th. r.inih drug night,
'dithdraw:1 caused some disruption initially, -specially
of sloop duration. but generally, thor: is record, in
terms of overall right sleep stage percentages, between
these results md those of Mscgini at 1 (1969).
From the subjects' point of view, the benefits
of tcmnzoparn were at l ast short--.lived, while withdrawal
brought about unpleasant foe lings. For the first three
clays of t-bine the drug, th subjec' • reported improved
sleep, reduced anxiety and elevated mood, but these
effect: quickly diminished, while morning vitality was
reduced for roost of the drug period. Tho major
disruptive effects, however, appeared on withdrawal
and rose to a peak an the third day. Although
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subsequent ly not go marked, self-rated feelings were
rated above cho laean on only five occasions out of a
possible 48 over the four rating scales.
It must be p Intod out, however, that only three
subjects were, studi xl end while every attempt was made
to control conditions as carefully as possible, there
-./..is considerable inter-subject variability in the degree
of variation from baseline values during 'rug administra¬
tion and v/ithdrov/al. The problem f extrapolation
might possibly have bean mate more difficult by the
fact that one of the subjects, undetected until the
end of the study, was taking another drug as well.
Consequently the usefulness of statistical techniques
was considered limited and no analysis was carried out
beyond the averaging f .he bjective measures and the
transformation of the subjective data as described
earlier.
However, the possibility that a similar pattern of
response to the administration and withdrawal of the
drug, i.e. Initial improvement of sleep on taking the
drug, and some disruption cn withdrawal, should not be
disregarded since, as was mentioned earlier, two of the
three subjects had not long previously been receiving
out-patient treatment for depression. Furthermore,
inter-subject variability is not unusual and the trend
of response is as important to consider as the degree.
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tt Is interesting to note that one, little-used,
criterion f hypnotic property (Isaacs, 1967) was
spontaneously reported by one of the subjects. This
subjoo*- (J. 3.) awoke on cl1 five pro-drug nights in
th" laborntcry ta urinate, a practice -.hioh also
occurred o'- home. On taking the drug, this habit
ceased, only pope or during the withdrawal neriod.
The "ccurreno 6 Tie most apparent effects in
the few lays after starting and stopping the drug is
a pattern not urlik- that found in studies of other
drugs (lewis et el, 1979; lewis and Oswald, 1969?
Lewis et el, 1971? Oswald et al, 1971). Fuccella
et al (1972), from a study of healthy volunteers,
suggested that the drug was almost totally cleared
fr m plasm?, in abmjst twenty-four hours. However, the
tot T_ amount of the metabolites recovered was just over
two-thirds of the dose administered. The excretion of
the remaining third would probably extend over several
days and might possibly be related to the changes in




It in difficult to relate some of the results
from studies reported in the preceding chapters to
the work of others. The principal reason for this
problem arises from the lack of significant drug
effects, but also from the fact that few others have
tested most of the drugs used here, e.g. Perlapine,
mesoridazins and temazepam, and few have assessed
behaviour, especially performance, following chronic
drug administration and withdrawal. Necessarily
then the studies reported here have often to be
related to studies which are not strictly comparable,
either in relation to drugs used or design employed.
For example, Bond and Lader (1972, 1973) tested drugs
considered to have the same type of effect to those
studied here and assessed the drugs* effects using
tests quite similar to those employed here, but their
results are comparable to those reported here to only
a limited extant since the single test time in the
first study and the three test times in the second
study were all within eighteen hours of taking the
first and only dose of the drug.
Similarly, Bixler, Scharf and Kales (1972)
described a study examining the effects of three drugs,
secobarbitone (190 mg), glutethimide (500 mg) and
flurazepam (30 mg), on performance of a selection of
tests including the Wilkinson continuous addition
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test, the Moskowitz divided attention and vigilance
test, a DSS task and a pursuit rotor, with repeated
administration for three days. Results indicated
that the effect of the barbiturate was strongest on
the first day of administration, while the effects
of the other two drugs were delayed and variable.
It is difficult to draw clear conclusions about the
effects of drugs from studies such as this, in
comparison with the studies reported here, since
although the tests may have been sensitive and have
covered a span of skills, only a small number of
subjects were used (n = 3), the drugs were given for
only three days, no consideration was taken of
possible withdrawal effects and no record was made
of subjective feeling states.
Accepting the limited nature of possible comparison
however, several problems remain since there are
conflicting reports of many drugs' effects. For
example, Bond and Lader (1972) reported that butobarbitone
had little effect on performance of a DSST since the
drug's effect was mainly to impair simple motor
performance, yet an earlier paper reported that
barbiturates had a significant effect on DSST
performance while not affecting scores on a continuous
performance task requiring frequent motor responses
(Mirsky and Kornetsky, 1964).
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Generally, however, drugs have been reported to
disrupt performance, but only for a limited length of
time, e.g. twelve hours (Bond and Lader, 1973),
although disruption may be measurable on the EEG for
longer, and often only cn some of the tests used.
For example, Adams (1974), examining the effects of
nitrazepam (5 and 10 rng) and butobarbitone (100 and
200 mg), on performance of five tests, reported that
only on an experimenter-paced short-term memory task
was thez-e any decrement and then only at the higher
dose level. In the study assessing the effects of
nitrazepam reported here, no significant drug effect
was found (Chapter 10) but no memory task was used and
the subjects were from a different age group.
Similarly, the only study assessing the effects of a
barbiturate reported here found no significant drug
effect on any of the tasks whereas others have reported
significant effects using similar tests and similar
dose levels (Bond and Lader, 1972, 1973). Some
disruption of performance was evident following
amylobarbitone, however, and even though the effect
was not significant, subjects appeared to be more
disi-upted than those receiving placebo (Chapter 4).
The effects of the other drugs investigated
here have not been previously examined on a performance
test batteryj the only information available derived
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from biochemical and sleep studies. The latter type
of study had indicated that the drugs were not
associated with excessive disruption of sleep stage
distribution. Consequently it might be conjectured
that if the drugs cause little disruption of sleep it
is possible that there might be little disruption of
performance either. The results in several of the
studies supported the suggestion that introduction
of the drugs caused no significant change in
behaviour (Chapters 4, 6, 10 and 11), but it may have
been, in some instances, not that there was no effect
but that tho methods of assessment employed were not
sensitive enough to detect the changes. This
possibility will be discussed later.
When results are not clear-cut, it is even less
easy to attempt to fit them into some form of
theoretical framework than it is to relate to others'
results. Several theories have been stsggested to
account for performance patterns and especially
vigilance phenomena. One of the earliest attempts
suggested that the vigilance decrement was caused by
the onset of an inhibitory state similar to that
found in classical conditioning (Mackworth, 1950).
This point of view was adopted following Mackworth's
finding that the introduction of a novel stimulus
during a task returned performance to its initial
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.level. This point of view might explain not only
the gradual decline of detection with time on task,
but also the decline with repeated testing.
Generally, however, this theory has not gained
acceptance and more recent work has proposed an
inhibition-arousal type of theory suggesting that an
increase in inhibition leads to a reduction in
arousal which results in a vigilance decrement
(J.F. Mackworth, 1968).
A second conditioning theory 'was developed by
Holland (1958). The detection of a signal was
assumed to be a rewarding experience which acted as
reinforcement towards continued performance.
Although there has been little experimental work
related to this paradigm, it has achieved some
support (Jerison and Pickett, 1964; Stroh, 1971).
Another approach has attempted to interpret
vigilance in terms of the data-processing
characteristics of the perceptual system (Broadbent,
1953, 1958). Filter theory assumes that the
perceptual system cannot cope with all incoming
information and that, therefore, some form of
selectivity is required. A selective filter
differentiates between important and less important
stimuli according to variable criteria. It has been
suggested that during the performance of a task these
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criteria change e.s -tank stimuli lose their novelty
and consequently filter deviations result in a decline
in vigilance accuracy. Although the results reported
here dc net disagree with this theory, it is difficult
to assert that they support it since, if it is assumed
that novelty deteriorates with continued presentation
of the stimulus to be detected, the simplest method
of testing the theory is to vary the rate of presentation
of the target stimulus. Only one target stimulus
presentation, rate was employed in this series of
studies.
It has been suggested that the presentation of
stimuli serves two functions, one of which is to
enable the making of decisions about the presence or
absence of signals' the other is to maintain a
general state of alertness (Hebb, 1955). Monotonous
conditions wore considered to lead to a reduced
level of alertness, and consequently poorer perfor¬
mance, 'whereas variety and change inhibited decrement.
These suggestions were founded on the results of the
investigation of various physiological indices of
arousal, which were initiated by the work of Moruzzi
and Magoun (1949). The long series of studies that
followed demonstrated a relationship between cortical
arousal and the reticular formation, although more
recent research has Indicated the importance of the
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limbic system and the existence rf two arousal
systems, rather then one (Green end Arduini, 1954),
between which there is 'a dynamic balance'
(Routtanberg, 1963). P.ysenck has suggested that the
two arousal systems are related to the two personality
dimensions, extroversion and neuroticism. Thus,
according to Hysenck, introverts have higher reticular
formation induced cortical arousal (Hysenck, 1967).
Under normal conditions, Hysenck's theory would
predict, that introverts would perform better on a
vigilance task since extroverts, already at a lower
level of arousal, would decline still further and
would consequently show a greater decrement with time
on task. Under quiet conditions (70dB) this pattern
has been reported to occur but the level of background
noise is evidently of importance since under noisy
conditions (95dB) neither introverts nor extroverts
showed a decrement of correct detection (Davies and
Hockey, .1966) . Similarly, Dav5.es et al (1969)
reported that extroverts performed better when
background noise level was 80dP> than when it was 59dB,
while introverts performed equally well under both
conditions but preferred the quieter condition if
given the choice. In the studies reported in the
earlier chapters the background noise level was 85dB
and it was not variable. It would seem that noise
of this intensity could, in comparison with the
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studios mentioned above, bo classified a? 'noisy*.
Extrapolation from the studio- by Davles and his
colleagues would, therefore, lead to the hypothesis
that thore would be no difference in correct detection
between the introverts and extroverts under placebo
conditions, A statistically significant difference
in correct detection between introverts and extroverts
was reported in Chapter 9 only when performance was
assessed in relation to time on task. btiile
extroverts detected slightly fewer signals than Intro¬
verts on the first test day, the reverse was true on
the second test day. On both placebo test days the
correct detection performance of both groups deteriorated
both through the day and with time on task; the first
quarter to last quarter decrement was consistently
greater in the introvert group. Thus there is only
tentative agreement with the results reported by
Davies.
Tune (1966b) reported that introverts made fewer
errors of commission than extraverts. A similar
result was found in the study reported earlier.
False positive detections were consistently more
frequent in the extrovert group, although neither
group showed a decline in commission errors with
time on task. Other researchers, however, have found
that introverts made significantly more commission
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errors thin did extroverts ("0,ivies and Hockey,
1966; Davies ct a I, 1969).
A general finding in the studies reported
earlier relates to response patterns in the vigilance
task. A decrement in detection rate was evident, in
both younger and older subjects, both with time on
task and with repeated testing. There was also a
gradual reduction in commission errors with repeated
testing. Others have reported similar patterns
(Davies and Tune, 1970, p 211) and the progressive
decline has been related to a decline in the level
of arousal (Davies and Krkovic, 1965). Bakon (1957)
described the behaviour of subjects in the monotonous
vigilance situation as being initially attentive, and
this phase would be longer if reinforcement was given,
but with attention being gradually reduced with the
monotony until a state of drowsiness or sleep exists.
Subjects often try to combat this and employ a variety
of strategies, including singing, whistling, day¬
dreaming and moving about. All of those approaches
have been noted in the studies reported here and some
others have been detected as well, including drawing,
talking, muttering and reading. Subjects, "/hen asked
about this have replied that it was done to keep
themselves awake since they would have felt guilty
should they have fallen asleep.
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Signal detection theTy hoc been applied to
vigilance performance in order to understand the
way in which decisions are made about the presence
or absence of , signal on the basis of sensory
information which has already been processed. Most
studies us5.ng this approach have reported that a
decline in the detection rate is associated with a
displacement of beta in the direction of increased
caution. Others, hot/ever, have reported that changes
in d' were associated with a detection decrement but
that interpretation of beta was not valid since "it
seemed more sensitive to the Inevitable violation of
detection theory assumptions" (Mackworth and Taylor,
1963). This is one of several difficulties in
relation to the applicability cf signal detection
theory to vigilance situations.
Signal detection theory was originally derived
from psychophysical data and deals with the situation
where an observer is instructed to detect the presence
of faint signals and decide whether "seme sensory
event was caused by a signal or by some random process,
such as background noise" (Green and Swets, 1966, p 30).
The theory has been applied to three main categories
of psychophysical situation, In the first the
observer is presented on each trial with a single
stimulus which may be either noise alone or signal
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plus noise-♦ anc! in required *o indicate his decision.
In the second situation the observer can indicate his
level of confidence about each trial's decision while
in the third situation the signal nay bo presented in
one of two or more intervals and the observer is
required to select the interval he considers to have
c on i a in ed th e- signa 1.
Signal detection theorists have assumed, in
analysing results from such experimental procedures,
that in the absence of a signal there is a randomly
varying constantly maintained neural discharge
occurring in some part of the nervous system, and that
the size of this varies about a mean such that it
follows a norma.! distribution, and shows an increase
only when a signal is presented.
Already then there are fundamental differences
between the vigilance situation and the classical
psychophysical situation to which signal detection
theory was originally applied. In the vigilance
situation the length of an observation period, in the
psychophysical sense, is unspecified. Secondly, the
observer in a vigilance task, is not required to make
a response after each observation period. Further¬
more, the length of the testing session is usually
not long in psychophysic:1 studies, while in vigilance
experiments the session is inevitably prolonged.
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Thus, the level of neural activation v/iU b?
different after observation neriods in which a
response was made and after periods when no response
was made, regardless of the- correctness of the
decision, and these levels will change with time on
task. Thus the rationale for the vigilance task*
i.e. to study the changes in alertness in terms of
correct and incorrect detection rates over time, are
in fundamental contradiction with the basic assumption
of signal detection theory, that the observer's
attention to the display is unchanging,
Jerison and his colleagues have distinguished
three ways in which a subject may observe a display
during a long vigil (Jerison, Pickett and Stone,on,
1965). alert observing was defined as the "optimum
observing of the psychophysical experiment", blurred
observing as the "orocess that increases the variance
in both the M and the S-N distributions relative to
that of alert observing" and distraction was described
as including "the daydreaming or autistic behaviour that
often occurs in prolonged vigils" (Jerison, Pickett and
Stenson, .1965, p 120). The high levels of beta which
would result from the latter two categories would
inevitably skew results and render as psychologically
meaningless the values of this decision process in
signal detection theory terms. Jerison has suggested
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that a response criterion ;>£ 1,0 Indicator; that an
observer "acceptr an even nonev hot on hie sensory
information that n particular stimulus which ho
reports as a signal is, in fact, - signal"
(Jerison, 1967a,. p 706). Psychophysical experiments
have indicated that a beta value of 1.0 is common
and a value in excess of 4.0 is unusual yet at the
orid of a vigil values of 750.0 (Loeb and Binford,
1964) and 500.0 (Jeriuon, Pickett and S+.cnson, 1965)
have been reported.
So far discussion of the applicability of signal
detection theory to the vigilance task situation has
focussed mainly on beta. However, the usefulness of
d1 has also been questioned. Mackworth and Taylor
(1963) reported changes in d' to be associated with
vigilance decrement but Green and Swots (1966) in their
discussion of this experiment concluded that the
vigilance decrement, could largely bo accounted for by
changes in beta rather than changes in d'. The
changes in d*, on the other hand, wore more likely to
be related to fatigue, which has been shown to have
affected performance in several studies (Berger and
Hahneke, 1954; Mackwcrth, 1964; Wolfcrd, 1968).
Thus while beta has been shown to be of doubtful
extrapolative validity in the vigilance situation, its
usefulness hs been indicated by the originators of
signal detection theory to be greater than that of d'
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in detecting "'igilanco decrements. finterpretive
problems are fur LI i •or compounded if unequal
variances occur since the table values for d' and
beta, which are used by moot researchers, assume a
Gaussian distribution (Freeman, 1973;, even though
the possibility of such a distribution occurring is
unlikely (Taylor, 1967; Muckwcrth, 1970).
a further problem arises from the different
methods used to obtain the calculated values.
Some researchers obtain d' and beta by first
calculating the group mean correct and false positive
detections' scores and transforming the mean into SDT
values (Davies and Hockey, 1966) while others
calculate the 3DT value for each score for each
subject and subsequently average the SDT scores.
The latter approach was used in the studies reported
earlier but even so, examination of the raw trans¬
formed scores lea to the conclusion that extrapolation
in terras of th:- signal detection theory parameters
of dotectabillty and caution wore meaningless and
shed no light on the effects of the drugs and of
repeated testing that could not bo gleaned from a
simpler examination of the correct and false positive
detection r vises and their respective standard
deviations. Indeed, the r nge of both inter- and
intra-subject scores was prodigious, especially with
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regard to beta. In the study comparing the effects
of three hypnotics in young adults, beta scores
ranged, over the whole study, from 2.071 to 1007.817,
and in the examination of the effects of mesoridazine on
a group of older subjects on one day one subject had
a beta score of 22,491 at lunchtime and a score of
935.710 four hours later. In the light of these
results and the preceding discussion, the value of the
interpretation of the vigilance data in signal detec¬
tion theory terms was considered to be limited and d'
and beta were not calculated in Chapters 9 and 10.
When results are inconclusive where others have
found clear-cut differences between groups and drug-
induced changes in performance as well, it might be
reasonable to conclude that the methods of assessment
used in the study have not been sensitive enough.
When other data regarding a drug's effect is sparse
or contradictory, however, it is not so easy to
determine whether the lack of significance results
from the drug's lack of effect or from insufficient
test sensitivity.
In the studies reported here it may be that both
of these possibilities occurred. Confidence about
the non-effect of the drugs could be increased if the
results were replicated. In the case of mesoridazine
this occurred. The drug was tested in three studies?
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in nono of them wore markedly deletersou o effects
or performance found. In one of the studies EEG
sleep date, conf5.rrr.c5d that disruption was not extensive
end the only evidence of a rignifier.nt drug effect
appeared in the self-rating feeling eta.to date in the
study of the effects 'f the drug in different
personality types. Despite this agreement, across
three studies, how vcr, the drug* s- lock of disruptive
effect cannot be assured, sine: the same tests were used
in all the studios. The- study of the drug at several
dose levels: would have given " clearer indication of
whether, and at whet dese in relation to its clinical
usage, disruptive effect s occur.
The lack of significant impairment in the group
which received any? obarbitor.e (2.00 mg) in the study
comparing the effects of the three hypnotics gives
little help in the assessment of the sensitivity of the
performance teste used since other research workers have
r ported that the disruptive effects of barbiturates, in
comparison with the benzodiazepines, tend to be mora
subjective (Haider, 1963) than objective (Bond and Lader,
1972). Similar results occurred in the study reported
here. While the performance of the arcup did not
differ significantly from the dher groups, their
subjective response to the drug, especially initially,
was clearly greater th-n all the other groups excepting
the perlapine (5 mg) group.
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McNair (1.97?) an ' lys ■ ' ™<? reviewed ra search
studies examining the off :ct. s of chlord* izepox5 ie,
diazepam and moorobamato. Tha drug sensitivity of
4? performance tapo.sums was evs.luatad and ranked in
forms of the percenta no of siudJ.os usino than tost
r/hich had report.nd significant results. Thus four
stud5.os reported the use of the Continuous Performance
task? two reportod that the drug facilitated perfor¬
mance , ono reported a d^crom^nt and one r°p •rind non¬
significant drug niacobo differences. The 75$
significant results* rating that McNoir gave this
test, the second highest ranked 'high sonsii5„vity1
measure. Although there are several drawbacks implicit
in -'•.his r'evJ.ow. including the pooling of fccilitetory
and deleterious results, the lack of consideration of
the number of studios which have used : particular
test end the consideration of only three drugs, it
does indicate the possibility that the tests used in
the studies reported in previous chapters are, apart
from the digit symbol substitution task, of low
sensitivity in determining the existence of drug
effects. For example, four studies assessing the
effects of these drugs in comparison with others on
auditory vigilance reported no statistically significant
effects (F!akan. 1961? Holmfoorg and. '"/il.liam-O! sen, 1963;
Idesirom and Cadenius, 1963: Pearson and Meal, 1970).
2.2.7
L variety . r mo: surer: voro usee: in the studies
reported horr, ouch intended to assess •: different
facet of skilled b :hnviour, since it was rppreciated
that drugs nay ffect only particular skills. Some
drugs have been .reported by other rcsearchers to
. ffect only notor performance. Thus. Bond and Lader
(1972), studying the effects of butoberbitone and
nitrazepam, reported that simple, repetitive, motor
tasks, such as, topping and the meter part of card-
sorting, v/ero severely impaired while cognitive
me. suren, such as DSST and arithmetic, were unaffected.
Kornetsky and Ornock (1964), on the other hand,
reported cognitive imp. irrnon-' following barbiturate
administration. .In •'•he light of conflicting reports,
such as these, the usefulness of n battery of test,
measures is evident.
Gome, however, have used as few as two tests and
yet have still consistently produced results of
practical v:lue and importance. Moskowitz and his
colleagues at the Institute of Transportation and
Traffic Engineering in Los Angeles have examined, in
both visual and auditory modalities, the effects of
alcohol and marihuana on concentrated and divided
attention and reported that, while concentrated,
attention naV n0"1" 1rir' impaired by either drug, the
rbility to assimilate and respond to information from
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several sources simultaneously, as in a driving
situation, is severely, but differentially, affected
by both drugs (Moskowitz, 1973).
It may be then that the tasks employed in the
studies reported here have not been sufficiently
difficult for the subjects. If this has been the
case then subjects who have felt affected by the drugs
have been able to compensate for their impairment by
making an extra effort. The need then would be to
employ tasks which do not allow such compensation by
making, under baseline conditions, demands which
require the subject to be performing near to the limit
of his capabilities. At the same time, however, the
task must not be sufficiently interesting to increase
the subject's motivation. Tasks similar to those used
by Moskowitz seem suitable since the demand made on the
subject can be varied so that the degree of complexity
with which the subject can cope before deterioration
may be assessed* Furthermore, the cause of the
deterioration can be isolated since both tho cognitive
and the motor aspects of the tasks can be evaluated
independently.
Subjects* performance may have been affected by
the laboratory environment* In several of the studies
subjects attended the laboratory in groups of six.
Although subjects could not see each other during the
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easting sessions, h '.c aus : :-.tch s..c if: a screened
J-> . J O d 1 5 L .i V iX O.'. > J-y^ . 4— — JL -.- <wi „L C t"' -i.-Liil-l.Ct 3 O 3 Ja 3 J.
.L > I O ^ J. C»* Cr lL i i a»* k > ijit .-\ 3d. -A. i 1 \g -111 \-i i—■■ MS t» »'J i«S 3 * 1 O w O O -i- J i i O • / ki^
^ utCLlp 1 WuS ; Ua '. , C • u'J -■■, J jpui-!-;ily d'Urmg CISt,
oajSionSf iau ^ 'ciio ueyrjt, oi jUCCc&o was lnsi coo by
saver .1 f. rtors, including the. no id to maintain
goodwill and mot iva-cion to continue participation
uVOX e i. .a C . X ,/CeKe -il'i 0Clue U-LIilU S iie'Vv,iai XlCnuhS.
••pt_ _ r* ... /» • 4 ■. . 7 ... - .»
iilh -{J G 0 4. i.U.v. . y* • 1' i ii ... 3 U.oiJ • .3 / -.3 -• t iO C113 .G
Cb-HlpiiCaliu'j 10• X';'l 1 0\XX - Cllv^ S3U'i.Lv23 *
• u, joc is vv.ro niddl:.-ag 1 .ad experimentally rwive.
•—oins aovino, i-'i" a. iicu.i't' tc accept ...ns a rue Ou.o.as oicom
someone considerably younger than themselves and to
appreciate that converse!!,should terminate when
o...'S*cing cos > - i. a s'..oa''r..• Others c aearly ruund che
presence of subj >cts of the opposite sex distracting
una occasxonuii.y inoi-ncos oa mtaxpsrsondi u en uon
occurred. —t may iao tna'c such aoccurs as those
interfered with performance: i is difficult to
quantray such sociar o_xa-c is bu*c 'cherr potential
disruptiveness is undeniable and hay ware possibly
relevant in the introversion to extroversion swing of
d sc. io scores by one of the groups in the study
examining the .effects of individual differences in
drug response {Chapter 0}. The differential effects
of social factors on different personality types has
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c rt. inly been not -d by others (Colquhoun one?
Corcoran, 1964).
The possibility of disruption of performance by
pharmacological . gents other than the experimental drug
is of importance as we!!. Several researchers have
made attempts to control for this by instructing
subjects not to take alcohol on the evening before or
during the tost -day (Bond and Lacier, 1972, 1973) and
others have ferhi Idon the use of tea, coffee and
cigarettes as vrll (Adams, 1974). In the studies
reported here, subjects wore requested to abstain
from alcohol for the period of the experiment; this
in some cases was for nine months. It was not
considered practical, however, to request subjects to
give up cigarettes us well, but an attempt was made to
control smoking on tho experimental days* Cigarettes
were not "confiscated* from subjects before experi¬
mental sessions since it was considered a possibility
that subjects would merely compensate for their
deprivation by smoking more before and between the
experimental sessions. Such behaviour is difficult to
control, especially with older subjects*
It is undeniable, however, that cigarette smoking
may influence behaviour at all levels. "Jhile there
,r • wide Intar-individux\ differences in consumption,
and therefore the probability of consequent disruption,
it has been suggested that anyone smoking more than
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10 cigarettes a day is maintained at a fairly
permanent and definite drug level (Tong et al, 1974).
Tong et al suggested that in all instances a stimulant
dose is taken but others have suggested that the
situation is more complicated than this and that
smokers may alter their nicotine intake depending on
the perceived significance of the task (Ashton and
Watson, 1970t Watson, 1975). Furthermore, there is
evidence suggesting that men may smoke more in low
arousal situations, whereas women may smoke more in
high arousal situations (Frith, 1971).
There is experimental evidence th it nicotine may
;ffeet performance in different ways. Frankenhaeuser
et al (1970, 1971) have reported that while intake of
nicotine led to reduced scores in a choice reaction
test, it ilso led to the maintenance of a higher level
of efficiency in the reaction time portion of a
vigilance task. Tarriere, Hartemann and Niarfeix
(1966) found that when subjects who were smokers were
allowed to smoke during a 150-minute visual vigilance
task, their performance w s significantly better than
when they were not allowed to smoke. In the latter
condition their performance was poorer than the
performance of non-smokers. Similarly, nicotine has
been reported to influence heart rate (Elliot and
Thyseli, 1968), performance on tapping and pursuit
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r- • r * ~nirg t (*rith, 1967, 1968) an' driving
skills (Heinetr t al, 1957).
".v/eroness f the ffects of nicotine on
performance ks, b-ath • :-ne .n.1 In interaction with
tho oxporlment .1 drug, does not simplify the dilemma
• *.eg on experiment r in-' arc-stud in the chronic
•Tocts of trugs nine- 1though two pproaches are
passible, ;>• 'h h :.v thoir die Hventagos. The first
it rnr'ivo involv r th"1 vcclur* >n f ~rokers from
the exporinonl 1 sample. Allowing 'ror social,
cultural, occupoti-,nol nd •go factors, this night
involve the exclusion o-c sublocto vAio ire roprosent ative
->f i 1 rg percentago of the population. For example,
figures pub'1.*.shed by Todd (197?.) indicated that, if
subjects 17or 'riwn ~ron tho Registrar-Genera 1* s Social
Class 1, exclusion of smokers would make the
experimental sample representative of 47/' of the
population where is if subjects v/oro drawn from Social
Class 5s the s rpl :reuld represent -nly 9.1% of the
p pulit.ion. Thus exclusion of smokers would inevitably
neon th t the sanpto would bo unrepresentative of the
general popu1 ition.
There has been research into why people smoke
and 3ome of the results have implications for pathology.
7 It2 --r (1967), in review of the literature, r sported
'hb smokers tended to be more jxtraverted, had more
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"~*'fn >mrsrti p-i*" p ^*vs - rv!—\pt;•> p g p * - * c-*- ,.T3 a.v
A '>••»■* fp "i 1 ~ T»1 JPf ' r"V 11 p •*>*"*» r •*• ?p.> r* ' o i* -J -n -»•■>•" o.
•
--
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+hot loo aro'm. Conn*?qu-?n11y, a rt in>o'of o-on Vv'-'?.s made
'Ohaptor 0) of both otncofn bnr,o.1.5.no "nr! drug porfor-
mnnco atooooo by voojnn • 'hi1 •'• 0 opt yv ~".! --•- odul.tr? .in the
a"'ojdinr, done—tbod *.n Chop^orn 1 and 6. It v;as
nugnor.t•••..-] that, •inn-amup dtffo:p.~noon oc.uld be ;!onon-
""•".rnted not in1'' *.n ro.npnnso oaf tern but. a'. c>r 5.n
n- rpon~ ~ under r>i *c '-bo conditions and that the
introduction rf m'-'Soridazino, ■ h:"1 " n '' rawing
^*p* f * C n.H'f". 1 ** f ^ pJ* pV_ * ' 'rr% ^ ra> if CTUGG
disruo""ion subiocfonre f•"•olinc !*.t11f ~ and that this
->,-A t1!"'" he I?""5 4 ' v in pp r 1 -?(-..•*■■ nr^aro. rant * 1 1
■?.no 15.a 1 1'r.
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It con No suggesto', . principle, herefore,
that when - drug is to bo b: ctad in hun ns, in order
to establish whether the extent cf its side-effects
night Interfart dth 'ho n .iiont's boh. viour, it
should be tested in the .go group which is likely to
contain most patients receiving the pre -parution.
Only by testing a drug in a group .s similar as
possible to the majority of proposed recipients will
...,.ny idea of ths possible effects be obtained*
Hie in tor-group different. >o described in
Chapter 9 wore not ;s clear as those suggested in
Chapter 8. There v/or differences, however, and
inter-indiviidu. 1 differ nees in response to drugs
should be examined further in order to isolate the
factors of greatest Importance in relation to degree
ant' pattern of response. At. the present time and
state of knowledge the area is only of theoretical
interest but if one or nor reliable dimensions of
responsivity v/ore to be isolated then there would
be Important clinical implications.
The existence of differences in inter-individual
response pcH-erns Is evident end there have been many
ittenpts to elucidate ^he important variables.
Several personality scales have been used to do this,
,nd ih' "ysonc! sc.: los h vo been use more extensively
than others, but, as b :s b; n mentioned (Chapter 9),
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severe doubts about the various scale-? have boon
raised and few would unoquivnc ably accept their
validity and usefulness. If one or more important
variables could bo identified and be shown to be
reliable indicators of differential response to
drugs in different types of people, then this would
be of importance in the proscription of drugs and the
selection of dose levels.
Straightforward experiment al proco lures have
often been used to :.nswor a number of the questions
•about drugs* effects. For example, questions have
been asked about movement opeod, as assessed by tapping
Morse key, about movement accuracy and about reaction
speed as well is memory and speed of addition. In
some coses tasks have been more complex but almost always the
approach has been academic and the suggestion made that
these tasks represent an attempt to assc-ss the effects
of drugs on laboratory analogues of skills required in
everyday life. While it may be true that some of the
tasks require the use of such skills the usefulness of
this approach, beyond academic interest, is open to
discussion. Thus Miller (1962) has suggested that
even when a drug effect is evident en the performance
of a task there exists a problem of hew much
deterioration is •"•ermiss.lble* before it constitutes
a hazard. The answr necessarily depends on the
nature of the hazard since it may be that in some
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situ tionn there * r a n rgln r orro e, who!: in
other situation- the margin r ay he so el*m that even
fully conscious alertness nay not be adequate, e.g.
dpivino•
It is, porch nc, natural to try t- be as
* cademic* or * scientific* as possibl but. r. long as
conclusions can only bo drawn In 'real-life* terras of
•possible* or *lik-'-ly* disruption it nnv be more
relevant to os-scus drug offoots in r * a'ion to the
real situations of driving (Klonoff, 197d), flying
(O'Connor, 1972) and work ( lluisi, 1972), rather
than simplified laboratory analogues.
Work boh viour is ch r 'ci • rise 1 by sustained
performance, for long periods of time, of tasks which
arc typically complex and mui - d5.menoiona1.
Generally, attention is divided and the individual has
to monitor several sources simultaneously while
assessing the probability of response requirement and
compensating for distraction. In comparison, laboratory
...scessment usually depends on single channel input and
cutput assorsod In terns af op ' and accuracy. The
simple-mindedness of the 1 boratory approach has been
criticised arm' some attempts have boon made to achieve
realism by the use of work-situation simulation. For
example, Mini si (1972) doscribed • multiple-task
performance battery vihich required monitoring of,
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and response to, six tasks. The tasks included three
v/ itch-koeping tasks vjhich the subject monitored for the
whole of the test period, and three active tasks
measuring computation, target identification and code
solving. The use, in this way, of t isks similar to
those encountered in work situation, and the testing
of subjects over periods of several hours and for
several days a week, is more likely to achieve a
situation, in terras of both performance! pattern and
attitude, from which meaningful conclusions can be
drawn. Although Uluisi and his colleagues have been
interested principally in assessing the efficiency of
different work-sleep cycles the possible usefulness of
this approach in the assessment of drug effects is
clear.
The usefulness of the study of the effects of
repeated administration of 'rugs is evident. The
argument has already been put that the amount of
extrapolation possible- from single cose studies is
limited since almost all drugs administered for
therapeutic purposes re taken chronically,
light is shed on whether a drug having n initially
disruptive effect continues to have such an effect
or ahether there is disruptive effect on withdrawal,
if only ... sing-e do so is used. However, a drug
which is ;> promising new effective therapeutic agent
is more likely to bo marketed if the side effects
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'urino c v' *am. ' "rurra-tr ■■' 1 an r? ' aghr \r
tr nsitory thnn *th ffoct n continu : to bo
disruptive mc- 11 no ffect parameters ouch as sleep
quality# vit. I'd .n 1 ty, a:1 -.r -p r ti n
trendy on the : lark should be more likely, all
things being equal, to bo prescribed if Its effects
:co known to bo less 'lorup-' Ivo than th so of mother
oqu lly sui? dole drug.
Ido: lly the -'ffoots T 'rugs ,-v?r th '/halo day
shoul1 be studied. Only by tv/onty-f-ur h air
„s.cessment woul ' it be possible to detect not just
the gross effects on sloop stages and aloop duration
nd on nerf-armnnce lav Is nd once- ,-d y self—rated
feelings, but loo possibl loytiroc compons' tion for
night-time cloop <'isruption, 'ho ro! itionship between
. p articul ar sloop stage ,nd lov/or Alertness, and
'•.bother poor porforrnanc is ml -t Nd t th.? affects of
th drug Itself >r th > sloop disruption It c uses.
The effects of 'rugs are soon not only at the
psychological and psychophysiological levels but at
the bioohon". 1 love 1 ;S vi 11 tnd any study cl lining
to examine the -fx nets of drugs with thoroughness
should include this f c-t* H na md Lad: r (1972)
used spectroftuorimetry to measure plasma nitrazepam
levels as one of a large variety of measures in an
at"t empt ;t blanket cover g .nd demonstr ted that
there is a relationship between the proportion of EEG
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fast wave activity (13.5 to 26.0 Hz) and the dose
level of nitrazepam. Only one blood sample was
taken from each subject, however, and the amount of
information that could be drawn was limited. The
study would have yielded much more useful informa¬
tion had it involved repeated drug administration and
repeated blood sampling in order to assess changing
blood concentration levels and their relationship with
changes in performance.
Cox, Simpson and Rothschild (1973) demonstrated
the usefulness of repeated sampling of blood when the
effects of a drug on performance under different
conditions are being assessed. Testing performance
on a stellate pursuit rotor they found little difference
in performance between a group which received glucose
and noise stress, a group which received glucose but
no noise stress and a group receiving neither; a
group receiving noise stress but no glucose performed
at an inferior level. On the basis of these results
the inference might be drawn that noise stress (80dBA)
impaired performance and glucose may inhibit the
occurrence of a decrement. The complementary blood
glucose data not only supported the inference but
clarified the picture considerably, since while blood
glucose level fell for all groups, the fall was
greater in the two groups receiving noise stress,
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whose levels fell to below baseline, and greatest
in the group which had the extra glucose reserve.
It was clear that the extra glucose enabled the
a-
subjects to overcome the effect of the noise, and
maintain their performance level but in doing this
glucose reserves were markedly depleted. Thus by
the use of several lines of approach a more complete
picture can be constructed and interpretation can
become more reliable.
In conclusion, perhaps it may be said that
large-scale general theories similar to those outlined
earlier, may be of less use in the attempt to under¬
stand some of the problems, factors and mechanisms
involved in this field of research than the more
empirical approach involved in the use of limited
theories. The diversity of action and discipline
effect of drugs which have similar therapeutic effects
has been shown by a number of research workers using a
large selection of measures. It is suggested that a
more harmonious and realistic approach should be taken
to assess the effects of drugs. Thus certain basic
principles would be followed. First, tests would be
used which have been shown to be sensitive to drug
effects and which realistically measure skills employed
in either everyday or working life, e.g. driving,
flying, etc. In this way the extent of disruption can
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be assessed practically and the effects of new drugs
can be assessed in comparison with established ones.
Second, design of experiments would take notice of,
and attempt to elucidate the effects of factors such
as individual differences and drugs which are commonly
taken, e.g. nicotine and alcohol. Third, drugs
would be assessed using subjects in the age group
for which the drug is, or will be, principally
prescribed. Fourth, the effects of drugs would be
assessed according to the way they are prescribed.
Thus evaluation of hypnotics should allow for periods
of continued administration with assessment at
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